TOKEN	PREDICTED
The	O
incidence	O
of	O
vitamin	O
D	O
deficiency	O
(˂	O
50	O
nmol	O
/	O
L	O
)	O
is	O
frequent	O
among	O
pregnant	O
women	O
even	B
in	O
areas	O
such	O
as	O
Australia	O
and	O
the	O
North	O
Island	O
of	O
New	O
Zealand	O
where	O
sunlight	O
exposure	O
is	O
high	O
.	O

Pollutants	O
,	O
selective	O
serotonin	O
reuptake	O
inhibitors	O
,	O
artificial	O
insemination	O
,	O
and	O
fertility	O
medications	O
may	B
have	O
a	O
link	B
,	O
but	O
results	O
are	O
often	O
conflicted	B
.	O

The	O
present	O
study	O
was	O
approved	O
by	O
the	O
Ethics	O
Committee	O
of	O
Shiraz	O
University	O
of	O
Medical	O
Sciences	O
with	O
the	O
ethics	O
code	O
93	O
–	O
7212	O
.	O

The	O
health	O
centres	O
are	O
run	O
by	O
senior	O
nurses	O
or	O
midwives	O
(	O
Head	O
of	O
centres	O
)	O
with	O
the	O
exception	O
of	O
Muea	O
health	O
centre	O
which	O
is	O
headed	O
by	O
a	O
medical	O
doctor	O
.	O

This	O
observation	O
is	O
similar	B
to	I
that	O
seen	O
in	O
Uganda	O
[	O
17	O
]	O
and	O
Zimbabwe	O
[	O
18	O
]	O
where	O
it	O
was	O
also	B
shown	I
that	O
the	O
quality	O
of	O
care	O
provided	O
was	O
contributory	B
.	O

Individuals	O
with	O
a	O
BMI	O
above	O
30	O
kg	O
/	O
m2are	O
classified	O
as	O
obese	O
;	O
those	O
with	O
a	O
BMI	O
between	O
25	O
and	O
30	O
kg	O
/	O
m2are	O
considered	O
to	O
be	O
overweight	O
.	O

Effects	B
of	O
dietary	O
energy	O
(	O
TDN	O
:	O
70	O
%,	O
80	O
%;	O
DM	O
basis	O
)	O
and	O
protein	O
levels	O
(	O
crude	O
protein	O
[	O
CP	O
]:	O
11	O
.	O
9	O
%,	O
14	O
.	O
3	O
%;	O
DM	O
basis	O
)	O
on	O
growth	O
performance	O
,	O
carcass	O
characteristics	O
and	O
meat	O
quality	O
were	O
examined	O
in	O
F1	O
Angus	O
×	O
Chinese	O
Xiangxi	O
yellow	O
cattle	O
[	O
125	O
].	O

Three	O
independent	O
reports	O
have	O
observed	O
a	O
peak	O
risk	O
for	O
winter	O
births	O
[	O
16	O
–	O
18	O
],	O
while	B
no	O
seasonal	O
variation	O
for	O
risk	O
was	O
noted	O
in	O
two	O
other	O
epidemiologic	O
studies	O
[	O
19	O
,	O
20	O
].	O

Alcohol	O
Alcohol	O
intake	O
should	B
be	I
avoided	O
by	O
the	O
pregnant	O
mother	O
because	B
of	O
well	B
-	I
known	I
toxic	O
effects	B
on	O
both	O
mother	O
and	O
fetus	O
.	O

This	O
tissue	O
also	O
responds	O
to	O
insulin	O
with	O
a	O
5	O
-	O
fold	O
increase	O
in	O
glucose	O
uptake	O
,	O
without	O
any	O
change	O
in	O
blood	O
flow	O
(	O
Orava	O
et	O
al	O
.,	O
2011	O
),	O
while	O
under	O
cold	O
exposure	O
,	O
glucose	O
uptake	O
increases	O
by	O
12	O
-	O
folds	O
,	O
dissipating	O
energy	O
as	O
a	O
function	O
of	O
increased	O
blood	O
flow	O
(	O
Orava	O
et	O
al	O
.,	O
2011	O
).	O

A	O
number	B
of	O
techniques	O
have	B
been	I
described	O
in	O
the	O
assessment	O
of	O
early	O
infant	O
body	O
composition	O
.	O

4	O
.	O

Adverse	O
environmental	O
conditions	O
during	O
fetal	O
development	O
provoke	B
an	O
intrauterine	O
adaptive	O
response	O
termed	O
'	O
fetal	O
programming	O
',	O
which	O
may	B
lead	O
to	O
both	O
persistently	O
biased	O
responsiveness	O
to	O
extrinsic	O
factors	O
and	O
permanent	O
consequences	O
for	O
the	O
organismal	O
phenotype	O
.	O

Those	O
interested	O
,	O
receive	O
a	O
study	O
information	O
leaflet	O
and	O
are	O
screened	O
for	O
eligibility	O
individually	O
in	O
a	O
private	O
space	O
upon	O
which	O
a	O
booking	O
date	O
is	O
supplied	O
if	O
eligible	O
.	O

Cluster	O
1	O
is	O
the	O
reference	O
group	O
.	O

The	O
vitamin	O
D3and	O
the	O
placebo	O
were	O
the	O
same	O
colour	O
(	O
pale	O
yellow	O
),	O
taste	O
,	O
and	O
quantity	O
(	O
0	O
·	O
5	O
mL	O
)	O
and	O
therefore	O
the	O
study	O
staff	O
and	O
the	O
families	O
did	O
not	O
know	O
to	O
which	O
group	O
the	O
children	O
were	O
assigned	O
.	O

This	O
may	B
be	I
attributable	O
to	O
the	O
synergistic	O
effects	B
of	O
food	O
[	O
34	O
]	O
and	O
associated	B
with	O
fish	O
being	O
a	O
source	O
of	O
other	B
nutrients	O
which	O
are	O
important	B
for	O
infant	O
development	O
such	O
as	O
iodine	O
and	O
vitamin	O
D	O
.	O
Presently	O
,	O
there	O
have	B
been	I
no	B
randomised	O-
control	O-
trials	I
examining	O
neurocognitive	O
outcomes	O
associated	B
with	O
prenatal	O
multivitamin	O
use	O
and	O
infant	O
neurodevelopment	O
,	O
and	O
these	O
are	O
unlikely	B
to	O
occur	O
given	O
ethical	O
implications	B
of	O
such	O
[	O
35	O
].	O

Although	B
a	O
weak	O
correlation	B
was	O
found	B
between	O
poor	O
intrauterine	O
environments	O
and	O
ASD	O
with	O
intellectual	O
disabilities	O
,	O
there	O
was	O
no	O
relationship	O
found	O
between	O
ASD	O
without	O
intellectual	O
disabilities	O
and	O
perinatal	O
factors	O
[	O
12	O
].	O

Hypothalamic	O
Gene	O
Expression	O
Each	O
dissected	O
hypothalamus	O
was	O
homogenized	O
using	O
a	O
tissue	O
ruptor	O
homogenizer	O
(	O
Qiagen	O
Tech	O
.,	O
Mississauga	O
,	O
ON	O
,	O
Canada	O
).	O

In	B
order	I
to	I
contribute	O
to	O
a	O
comprehensive	O
inventory	O
of	O
genes	O
and	O
functional	O
networks	O
that	O
are	O
targets	O
of	O
nutritional	O
programming	O
initiated	O
during	O
fetal	O
life	O
,	O
we	O
applied	O
whole	O
-	O
genome	O
microarrays	O
for	O
expression	O
profiling	O
in	O
a	O
longitudinal	O
experimental	O
design	O
covering	O
prenatal	O
,	O
perinatal	O
,	O
juvenile	O
and	O
adult	O
ontogenetic	O
stages	O
in	O
a	O
porcine	O
model	O
.	O

Eighty	O
-	O
four	O
cases	O
(	O
85	O
.	O
7	O
%)	O
took	O
Vitamin	O
D	O
supplements	O
with	O
duration	O
of	O
2w	O
-	O
31w	O
,	O
and	O
with	O
average	O
daily	O
intake	O
dose	O
of	O
517	O
.	O
5	O
±	O
113	O
.	O
1	O
IU	O
.	O

According	O
to	O
Du	O
et	O
al	O
[	O
16	O
],	O
this	O
adipogenesic	O
phase	O
extends	O
to	O
the	O
neonatal	O
period	O
for	O
abdominal	O
adipocytes	O
,	O
to	O
the	O
early	O
weaning	O
stage	O
for	O
subcutaneous	O
and	O
intermuscular	O
adipocytes	O
,	O
and	O
to	O
around	O
250	O
d	O
of	O
age	O
for	O
IMF	O
.	O

The	O
coordination	O
of	O
several	O
factors	O
affects	B
IMF	O
deposition	O
.	O

Macrosomia	O
,	O
shoulder	O
dystocia	O
with	O
its	O
attendant	O
risks	O
of	O
brachial	O
plexus	O
injury	O
and	O
clavicle	O
fracture	O
,	O
and	O
neonatal	O
hypoglycemia	O
are	O
the	O
serious	B
complications	B
which	O
most	B
commonly	I
occur	O
.	O
6	O
–	O
11Jaundice	O
,	O
polycythemia	O
,	O
respiratory	O
distress	O
,	O
and	O
hypocalcemia	O
have	B
also	O-
been	I
reported	B
.	O

There	O
were	O
1754	O
infants	O
who	O
were	O
assessed	O
at	O
6	O
months	O
of	O
age	O
(	O
Lifestyle	O
Advice	O
n	O
=	O
869	O
;	O
Standard	O
Care	O
n	O
=	O
885	O
),	O
representing	O
82	O
.	O
1	O
%	O
of	O
the	O
eligible	O
sample	O
.	O

Supplementary	O
materialERJ	O
-	O
00073	O
-	O
2017_Supplement	O
Disclosures10	O
.	O
1183	O
/	O
13993003	O
.	O
00073	O
-	O
2017	O
.	O
Supp2	O
A	O
.	O
BédardERJ	O
-	O
00073	O
-	O
2017_Bedard	O
A	O
.	O
J	O
.	O

This	O
was	O
mediated	O
by	O
phosphorylation	O
of	O
the	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
3	O
(	O
pSTAT3	O
).	O

No	O
effects	O
of	O
diet	O
and	O
sex	O
were	O
detected	O
,	O
but	O
interaction	B
between	O
time	O
and	O
diet	O
was	O
significant	O
[	O
F	O
(	O
22	O
,	O
145	O
)=	O
11	O
.	O
27	O
,	O
P	O
<	O
0	O
.	O
001	O
].	O

Currently	O
,	O
the	O
ICDS	O
scheme	O
symbolizes	O
one	O
of	O
the	O
most	O
extensive	O
and	O
the	O
unique	O
initiative	O
for	O
safeguarding	O
early	O
childhood	O
development	O
,	O
catering	O
to	O
more	O
than	O
100	O
million	O
under	O
-	O
six	O
year	O
children	O
under	O
the	O
different	O
provisions	O
available	O
in	O
the	O
scheme	O
(	O
2	O
).	O

Sleep	O
was	O
assessed	O
using	O
the	O
General	O
Sleep	O
Disturbance	O
questionnaire	O
[	O
30	O
].	O

Further	O
investigation	O
of	O
potential	O
confounding	O
/	O
mediation	O
of	O
main	O
findings	O
and	O
sensitivity	O
analyses	O
Additional	O
separate	O
adjustment	O
for	O
maternal	O
pre	O
-	O
pregnancy	O
BMI	O
,	O
gestational	O
age	O
at	O
delivery	O
,	O
birthweight	O
,	O
maternal	O
weight	O
gain	O
during	O
pregnancy	O
and	O
child	O
'	O
s	O
BMI	O
at	O
age	O
7	O
years	O
did	B
not	I
substantially	O
alter	O
the	O
main	O
findings	O
and	O
therefore	B
no	O
further	O
formal	O
mediation	O
analysis	O
was	O
conducted	O
(	O
supplementary	O
table	O
E3	O
).	O

Similarly	O
as	O
in	O
our	O
pregnant	O
women	O
population	O
,	O
in	O
the	O
adult	O
population	O
the	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
was	O
higher	O
in	O
winter	O
than	O
in	O
summer	O
and	O
increased	O
with	O
BMI	O
[	O
36	O
],[	O
37	O
],[	O
44	O
],[	O
45	O
],[	O
46	O
].	O

Detecting	O
a	O
thyroid	O
cancer	O
during	O
pregnancy	O
should	B
not	I
be	I
a	O
reason	O
for	O
termination	O
of	O
pregnancy	O
,	O
and	O
in	O
the	O
large	O
majority	B
of	O
cases	O
it	O
does	O
not	O
require	I
urgent	O
surgery4	O
.	O

Cost	O
-	O
effectiveness	O
analysis	O
The	O
economic	O
evaluation	O
will	O
take	O
a	O
societal	O
perspective	O
.	O

Humans	O
get	O
vitamin	O
D	O
(	O
cholecalciferol	O
)	O
from	O
exposure	O
to	O
sunlight	O
,	O
diet	O
and	O
dietary	O
supplements	O
.	O

On	O
the	O
contrary	B
to	O
the	O
above	O
mentioned	O
studies	O
,	O
Neilson	O
et	O
al	O
.,	O
in	O
a	O
case	O
–	O
control	O
study	O
,	O
found	B
that	O
an	O
increase	O
in	O
25	O
-	O
hydroxyvitamin	O
D	O
level	O
can	B
enhance	B
the	O
possibility	B
of	O
postnatal	O
depression	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Overall	O
,	O
the	O
sequence	O
of	O
events	O
in	O
this	O
patient	O
suggests	B
that	O
the	O
metabolic	O
and	O
trophic	O
effects	B
of	O
THs	O
on	O
BAT	O
may	B
play	O
a	O
critical	B
role	B
in	O
non	O
-	O
insulin	O
-	O
mediated	O
glucose	O
utilization	O
,	O
ultimately	B
leading	O
to	O
near	O
-	O
normal	O
glucose	O
levels	O
(	O
Skarulis	O
et	O
al	O
.,	O
2010	O
).	O

Therefore	B
,	O
there	O
is	O
a	O
need	B
to	O
establish	O
effective	O
and	O
safe	B
doses	O
of	O
supplemental	O
iron	O
with	O
folic	O
acid	O
either	B
as	O-
daily	O-
or	I
weekly	O
supplementation	O
;	O
this	O
should	B
take	O
into	O
consideration	B
nutritional	O
and	O
haematological	O
status	O
of	O
women	O
in	O
developing	O
countries	O
.	O

Based	B
on	I
these	O
considerations	B
,	O
we	O
aim	B
to	O
focus	B
on	O
the	O
long	O
-	O
term	O
effects	B
on	O
cannabinoid	O
-	O
related	B
behaviors	O
(	O
i	O
.	O
e	O
.,	O
cannabinoid	O
receptor	O
antagonist	O
-	O
induced	O
suppression	O
of	O
feeding	O
),	O
and	O
effects	B
on	O
lipid	O
-	O
related	B
metabolic	O
pathways	O
of	O
a	O
maternal	O
exposure	O
to	O
a	O
moderate	O
caloric	O
restriction	O
during	O
the	O
preconceptional	O
and	O
gestational	O
period	O
.	O

In	O
addition	O
,	O
a	O
significant	O
percentage	O
of	O
infants	O
from	O
families	O
with	O
an	O
atopic	O
background	O
do	O
not	O
develop	O
atopy	O
during	O
childhood	O
.	O

Mean	O
birth	O
weights	O
of	O
LP	O
newborn	O
piglets	O
used	O
for	O
microarray	O
analyses	O
were	O
numerically	O
lower	O
than	O
birth	O
weights	O
of	O
AP	O
offspring	O
(	O
LP	O
:	O
1	O
.	O
21	O
±	O
0	O
.	O
30	O
kg	O
,	O
AP	O
:	O
1	O
.	O
36	O
±	O
0	O
.	O
31	O
kg	O
,	O
P	O
=	O
0	O
.	O
08	O
,	O
n	O
=	O
32	O
).	O

Further	B
studies	B
should	B
be	I
performed	O
to	O
clarify	O
the	O
role	B
of	O
the	O
endocannabinoid	O
system	O
and	O
other	B
homeostatic	O
mechanisms	O
implicated	B
in	O
the	O
process	O
of	O
nutritional	O
programming	O
.	O

A	O
diagnosis	O
of	O
1	O
)	O
sensitised	O
with	O
clinical	O
symptoms	O
,	O
2	O
)	O
sensitised	O
and	O
clinically	O
tolerant	O
,	O
3	O
)	O
sensitised	O
and	O
unknown	O
clinical	O
reactivity	O
,	O
4	O
)	O
not	O
sensitised	O
with	O
clinical	O
symptoms	O
,	O
5	O
)	O
unknown	O
sensitization	O
with	O
clinical	O
symptoms	O
or	O
6	O
)	O
not	O
sensitized	O
with	O
no	O
clinical	O
symptoms	O
is	O
made	O
.	O

An	O
adapted	O
questionnaire	O
previously	O
used	O
in	O
the	O
South	O
African	O
context	O
is	O
used	O
[	O
58	O
].	O

In	O
this	O
model	B
,	O
environmental	O
exposures	O
and	O
lifestyle	O
changes	O
that	O
occur	O
afterwards	O
play	O
a	O
mainly	B
secondary	O
role	B
to	O
the	O
programming	O
or	O
imprinting	O
that	O
occurs	O
during	O
pregnancy	O
and	O
/	O
or	O
early	O
infancy	O
[	O
14	O
,	O
15	O
].	O

Immediate	O
-	O
phase	O
type	O
I	O
allergic	O
symptoms	O
usually	B
occur	O
within	O
several	O
minutes	O
after	O
allergen	O
contact	O
.	O

Interpretations	O
Quarterly	O
bolus	O
doses	O
of	O
oral	O
vitamin	O
D3supplementation	O
to	O
infants	O
are	O
not	O
an	O
effective	O
intervention	O
to	O
reduce	O
the	O
incidence	O
of	O
pneumonia	O
in	O
infants	O
in	O
this	O
setting	O
.	O

In	O
addition	O
,	O
our	O
recent	B
research	I
has	B
shown	I
that	O
transport	O
stress	O
causes	O
temporal	O
increases	O
in	O
circulating	O
cortisol	O
and	O
NEFA	O
concentrations	O
,	O
along	O
with	O
a	O
decrease	O
in	O
circulating	O
TG	O
concentration	O
in	O
pregnant	O
Holstein	O
heifers	O
[	O
103	O
],	O
consistent	B
with	O
transport	O
stress	O
also	O
causing	O
lipolysis	O
.	O

If	B
this	O
is	O
the	O
case	O
,	O
adult	O
health	O
outcomes	O
may	B
reflect	O
season	O
of	O
birth	O
if	B
food	O
intake	O
is	O
seasonal	O
,	O
and	O
if	B
exposure	O
occurs	O
at	O
a	O
critical	O
stage	O
of	O
fetal	O
development	O
.	O

furthered	B
our	I
understanding	I
of	O
the	O
effects	B
of	O
paternal	O
folate	O
deficiency	O
[	O
6	O
].	O

First	O
,	O
pregnant	O
women	O
were	O
briefed	O
on	O
the	O
study	O
objectives	O
and	O
the	O
confidentiality	O
of	O
maternal	O
and	O
neonatal	O
information	O
,	O
and	O
they	O
then	O
signed	O
informed	O
consents	O
.	O

Pre	O
-	O
pregnancy	O
BMI	O
based	O
on	O
pre	O
-	O
pregnancy	O
weight	O
was	O
calculated	O
using	O
the	O
following	O
equation	O
as	O
defined	O
by	O
the	O
World	O
Health	O
Organization	O
:	O
weight	O
/	O
height2	O
.	O

The	O
main	O
aim	B
was	O
to	O
study	O
factors	O
identified	O
in	O
a	O
previous	B
study	I
as	O
potentially	B
causally	O
related	B
to	O
cancer	O
of	O
the	O
oesophagus	O
.	O

For	O
example	O
,	O
the	O
maternal	O
aMED	O
score	O
was	O
consistently	B
positively	O
and	O
negatively	O
associated	B
with	O
the	O
Enterobacteriaceae	O
family	O
,	O
and	O
additionally	O
negatively	O
associated	B
with	O
the	O
species	O
Escherichia	O
coli	O
,	O
in	O
both	O
delivery	O
mode	O
strata	O
.	O

Thus	B
,	O
the	O
majority	B
of	O
whole	O
system	O
studies	O
have	O
been	O
performed	O
in	O
animal	O
models	B
,	O
predominantly	O
rodents	O
.	O

In	O
our	O
setting	O
,	O
family	O
planning	O
and	O
care	O
of	O
the	O
newborn	O
are	O
usually	O
discussed	O
in	O
Infant	O
Welfare	O
Clinic	O
.	O

Results	O
The	O
two	O
groups	O
were	O
similar	B
in	O
relation	B
to	O
baseline	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
.	O

These	O
disparities	B
may	B
have	B
been	I
due	B
to	I
the	O
use	O
of	O
different	B
routes	O
of	O
administration	O
and	O
variations	B
in	O
rat	O
strains	O
/	O
stocks	O
.	O

Routine	O
use	O
of	O
iron	O
supplements	O
is	O
common	O
,	O
as	B
it	O
is	O
difficult	B
to	O
ensure	O
adequate	O
intake	O
from	O
food	O
sources	O
,	O
even	B
from	O
those	O
with	O
relatively	O
high	O
iron	O
bioavailability	O
[	O
29	O
,	O
30	O
].	O

Between	O
birth	O
and	O
6	O
months	O
,	O
the	O
percentage	O
of	O
children	O
with	O
WFA	O
>	O
90th	O
percentile	O
declined	O
slightly	O
in	O
overweight	O
/	O
obese	O
mothers	O
(	O
from	O
19	O
.	O
6	O
%	O
to	O
17	O
.	O
6	O
%)	O
but	O
increased	O
from	O
7	O
%	O
to	O
15	O
%	O
in	O
the	O
offspring	O
of	O
normal	O
weight	O
mothers	O
(	O
Table	O
1	O
).	O

According	O
to	O
the	O
Lambda	O
test	O
,	O
this	O
correlation	B
was	O
significantly	O
greater	O
in	O
group	O
A	O
than	O
in	O
group	O
B	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

There	O
were	O
nine	O
cases	O
of	O
IUFD	O
at	O
gestational	O
week	O
≥	O
22	O
+	O
0	O
.	O

There	O
was	O
insufficient	B
case	O-
information	I
available	O
to	O
assess	O
any	O
causal	O
association	B
between	O
the	O
allergic	O
reaction	O
and	O
the	O
fetal	O
loss	O
.	O

The	O
main	O
positive	O
findings	O
of	O
our	O
study	O
are	O
summarised	O
infigure	O
1	O
.	O

It	O
is	O
the	O
precursor	O
to	O
form	O
25	O
-	O
hydroxyvitamin	O
D3	O
[	O
25	O
(	O
OH	O
)	O
D3	O
],	O
a	O
prehormone	O
,	O
which	O
is	O
ultimately	O
converted	O
to	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3	O
[	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
],	O
one	O
of	O
the	O
most	O
potent	O
steroid	O
hormones	O
known	O
.	O

The	O
inclusion	O
criteria	O
applied	O
during	O
recruitment	O
screening	O
are	O
:	O
1	O
)	O
Confirmed	O
pregnancy	O
and	O
planning	O
to	O
deliver	O
her	O
baby	O
at	O
RMMCH	O
;	O
2	O
)	O
<	O
18	O
weeks	O
’	O
gestational	O
age	O
;	O
3	O
)	O
Born	O
in	O
South	O
Africa	O
,	O
Lesotho	O
,	O
Swaziland	O
,	O
Zimbabwe	O
,	O
Botswana	O
or	O
Namibia	O
and	O
has	O
been	O
living	O
in	O
South	O
Africa	O
for	O
at	O
least	O
12	O
months	O
;	O
4	O
)	O
Able	O
to	O
communicate	O
effectively	O
in	O
one	O
of	O
the	O
following	O
languages	O
:	O
English	O
,	O
Afrikaans	O
,	O
Sotho	O
,	O
Zulu	O
or	O
Xhosa	O
.	O

Prenatal	O
folic	O
acid	O
supplements	O
have	B
been	I
shown	I
to	O
reduce	O
the	O
risk	O
of	O
neural	O
tube	O
defects	O
in	O
children	O
and	O
are	O
associated	B
with	O
a	O
lower	O
risk	O
of	O
autistic	O
disorder	O
[	O
32	O
].	O

Avoidance	O
of	O
Other	O
Allergens	O
During	O
Pregnancy	O
Avoidance	O
of	O
other	O
allergens	O
is	O
necessary	B
only	B
if	B
the	O
pregnant	O
patients	O
are	O
already	O
sensitized	O
(	O
eg	O
,	O
to	O
cats	O
,	O
dogs	O
,	O
horses	O
,	O
or	O
house	O
dust	O
).	O

SGA	O
was	O
defined	O
as	O
weight	O
and	O
/	O
or	O
length	O
at	O
birth	O
<	O
2	O
SD	O
of	O
the	O
population	O
mean	O
and	O
LBW	O
as	O
<	O
2500	O
g	O
.	O
Preterm	O
delivery	O
was	O
defined	O
as	O
delivery	O
<	O
37	O
+	O
0	O
gestational	O
weeks	O
and	O
pregnancy	O
loss	O
as	O
spontaneous	O
abortion	O
or	O
intrauterine	O
fetal	O
death	O
.	O

Discussion	O
Season	O
of	O
birth	O
in	O
its	O
own	O
right	O
cannot	B
be	I
deemed	I
a	O
cause	O
for	O
glioma	O
.	O

Similarly	B
,	O
animal	O
studies	O
documented	B
normoweight	O
at	O
birth	O
when	O
the	O
early	O
pregnancy	O
was	O
conducted	O
under	O
caloric	O
restriction	O
(	O
Cleal	O
et	O
al	O
.,	O
2007	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Poore	O
et	O
al	O
.,	O
2010	O
).	O

As	O
shown	O
in	O
Table	O
1	O
,	O
the	O
age	O
was	O
33	O
.	O
4	O
±	O
4	O
.	O
1	O
years	O
old	O
(	O
ranges	O
from	O
24	O
to	O
46	O
years	O
old	O
),	O
the	O
gestational	O
weeks	O
were	O
29	O
.	O
0	O
±	O
3	O
.	O
3	O
weeks	O
(	O
ranges	O
from	O
14	O
to	O
39	O
weeks	O
),	O
pre	O
-	O
pregnancy	O
BMI	O
was	O
23	O
.	O
0	O
±	O
3	O
.	O
7	O
(	O
ranges	O
from	O
15	O
.	O
6	O
to	O
37	O
.	O
2	O
)	O
kg	O
/	O
m2	O
.	O

The	O
study	O
was	O
approved	O
by	O
the	O
Institutional	O
Review	O
Boards	O
at	O
the	O
Miriam	O
Hospital	O
,	O
in	O
Providence	O
,	O
RI	O
.,	O
Women	O
and	O
Infants	O
Hospital	O
of	O
Rhode	O
Island	O
Providence	O
,	O
RI	O
and	O
California	O
Polytechnic	O
State	O
University	O
,	O
in	O
San	O
Luis	O
Obispo	O
,	O
Calif	O
.	O
2	O
.	O
2	O
.	O

The	O
observed	O
transcriptional	O
postnatal	O
regulations	O
were	O
delayed	O
long	O
-	O
term	O
effects	B
of	O
the	O
prenatal	O
nutritional	O
supply	O
.	O

According	O
to	O
this	O
,	O
AM251	O
was	O
specifically	O
able	O
to	O
reduce	O
chocolate	O
intake	O
in	O
CC	O
male	O
offspring	O
,	O
but	O
not	O
in	O
CC	O
females	O
or	O
RC	O
males	O
.	O

Patients	O
with	O
MTC	O
whose	O
tumours	O
deriving	O
from	O
C	O
cells	O
are	O
not	O
TSH	O
-	O
dependent	O
do	O
not	O
require	I
suppressive	O
therapy	O
,	O
but	B
only	I
thyroxine	O
replacement	O
therapy	O
after	O
surgery	O
,	O
and	O
the	O
dosages	O
are	O
the	O
same	O
as	O
those	O
used	O
for	O
hypothyroidism	O
.	O

In	O
contrast	O
maternal	O
intakes	O
of	O
carbohydrate	O
were	O
negatively	O
associated	B
with	O
infant	O
length	O
and	O
abdominal	O
circumference	O
[	O
26	O
].	O

Concerning	O
the	O
potential	B
explanations	B
of	O
the	O
differential	B
phenotypic	O
features	O
between	O
males	O
and	O
females	O
,	O
the	O
leptin	O
sensibility	O
can	B
play	O
an	O
important	B
role	B
.	O

This	O
test	O
allows	O
us	O
to	O
measure	O
food	O
intake	O
,	O
chocolate	O
preference	O
as	O
well	O
as	O
to	O
detect	O
the	O
development	O
of	O
inflexible	O
feeding	O
behavior	O
.	O

No	B
data	I
are	O-
available	I
as	O
yet	O
with	O
regard	O
to	O
the	O
impact	B
of	O
early	O
leptin	O
administration	O
on	O
the	O
subsequent	O
“	O
browning	O
”	O
of	O
WAT	O
and	O
the	O
related	B
regulation	O
of	O
glucose	O
metabolism	O
,	O
as	O
well	O
as	O
the	O
response	O
to	O
hypercaloric	O
diets	O
later	O
in	O
life	O
in	O
the	O
offspring	O
.	O

Normal	O
weight	O
and	O
overweight	O
/	O
obese	O
categories	O
were	O
based	O
on	O
the	O
1990	O
IOM	O
cut	O
points	O
[	O
17	O
]:	O
normal	O
weight	O
BMI	O
=	O
19	O
.	O
8	O
to	O
26	O
.	O
0	O
or	O
overweight	O
/	O
obese	O
BMI	O
26	O
.	O
1	O
–	O
40	O
.	O
0	O
[	O
17	O
].	O

Background	O
Gestational	O
diabetes	O
(	O
GDM	O
)	O
is	O
defined	O
as	O
“	O
carbohydrate	O
intolerance	O
with	O
onset	O
or	O
first	O
recognition	O
during	O
pregnancy	O
”.	O
1Large	O
studies	O
have	O
found	B
that	O
GDM	O
occurs	O
in	O
2	O
.	O
2	O
%–	O
8	O
.	O
8	O
%	O
of	O
pregnancies	O
,	O
depending	B
on	I
the	O
ethnic	O
mix	O
of	O
the	O
population	O
and	O
the	O
criteria	O
used	O
for	O
diagnosis	O
.	O
2In	B
some	B
specific	O
populations	O
however	B
,	O
the	O
incidence	O
can	B
be	O
considerably	B
higher	O
.	O

Phylogenetic	O
trees	O
were	O
constructed	O
using	O
the	O
FastTree	O
method	O
[	O
41	O
].	O

Understanding	O
the	O
factors	O
affecting	B
IMF	O
deposition	O
and	O
the	O
mechanisms	O
responsible	O
for	O
its	O
deposition	O
is	O
important	B
when	O
manipulating	O
IMF	O
deposition	O
.	O

She	O
denied	O
contractions	O
,	O
vaginal	O
bleeding	O
,	O
or	O
leakage	O
of	O
fluid	O
.	O

Intravenous	O
epinephrine	O
may	B
be	I
required	B
despite	B
its	O
potential	B
to	O
cause	O
decreased	O
uteroplacental	O
blood	O
flow	O
.	O

Further	O
,	O
the	O
various	O
chapters	O
in	O
the	O
book	O
explain	O
the	O
basic	O
principles	O
in	O
nutrition	O
coupled	O
with	O
applications	O
in	O
different	O
clinical	O
conditions	O
.	O

Excluding	O
infants	O
who	O
may	O
have	O
received	O
antibiotics	O
,	O
or	O
those	O
delivered	O
prematurely	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S10	O
,	O
Figure	O
S7a	O
),	O
did	O
not	O
qualitatively	O
change	O
the	O
results	O
.	O

Using	O
data	O
from	O
a	O
U	O
.	O
S	O
.	O
national	O
study	O
on	O
the	O
health	O
effects	O
of	O
prenatal	O
diethylstilbestrol	O
exposure	O
,	O
a	O
team	O
of	O
researchers	O
reported	O
in	O
the	O
11	O
January	O
2008	O
advance	O
access	O
edition	O
of	O
the	O
American	O
Journal	O
of	O
Epidemiology	O
that	O
study	O
participants	O
who	O
had	O
never	O
smoked	O
cigarettes	O
but	O
had	O
been	O
prenatally	O
exposed	O
to	O
maternal	O
cigarette	O
smoke	O
experienced	O
earlier	O
-	O
onset	O
menopause	O
.	O

showed	B
a	O
statistically	O
significant	O
increase	O
in	O
autism	O
and	O
other	O
mental	O
health	O
disorders	O
following	O
ovulation	O
induction	O
[	O
41	O
].	O

Of	O
all	O
pregnant	O
women	O
included	O
,	O
640	O
were	O
in	O
the	O
first	O
,	O
666	O
were	O
in	O
the	O
third	O
and	O
2	O
were	O
in	O
the	O
second	O
trimester	O
of	O
pregnancy	O
.	O

Therefore	O
,	O
the	O
transcriptional	O
control	O
of	O
cyclins	O
provides	O
an	O
additional	O
level	O
of	O
growth	O
regulation	O
.	O

IMF	O
deposition	O
can	B
positively	O
affect	B
beef	O
taste	O
including	O
tenderness	O
and	O
flavor	O
,	O
favoring	O
highly	O
marbled	O
beef	O
.	O

Unfortunately	B
,	O
we	O
do	B
not	I
have	I
information	O
about	O
specific	O
vitamin	O
D	O
supplementation	O
.	O

Following	O
weaning	O
,	O
steers	O
were	O
grown	O
with	O
a	O
forage	O
-	O
only	O
system	O
and	O
forage	O
with	O
high	O
-	O
energy	O
supplemented	O
system	O
to	O
test	O
effects	B
of	O
a	O
high	O
-	O
energy	O
grain	O
-	O
based	O
substitution	O
on	O
fat	O
deposition	O
with	O
5	O
times	O
serial	O
slaughter	O
.	O

Rojroongwasonkul	O
et	O
al	O
.	O

In	O
addition	O
,	O
not	O
all	O
of	O
the	O
spermatozoal	O
histones	O
are	O
replaced	O
with	O
protamines	O
during	O
spermiogenesis	O
,	O
up	O
to	O
15	O
%	O
of	O
histones	O
within	O
human	O
spermatozoa	O
and	O
1	O
%	O
in	O
mouse	O
spermatozoa	O
are	O
retained	O
(	O
Miller	O
et	O
al	O
.	O
2010	O
;	O
Carrell2012	O
).	O

This	O
data	O
-	O
driven	O
clustering	O
allowed	O
us	O
to	O
define	O
stable	O
classes	O
of	O
CpG	O
loci	O
demonstrating	O
similar	O
patterns	O
of	O
methylation	O
,	O
which	O
we	O
used	O
to	O
examine	O
associations	O
between	O
methylation	O
of	O
these	O
classes	O
of	O
CpGs	O
and	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
.	O

A	O
meta	O
-	O
analysis	O
of	O
prospective	O
observational	O
studies	O
,	O
reported	B
reductions	O
in	O
perinatal	O
mortality	O
(	O
stillbirth	O
and	O
early	O
neonatal	O
mortality	O
)	O
with	O
each	O
1	O
g	O
/	O
dl	O
increase	O
in	O
the	O
population	O
mean	O
haemoglobin	O
(	O
RR	O
0	O
.	O
72	O
,	O
95	O
%	O
CI	O
:	O
0	O
.	O
65	O
–	O
0	O
.	O
81	O
)	O
[	O
9	O
].	O

Spearman	O
Rank	O
correlation	O
test	O
showed	O
a	O
negative	O
significant	O
relationship	B
between	O
second	O
trimester	O
visfatin	O
level	O
and	O
birth	O
height	O
(	O
p	O
=	O
0	O
.	O
015	O
,	O
r	O
=-	O
0	O
.	O
523	O
)	O
in	O
group	O
B	O
(	O
Table	O
2	O
).	O

However	B
,	O
according	B
to	I
national	O
figures	O
from	O
the	O
National	O
Food	O
Administration	O
,	O
a	O
low	O
number	O
of	O
Swedish	O
women	O
took	O
fish	O
oil	O
supplements	O
(	O
1	O
%)	O
at	O
the	O
time	O
of	O
the	O
study	O
.	O

Conversely	B
,	O
the	O
two	O
studies	O
by	O
Oken	O
et	O
al	O
.	O

Considering	B
cut	O
-	O
off	O
point	O
of	O
≥	O
9	O
,	O
data	O
analysis	O
showed	B
that	O
a	O
lot	O
of	O
participants	O
(	O
more	O
than	O
50	O
%)	O
were	O
susceptible	O
to	O
prenatal	O
depression	O
at	O
26	O
–	O
28	O
weeks	O
.	O

Furthermore	O
,	O
the	O
divergence	O
of	O
results	O
observed	O
between	O
LINE	O
-	O
1	O
and	O
AluYb8	O
reported	O
throughout	O
this	O
work	O
suggests	B
that	O
these	O
repetitive	O
element	O
methylation	O
markers	O
are	O
distinct	O
measures	O
and	O
may	B
not	O
represent	O
true	O
,	O
and	O
potentially	B
interchangeable	O
,	O
surrogates	O
of	O
“	O
global	O
”	O
methylation	O
.	O

Bile	O
salts	O
are	O
amphipathic	O
compounds	O
that	O
act	O
as	O
biological	O
detergents	O
,	O
converting	O
dietary	O
fats	O
into	O
mixed	O
micelles	O
of	O
bile	O
salts	O
and	O
TGs	O
[	O
109	O
].	O

The	O
masked	O
radiographs	O
were	O
read	O
by	O
two	O
independent	O
paediatric	O
radiologists	O
(	O
based	O
at	O
the	O
Acute	O
Respiratory	O
Infections	O
Unit	O
of	O
the	O
Pakistan	O
Institute	O
of	O
Medical	O
Sciences	O
),	O
experienced	O
in	O
reading	O
paediatric	O
chest	O
radiographs	O
from	O
WHO	O
vaccine	O
trials	O
,	O
with	O
WHO	O
proformas	O
for	O
standardised	O
interpretation	O
of	O
paediatric	O
chest	O
radiographs	O
for	O
the	O
diagnosis	O
of	O
pneumonia	O
.	O
17In	O
case	O
of	O
disagreement	O
,	O
radiographs	O
were	O
read	O
by	O
a	O
third	O
independent	O
radiologist	O
and	O
most	O
decisions	O
were	O
accepted	O
.	O

proposed	B
that	O
permanent	O
changes	O
in	O
autonomic	O
tone	O
could	B
result	O
in	O
neurological	O
changes	O
in	O
the	O
fetus	O
,	O
especially	O
after	O
two	O
or	O
more	O
weeks	O
of	O
high	O
dose	O
β	O
2	O
adrenergic	O
receptor	O
agonist	O
exposure	O
.	O

This	O
group	O
often	B
uses	O
dietary	O
supplements	O
containing	O
Vitamin	O
D	O
.	O
They	O
also	O
have	O
a	O
Vitamin	O
D2	O
detection	B
rate	O
of	O
19	O
.	O
4	O
%,	O
which	O
can	B
be	O
explained	B
by	O
consuming	O
edible	O
fungi	O
or	O
supplements	O
containing	O
Vitamin	O
D2	O
.	O

of	O
regulated	O
probe	O
-	O
sets	O
private	O
to	O
AP	O
offspringNo	O
.	O

Lindberg	O
et	O
al	O
[	O
37	O
],	O
in	O
their	O
cross	O
sectional	O
study	O
of	O
6	O
,	O
799	O
Swedish	O
women	O
,	O
for	O
instance	O
,	O
reported	B
that	O
self	O
-	O
reported	O
snoring	O
and	O
excessive	O
daytime	O
sleepiness	O
was	O
an	O
independent	O
risk	O
factor	O
for	O
type	O
2	O
diabetes	O
(	O
OR	O
=	O
1	O
.	O
82	O
;	O
95	O
%	O
CI	O
0	O
.	O
97	O
-	O
3	O
.	O
43	O
).	O

The	O
majority	O
of	O
women	O
(	O
80	O
.	O
8	O
%)	O
were	O
married	O
.	O

In	B
order	I
to	I
further	I
explore	I
the	O
impact	B
of	O
DVD	O
on	O
brain	O
function	O
,	O
we	O
undertook	O
a	O
proteomic	O
study	O
of	O
the	O
nucleus	O
accumbens	O
.	O

Information	B
obtained	O
from	O
the	O
Finnish	O
prenatal	O
study	O
of	O
autism	O
and	O
autism	O
spectrum	O
disorders	O
correlated	B
advanced	O
paternal	O
age	O
with	O
an	O
increased	O
risk	O
of	O
ASD	O
[	O
10	O
].	O

Allergic	O
rhinitis	O
is	O
often	O
preexisting	O
but	O
may	B
occur	O
or	O
be	O
recognized	O
for	O
the	O
first	O
time	O
during	O
pregnancy	O
.	O

Women	O
with	O
T3	O
25OHD	O
≥	O
100	O
nmol	O
/	O
L	O
had	O
a	O
lower	O
OR	O
for	O
SGA	O
(	O
OR	O
=	O
0	O
.	O
32	O
,	O
p	O
=	O
0	O
.	O
031	O
)	O
compared	O
to	O
those	O
with	O
vitamin	O
D	O
deficiency	O
(<	O
30	O
nmol	O
/	O
L	O
).	O

Thus	B
,	O
we	O
do	B
not	B
know	I
the	O
stage	O
of	O
maturation	O
when	B
the	O
post	O
-	O
weaning	O
diets	O
altered	O
the	O
hypothalamus	O
.	O

Here	B
,	I
no	I
confounders	I
were	I
included	I
due	B
to	I
the	I
small	B
number	I
of	I
cases	O-
(	O
N	O-
=	I
9	O
).	I

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Frequency	O
of	O
distribution	O
of	O
health	O
topics	O
discussed	O
during	O
ANC	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
P	O
-	O
Value	O
of	O
the	O
different	O
service	O
satisfaction	O
rating	O
with	O
respect	O
to	O
the	O
educational	O
level	O
in	O
the	O
study	O
populationServicesFisher	O
'	O
s	O
exact	O
testp	O
-	O
valueReception0	O
.	O
091P	O
>	O
O	O
.	O
O5Sitting	O
area	O
comfort0	O
.	O
842Waiting	O
time4	O
.	O
357Staff	O
rapport1	O
.	O
838Competence	O
of	O
personnel0	O
.	O
672Health	O
talks5	O
.	O
43	O
Pregnancy	O
groups	O
There	O
was	O
a	O
statistically	O
significant	O
association	B
when	O
comparing	O
respondents	O
at	O
their	O
first	O
pregnancy	O
with	O
those	O
at	O
their	O
second	O
or	O
more	O
pregnancies	O
in	O
terms	O
of	O
their	O
satisfaction	O
ratings	O
;	O
the	O
sitting	O
area	O
comfort	O
(	O
F	O
=	O
7	O
.	O
052	O
;	O
P	O
=	O
0	O
.	O
04	O
),	O
competence	O
of	O
staff	O
(	O
F	O
=	O
8	O
.	O
92	O
,	O
P	O
=	O
0	O
.	O
02	O
)	O
and	O
health	O
talk	O
comprehensiveness	O
(	O
F	O
=	O
18	O
.	O
499	O
,	O
P	O
Number	O
of	O
Visits	O
at	O
the	O
time	O
of	O
study	O
There	O
was	O
no	O
statistically	O
significant	O
difference	O
when	O
the	O
service	O
rating	O
(	O
reception	O
,	O
sitting	O
area	O
comfort	O
,	O
waiting	O
time	O
,	O
staff	O
rapport	O
,	O
competence	O
of	O
personnel	O
and	O
health	O
talk	O
)	O
of	O
women	O
attending	O
their	O
second	O
visit	O
and	O
those	O
attending	O
subsequent	O
visits	O
was	O
compared	O
.	O

The	O
association	B
of	O
later	O
life	O
health	O
with	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
or	O
childhood	O
environmental	O
factors	B
has	O
led	O
to	I
the	O
“	O
Developmental	O
Origins	O
of	O
Health	O
and	O
Disease	O
”	O
(	O
DOHaD	O
)	O
hypothesis	B
(	O
Wadhwa	O
et	O
al	O
.	O
2009	O
).	O

RPMM	O
classes	O
were	O
labeled	O
using	O
a	O
series	O
of	O
numbers	O
,	O
ranging	O
from	O
1	O
to	O
16	O
(	O
with	O
class	O
1	O
having	O
the	O
lowest	O
methylation	O
level	O
and	O
class	O
16	O
having	O
the	O
highest	O
methylation	O
level	O
).	O

The	O
mother	O
is	O
given	O
medical	O
advice	O
and	O
referred	O
if	O
necessary	O
.	O

We	O
evaluated	O
confounding	B
due	B
to	I
several	O
maternal	O
characteristics	O
.	O

Our	O
recent	B
study	I
indicated	B
that	O
a	O
lower	O
ambient	O
temperature	O
decreased	O
growth	O
and	O
feed	O
efficiency	O
in	O
Korean	O
cattle	O
steers	O
[	O
78	O
].	O

The	O
research	O
that	O
ensued	O
found	B
significantly	O
different	B
results	O
between	O
population	O
-	O
based	O
studies	O
and	O
clinic	O
based	O
studies	O
.	O

The	O
second	O
section	O
covers	O
the	O
role	O
of	O
nutrition	O
in	O
pregnancy	O
and	O
lactation	O
,	O
exocrine	O
and	O
sports	O
as	O
also	O
food	O
allergy	O
.	O

Pre	O
-	O
pregnancy	O
nutritional	O
status	O
and	O
weight	O
gain	O
were	O
classified	O
according	O
to	O
the	O
Institute	O
of	O
Medicine	O
guidelines	O
.	O

They	O
drink	O
more	O
water	O
and	O
eat	O
more	O
foods	O
per	O
unit	O
of	O
body	O
weight	O
than	O
adults	O
and	O
will	O
therefore	O
ingest	O
more	O
toxins	O
from	O
well	O
water	O
and	O
agriculturally	O
treated	O
foods	O
[	O
33	O
,	O
34	O
].	O

Thus	O
,	O
the	O
amount	O
of	O
UCP1	O
increases	O
during	O
fetal	O
development	O
,	O
peaks	O
at	O
birth	O
,	O
before	O
declining	O
over	O
the	O
first	O
9	O
months	O
(	O
Lean	O
et	O
al	O
.,	O
1986	O
;	O
Tews	O
and	O
Wabitsch	O
,	O
2011	O
).	O

It	O
is	O
also	O
needed	O
for	O
bone	O
growth	O
and	O
bone	O
remodeling	O
by	O
osteoblasts	O
.	O

HELLP	O
syndrome	O
is	B
considered	I
a	O
spectrum	O
of	O
preeclampsia	O
.	O

The	O
study	O
investigates	O
the	O
indicated	O
variables	O
from	O
early	O
pregnancy	O
to	O
infants	O
up	O
to	O
12	O
months	O
.	O

This	O
limits	B
the	O
accuracy	O
of	O
a	O
quantifiable	O
conclusion	O
as	O
due	B
to	I
individual	O
variability	B
in	O
the	O
perception	O
of	O
a	O
‘	O
serving	O
size	O
’.	O

If	O
a	O
child	O
was	O
not	O
seen	O
for	O
more	O
than	O
45	O
days	O
,	O
at	O
the	O
two	O
weekly	O
visits	O
,	O
or	O
at	O
the	O
hospital	O
,	O
they	O
were	O
censored	O
for	O
that	O
period	O
of	O
our	O
study	O
.	O

A	O
rise	O
in	O
Nampt	O
leads	O
to	O
higher	O
concentrations	O
of	O
NAD	O
+	O
and	O
higher	O
activity	O
of	O
SIRT1	O
.	O

Given	B
the	O
rarity	B
of	O
some	B
infections	O
and	O
brain	O
tumors	O
,	O
the	O
interpretability	O
of	O
seasonal	O
patterns	O
,	O
or	O
the	O
lack	B
thereof	O
,	O
may	B
be	I
confounded	B
by	O
time	O
-	O
and	O
/	O
or	O
space	O
-	O
dependent	O
factors	O
[	O
126	O
].	O

In	O
the	O
second	O
experiment	O
(	O
EXP2	O
)	O
offspring	O
selected	O
for	O
the	O
postnatal	O
time	O
points	O
was	O
born	O
to	O
primiparous	O
sows	O
after	O
prostaglandin	O
induction	O
of	O
parturition	O
as	O
described	O
[	O
15	O
]	O
and	O
farrowed	O
after	O
mean	O
pregnancy	O
duration	O
of	O
115	O
days	O
.	O

In	B
contrast	I
,	O
the	O
decreased	O
gene	O
expression	O
of	O
the	O
2	O
-	O
AG	O
-	O
synthesizing	O
enzymes	O
Dagl	O
α	O
and	O
Dagl	O
β	O
is	O
opposed	B
to	I
what	O
was	O
previously	B
found	B
in	O
the	O
adipose	O
tissue	O
of	O
obese	O
subjects	O
(	O
Engeli	O
et	O
al	O
.,	O
2014	O
).	O

Several	O
of	O
the	O
components	O
of	O
the	O
network	O
converge	B
on	O
MAPK1	O
,	O
a	O
MAP	O
kinase	O
that	O
serves	O
to	O
integrate	O
multiple	O
biochemical	O
signals	O
(	O
previously	O
known	O
as	O
ERK2	O
),	O
that	O
was	O
found	B
to	I
be	I
significantly	O
down	O
-	O
regulated	O
in	O
the	O
proteomics	O
study	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0002383	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Network	O
analysis	O
of	O
the	O
proteins	O
assembled	O
by	O
Ingenuity	O
Pathway	O
Analysis	O
.	O

Vitamin	O
D	O
status	O
trajectory	O
during	O
pregnancy	O
was	O
inversely	O
associated	B
with	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

But	O
the	O
implementation	O
of	O
this	O
recommendation	B
is	O
inadequate	B
.	O

Similar	O
analyses	O
were	O
conducted	O
using	O
logistic	O
regression	O
to	O
examine	O
impact	O
on	O
odds	O
of	O
macrosomia	O
.	O

Data	O
on	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
were	O
collected	O
from	O
obstetrics	O
charts	O
based	O
on	O
standardized	O
measures	O
.	O

In	O
recent	O
times	O
,	O
when	O
food	O
has	O
become	O
cheaper	O
and	O
more	O
widely	O
available	O
,	O
excessive	O
WAT	O
storage	O
contributed	O
to	O
the	O
worldwide	O
alarming	O
development	O
of	O
obesity	O
mentioned	O
above	O
(	O
World	O
Health	O
Organization	O
,	O
2009	O
).	O

In	O
the	O
entire	O
country	O
,	O
by	O
the	O
end	O
of	O
June	O
2013	O
,	O
1373349	O
AWCs	O
/	O
mini	O
-	O
AWCs	O
have	O
been	O
sanctioned	O
,	O
of	O
which	O
around	O
1339410	O
(	O
97	O
.	O
5	O
%)	O
are	O
operational	O
.	O

Laboratory	O
studies	O
revealed	O
a	O
serum	O
sodium	O
of	O
171	O
mEq	O
/	O
L	O
,	O
potassium	O
4	O
.	O
1	O
mEq	O
/	O
L	O
,	O
chloride	O
138	O
mEq	O
/	O
L	O
,	O
bicarbonate	O
21	O
mEq	O
/	O
L	O
,	O
glucose	O
197	O
mg	O
/	O
dL	O
,	O
BUN	O
49	O
mg	O
/	O
dL	O
,	O
creatinine	O
3	O
.	O
2	O
mg	O
/	O
dL	O
,	O
calcium	O
7	O
.	O
8	O
mEq	O
/	O
L	O
,	O
total	O
protein	O
5	O
.	O
4	O
gm	O
/	O
dL	O
,	O
albumin	O
1	O
.	O
6	O
gm	O
/	O
dL	O
,	O
alkaline	O
phosphatase	O
576	O
units	O
/	O
L	O
,	O
AST	O
391	O
units	O
/	O
L	O
,	O
and	O
ALT	O
443	O
units	O
/	O
L	O
.	O

Pethick	O
et	O
al	O
[	O
69	O
]	O
suggested	B
that	O
a	O
prolonged	O
feeding	O
period	O
gives	O
the	O
cattle	O
time	O
to	O
obtain	O
high	O
IMF	O
levels	O
because	O
time	O
is	O
needed	O
for	O
muscle	O
to	O
reach	O
maturity	O
,	O
followed	O
by	O
time	O
for	O
the	O
muscle	O
to	O
fill	O
up	O
with	O
IMF	O
.	O

Thus	B
,	O
not	O
all	O
humans	O
will	B
respond	O
to	O
an	O
environmental	O
exposure	O
in	O
the	O
same	O
way	O
.	O

American	O
Wagyu	O
steers	O
fed	O
a	O
high	O
-	O
corn	O
diet	O
had	O
greater	O
fat	O
accumulation	O
than	O
did	O
animals	O
fed	O
a	O
hay	O
-	O
based	O
diet	O
[	O
120	O
].	O

Lastly	O
,	O
the	O
environmental	O
impact	B
of	O
perinatal	O
air	O
pollutants	O
has	B
also	O-
been	I
observed	O
[	O
20	O
,	O
21	O
].	O

Concentrate	O
diets	O
are	O
generally	B
a	O
major	O
glucose	O
source	O
through	O
either	O
production	O
of	O
rumen	O
propionate	O
or	O
glucose	O
absorption	O
from	O
the	O
small	O
intestine	O
from	O
a	O
rumen	O
-	O
bypassed	O
concentrate	O
,	O
as	O
described	O
above	O
,	O
whereas	B
roughage	O
is	O
a	O
major	O
acetate	O
source	O
that	O
results	O
from	O
the	O
rumen	O
fermentation	O
process	O
.	O

This	O
is	O
where	O
dose	O
/	O
level	O
of	O
exposure	O
and	O
relevance	O
to	O
humans	O
is	O
crucial	B
,	O
but	B
considerations	B
of	O
alternative	B
replacements	O
are	O
also	O
important	B
.	O

Formative	O
research	O
Before	O
the	O
intervention	O
started	O
,	O
we	O
conducted	O
a	O
formative	O
study	O
using	O
qualitative	O
methods	O
.	O

The	O
women	O
were	O
selected	O
according	O
to	O
a	O
multi	O
-	O
stage	O
proportionate	O
-	O
to	O
-	O
size	O
stratified	O
sampling	O
design	O
as	O
recommended	B
for	O
studies	O
assessing	O
iodine	O
deficiency	O
[	O
31	O
].	O

Although	B
earlier	B
studies	I
have	O
mostly	B
examined	O
the	O
effects	B
of	O
particular	O
nutrients	O
or	O
foods	O
during	O
gestational	O
period	O
on	O
neonatal	O
anthropometric	O
measurements	O
,	O
there	O
are	O
few	B
studies	I
regarding	O
the	O
association	B
of	O
dietary	O
patterns	O
and	O
mentioned	O
measurements	O
.	O

Seasonal	O
variation	O
in	O
vitamin	O
D	O
followed	O
a	O
similar	O
pattern	O
to	O
hours	O
of	O
sunlight	O
although	O
was	O
slightly	O
shifted	O
.	O

Women	O
living	O
in	O
a	O
nursing	O
home	O
have	O
a	O
higher	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
than	O
in	O
free	O
-	O
living	O
women	O
,	O
39	O
.	O
8	O
%	O
compared	O
to	O
30	O
%,	O
respectively	O
[	O
13	O
].	O

Alternatively	B
,	O
maternal	O
diet	O
may	B
affect	B
fetal	O
development	O
and	O
subsequent	O
host	O
response	O
to	O
microbial	O
populations	O
at	O
and	O
after	O
birth	O
.	O

DNA	O
methylation	O
is	O
a	O
key	O
mode	O
of	O
epigenetic	O
regulation	O
,	O
which	O
can	O
lead	O
to	O
silencing	O
of	O
genomic	O
regions	O
.	O

Potential	O
confounders	O
for	O
vitamin	O
D	O
status	O
were	O
assessed	O
using	O
linear	O
modelling	O
.	O

The	O
most	O
abundant	O
taxonomic	O
group	O
was	O
Enterobacteriaceae	O
comprising	O
20	O
.	O
0	O
%	O
of	O
the	O
6	O
-	O
week	O
infant	O
stool	O
microbiome	O
,	O
followed	O
by	O
Bifidobacterium	O
(	O
18	O
.	O
4	O
%),	O
Bacteroides	O
(	O
10	O
.	O
4	O
%),	O
and	O
Streptococcus	O
(	O
8	O
.	O
10	O
%)	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S1	O
).	O

(	O
2014b	O
)*/†	O
Vinyl	O
carbamateMouseInjection	O
(	O
ip	O
)	O
(	O
0	O
.	O
32	O
mg	O
/	O
mouse	O
)	O
Adolescence	O
/	O
early	O
adulthoodAdulthoodPulmonary	O
carcinogenesismiRNAsKassie	O
et	O
al	O
.	O

Utrera	O
and	O
Van	O
Vleck	O
[	O
41	O
]	O
presented	O
estimates	B
of	O
heritability	O
for	O
cattle	O
carcass	O
traits	O
in	O
72	O
studies	O
(	O
1962	O
through	O
2004	O
).	O

However	B
,	O
inconsistencies	B
between	O
studies	O
reflect	O
uncertainty	B
about	O
the	O
true	B
effect	B
of	O
vitamin	O
D	O
deficiency	O
on	O
pregnancy	O
outcome	O
[	O
5	O
,	O
6	O
].	O

However	B
,	O
some	B
recent	O
insights	B
are	O
presented	O
and	O
discussed	O
in	O
Hatanaka	O
et	O
al	O
.	O

Epigenetics	O
and	O
the	O
mammalian	O
life	O
cycle	O
.	O

The	O
supernatant	O
was	O
reduced	O
and	O
alkylated	O
in	O
5	O
mM	O
tributylphosphine	O
(	O
TBP	O
)	O
and	O
1M	O
acrylamide	O
monomer	O
at	O
room	O
temperature	O
for	O
2	O
hr	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

To	O
exercise	O
the	O
delivery	O
of	O
services	O
Anganwadi	O
centres	O
(	O
AWCs	O
)	O
has	O
been	O
created	O
in	O
all	O
regions	O
of	O
the	O
country	O
.	O

Results	O
Mean	O
serum	O
25	O
(	O
OH	O
)	O
D	O
in	O
all	O
women	O
was	O
68	O
.	O
1	O
±	O
27	O
.	O
1	O
nmol	O
/	O
L	O
and	O
28	O
%	O
(	O
n	O
=	O
772	O
)	O
were	O
considered	O
vitamin	O
D	O
deficient	O
(<	O
50	O
nmol	O
/	O
L	O
).	O

High	O
dose	O
of	O
oral	O
iron	O
supplements	O
is	O
commonly	O
associated	B
with	O
gastrointestinal	O
effects	B
such	O
as	O
constipation	O
,	O
nausea	O
,	O
vomiting	O
,	O
and	O
diarrhea	O
;	O
the	O
frequency	O
and	O
severity	O
of	O
which	O
vary	B
according	B
to	I
the	O
amount	O
of	O
elemental	O
iron	O
released	O
into	O
the	O
stomach	O
.	O

Excessive	O
gestational	O
weight	O
gain	O
is	O
also	O
associated	B
with	O
risk	O
of	O
GDM	O
.	O

Vitamin	O
D	O
deficiency	O
increases	O
the	O
risk	O
of	O
osteoporosis	O
[	O
3	O
]	O
and	O
fractures	O
[	O
4	O
],	O
while	O
in	O
its	O
most	O
severe	O
form	O
it	O
causes	O
rickets	O
in	O
children	O
[	O
5	O
]	O
and	O
osteomalacia	O
in	O
adults	O
[	O
6	O
].	O

One	O
recent	O
study	O
suggests	B
that	O
both	O
the	O
microbial	O
and	O
fatty	O
acid	O
composition	O
of	O
breast	O
milk	O
may	B
differ	O
by	O
delivery	O
mode	O
[	O
18	O
],	O
so	O
the	O
differential	O
effect	B
of	O
maternal	O
dairy	O
intake	O
by	O
delivery	O
mode	O
on	O
the	O
infant	O
gut	O
microbiome	O
may	B
be	I
attributable	O
to	O
the	O
differences	O
in	O
breast	O
milk	O
microbiota	O
or	O
lipids	O
in	O
relation	B
to	O
maternal	O
diet	O
by	O
delivery	O
mode	O
.	O

[	O
48	O
],	O
which	O
has	B
been	I
validated	B
against	O
weighed	O
dietary	O
records	O
and	O
modified	O
in	O
the	O
light	O
of	O
a	O
more	O
recent	O
weighed	O
dietary	O
survey	O
[	O
13	O
].	O

Between	O
1970	O
and	O
2000	O
,	O
there	O
was	O
a	O
25	O
%	O
increase	O
in	O
the	O
per	O
capita	O
consumption	O
of	O
all	O
refined	O
sugars	O
in	O
the	O
USA	O
,	O
matching	O
a	O
worldwide	O
trend	B
[	O
3	O
].	O

The	O
dosage	O
is	O
based	B
on	I
dietary	O
intake	O
recommendations	B
[	O
10	O
,	O
11	O
].	O

Other	O
tumours	O
(	O
lung	O
,	O
stomach	O
,	O
breast	O
,	O
large	O
bowel	O
,	O
larynx	O
and	O
pharynx	O
)	O
were	O
included	O
to	O
distinguish	O
findings	O
specific	O
for	O
oesophageal	O
cancer	O
from	O
general	O
characteristics	O
of	O
cancer	O
patients	O
,	O
due	O
for	O
example	O
to	O
ascertainment	O
bias	B
,	O
and	O
to	O
verify	O
that	O
expected	B
associations	B
,	O
such	O
as	O
between	O
lung	O
cancer	O
and	O
cigarette	O
smoking	O
,	O
would	B
emerge	O
under	O
the	O
prevailing	O
field	O
conditions	O
.	O

So	O
patyas	O
prescribed	O
are	O
diuretics	O
.	O

We	O
found	O
no	O
significant	O
prenatal	O
predictors	O
of	O
change	O
in	O
WFA	O
z	O
-	O
scores	O
between	O
birth	O
and	O
6	O
months	O
.	O

The	O
respondents	O
also	O
wished	B
that	O
the	O
health	O
talks	O
(	O
16	O
.	O
3	O
%)	O
should	B
be	I
more	O
regular	O
and	O
that	O
primigravida	O
should	B
be	I
encouraged	B
to	O
come	O
regularly	O
.	O

In	O
the	O
high	O
level	O
symptoms	O
group	O
compared	O
with	O
the	O
low	O
level	O
symptoms	O
group	O
,	O
the	O
intake	O
of	O
shellfish	O
1	O
-	O
3	O
times	O
per	O
month	O
was	O
associated	B
with	O
a	O
reduced	O
risk	O
,	O
whereas	B
the	O
intake	O
of	O
shellfish	O
more	O
than	O
three	O
times	O
per	O
week	O
was	O
associated	B
with	O
an	O
increased	O
risk	O
.	O

The	O
current	O
stage	O
-	O
specific	O
feeding	O
program	O
for	O
producing	O
Korean	O
cattle	O
with	O
highly	O
marbled	O
beef	O
relies	O
heavily	O
on	O
feeding	O
a	O
concentrate	O
diet	O
during	O
the	O
fattening	O
period	O
.	O

Based	O
on	O
these	O
scores	O
,	O
we	O
created	O
the	O
following	O
categories	O
of	O
nutritional	O
knowledge	O
:	O
low	O
level	O
(<	O
mean	O
–	O
standard	O
deviation	O
),	O
medium	O
level	O
(	O
mean	O
±	O
standard	O
deviation	O
)	O
and	O
high	O
level	O
(>	O
mean	O
+	O
standard	O
deviation	O
).	O

The	O
strengths	O
of	O
this	O
study	O
include	O
the	O
large	O
sample	O
size	O
,	O
population	O
-	O
based	O
ascertainment	O
of	O
placenta	O
samples	O
,	O
quantitative	O
assessment	O
of	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
,	O
and	O
the	O
use	O
of	O
a	O
well	O
-	O
established	O
,	O
high	O
-	O
density	O
methylation	O
array	O
for	O
methylation	O
profiling	O
.	O

A	O
high	B
index	I
of	I
suspicion	I
by	O
the	O
emergency	O
physician	O
in	O
addition	O
to	O
successful	O
coordination	O
of	O
care	O
between	O
the	O
emergency	O
physician	O
,	O
obstetrician	O
,	O
and	O
cardiothoracic	O
/	O
vascular	O
surgeon	O
is	O
necessary	B
for	O
a	O
successful	O
outcome	O
.	O

Date	O
of	O
registration	O
:	O
March	O
9th	O
2015	O
.	O

They	O
examined	O
milk	O
and	O
venous	O
blood	O
samples	O
of	O
24	O
healthy	O
breastfeeding	O
women	O
with	O
complication	O
-	O
free	O
physiologic	O
pregnancies	O
and	O
neonates	O
with	O
appropriate	O
weight	O
for	O
gestational	O
age	O
at	O
birth	O
and	O
180	O
days	O
after	O
birth	O
.	O

However	B
,	O
as	O
stated	O
above	O
,	O
all	O
10	O
of	O
the	O
studies	O
shown	O
inTable	O
1further	B
confirmed	B
identified	B
associations	B
between	O
environmental	O
exposures	O
,	O
specific	O
epigenetic	O
changes	O
and	O
adverse	O
phenotypes	O
in	O
a	O
relevant	B
in	O
vivo	O-
and	O
/	O
or	O
in	O
vitro	O-
system	O
;	O
and	O
seven	O
of	O
the	O
10	O
studies	O
either	B
directly	O-
sampled	O
the	O
target	O
tissue	O-
or	I
validated	B
the	O
same	O
change	O
in	O
the	O
blood	O
and	O
target	O
tissue	O
of	O
an	O
appropriate	O
in	O
vivo	O
model	B
.	O

During	O
this	O
period	O
the	O
brain	O
and	O
immune	O
systems	O
are	O
less	O
developed	O
,	O
undergoing	O
greater	O
cell	O
growth	O
and	O
differentiation	O
,	O
and	O
possibly	B
more	O
susceptible	O
to	O
DNA	O
and	O
epigenetic	O
changes	O
underlying	O
cancer	O
development	O
in	O
the	O
near	O
or	O
distant	O
future	O
[	O
5	O
,	O
8	O
–	O
13	O
].	O

Altogether	O
,	O
the	O
existing	B
literature	I
suggests	B
that	O
BAT	O
activation	O
is	O
not	O
only	O
involved	B
in	O
non	O
-	O
shivering	O
thermogenesis	O
,	O
but	O
also	O
in	O
the	O
regulation	O
of	O
insulin	O
-	O
mediated	O
glucose	O
disposal	O
.	O

Nodes	O
in	O
the	O
jugular	O
chains	O
should	B
also	O
be	O
carefully	O
examined	O
with	O
US	O
before	O
surgery	O
and	O
,	O
when	O
suspicious	O
,	O
FNAB	O
should	B
be	I
obtained	O
.	O

A	O
comprehensive	O
systematic	O
review	O
by	O
Thangaratinam	O
and	O
colleagues	O
[	O
14	O
]	O
has	O
identified	O
numerous	O
studies	I
assessing	O
dietary	O
and	O
lifestyle	O
interventions	O
in	O
pregnancy	O
,	O
albeit	B
mostly	B
small	B
in	I
scope	I
.	O

The	O
ncRNA	O
superfamily	O
encompasses	O
a	O
number	O
of	O
families	O
broadly	O
classified	O
according	O
to	O
their	O
length	O
:	O
long	O
non	O
-	O
coding	O
RNAs	O
(	O
lncRNAs	O
)	O
(>	O
200	O
nt	O
)	O
and	O
short	O
non	O
coding	O
RNAs	O
(	O
sncRNAs	O
)	O
(<	O
200	O
nt	O
),	O
which	O
include	O
microRNAs	O
(	O
miRNAs	O
,	O
single	O
stranded	O
,	O
∼	O
19	O
–	O
25	O
nt	O
),	O
piwi	O
-	O
interacting	O
RNAs	O
(	O
piRNAs	O
,	O
single	O
stranded	O
,	O
∼	O
24	O
–	O
30	O
nt	O
)	O
and	O
endogenous	O
short	O
interfering	O
RNAs	O
(	O
esiRNAs	O
,	O
double	O
stranded	O
,	O
∼	O
21	O
–	O
22	O
nt	O
).	O

Animals	O
were	O
housed	O
on	O
a	O
12	O
-	O
h	O
light	O
/	O
dark	O
cycle	O
(	O
lights	O
on	O
at	O
06	O
:	O
00	O
h	O
)	O
using	O
incandescent	O
lighting	O
,	O
to	O
avoid	O
ultraviolet	O
radiation	O
within	O
the	O
vitamin	O
D3action	O
spectrum	O
.	O

Estimation	O
of	O
foetal	O
crown	O
rump	O
length	O
and	O
/	O
or	O
biparietal	O
diameter	O
or	O
femur	O
length	O
between	O
6	O
and	O
18	O
weeks	O
’	O
gestation	O
indicates	O
an	O
accuracy	O
within	O
5	O
–	O
7	O
days	O
[	O
54	O
].	O

First	O
and	O
second	O
trimester	O
visfatin	O
levels	O
were	O
significant	O
independent	O
predictors	B
of	O
infant	O
’	O
s	O
weight	O
in	O
group	O
B	O
and	O
infant	O
’	O
s	O
height	O
in	O
both	O
groups	O
.	O

Of	O
those	O
who	O
delivered	O
preterm	O
,	O
10	O
delivered	O
before	O
gestational	O
week	O
31	O
and	O
thus	O
before	O
the	O
T3	O
blood	O
sample	O
could	O
be	O
drawn	O
.	O

The	O
active	O
metabolite	O
of	O
vitamin	O
D	O
,	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
[	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
]	O
increases	O
intestinal	O
calcium	O
absorption	O
and	O
decreases	O
renal	O
calcium	O
excretion	O
,	O
thus	O
increasing	O
the	O
pool	O
of	O
calcium	O
available	O
both	O
for	O
mother	O
and	O
foetus	O
.	O

According	B
to	I
the	O
Institute	O
of	O
Medicine	O
(	O
IOM	O
),	O
we	O
considered	B
vitamin	O
D	O
deficiency	O
as	B
a	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
of	O
less	O
than	O
20	O
ng	O
/	O
ml	O
.	O

Focusing	O
on	O
post	O
-	O
natal	O
issues	O
was	O
not	O
usually	O
appealing	O
to	O
pregnant	O
women	O
who	O
were	O
more	O
eager	O
to	O
learn	O
about	O
labor	O
.	O

Mean	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
levels	O
were	O
also	O
found	O
to	O
be	O
weakly	O
to	O
moderately	O
correlated	B
,	O
with	O
a	O
Pearson	O
correlation	O
of	O
0	O
.	O
29	O
[	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
):	O
0	O
.	O
20	O
,	O
0	O
.	O
38	O
].	O

Treatment	O
to	O
post	O
-	O
prandial	O
targets	O
results	O
in	O
superior	O
pregnancy	O
outcomes	O
compared	O
to	O
pre	O
-	O
prandial	O
targets	O
.	O
25The	O
recommended	B
treatment	O
targets	O
vary	B
from	O
country	O
to	O
country	O
(	O
Table	O
2	O
).	O

There	O
was	O
no	O
effect	O
of	O
the	O
gestational	O
or	O
pup	O
diets	O
on	O
hypothalamic	O
expression	O
of	O
other	O
genes	O
.	O

For	O
example	O
,	O
researchers	O
have	B
reported	I
a	O
common	O
occurrence	O
of	O
unbooked	O
pregnancies	O
[	O
49	O
,	O
50	O
]	O
and	O
a	O
wide	B
range	I
(	O
60	O
%	O
to	O
90	O
%)	O
of	O
antenatal	O
care	O
utilization	O
rates	O
(	O
i	O
.	O
e	O
.,	O
antenatal	O
care	O
clinic	O
attendance	O
of	O
at	O
least	O
once	O
during	O
most	O
recent	O
pregnancy	O
)	O
[	O
51	O
–	O
53	O
].	O

Much	O
of	O
the	O
controversy	B
is	O
concerned	B
with	O
multigenerational	O
versus	O
transgenerational	O
epigenetic	O
toxicity	O
(	O
or	O
epigenetic	O
effect	B
(	O
s	O
)	O
versus	O
epigenetic	O
inheritance	O
)	O
(	O
Figure	O
3	O
).	O

Researchers	O
at	O
the	O
University	O
of	O
Texas	O
M	O
.	O
D	O
.	O

of	O
commonly	O
regulated	O
probe	O
-	O
sets	O
of	O
LP	O
and	O
AP	O
offspring	O
(	O
intersection	O
)	O
94	O
dpc	O
12	O
,	O
6507	O
,	O
9371	O
,	O
001	O
(	O
541	O
up	O
,	O
460	O
down	O
)	O
1	O
dpn	O
12	O
,	O
0059	O
,	O
0991	O
(	O
0	O
up	O
,	O
1	O
down	O
)	O
28	O
dpn	O
12	O
,	O
3078	O
,	O
250483	O
(	O
214	O
up	O
,	O
269	O
down	O
)	O
188	O
dpn	O
11	O
,	O
7848	O
,	O
9432	O
,	O
084	O
(	O
952	O
up	O
,	O
1	O
,	O
132	O
down	O
)	O
developmental	O
period	O
1	O
13	O
,	O
35710	O
,	O
2938	O
,	O
166	O
(	O
3	O
,	O
731	O
up	O
,	O
4	O
,	O
435	O
down	O
)	O
1	O
,	O
042	O
(	O
384	O
up	O
,	O
658	O
down	O
)	O
1	O
,	O
034	O
(	O
503	O
up	O
,	O
531	O
down	O
)	O
6	O
,	O
090	O
(	O
2	O
,	O
844	O
up	O
,	O
3	O
,	O
246	O
down	O
)	O
developmental	O
period	O
2	O
13	O
,	O
35910	O
,	O
3178	O
,	O
329	O
(	O
4	O
,	O
118	O
up	O
,	O
4	O
,	O
211	O
down	O
)	O
881	O
(	O
423	O
up	O
,	O
458	O
down	O
)	O
991	O
(	O
448	O
up	O
,	O
543	O
down	O
)	O
6	O
,	O
457	O
(	O
3	O
,	O
247	O
up	O
,	O
3	O
,	O
210	O
down	O
)	O
developmental	O
period	O
3	O
12	O
,	O
6378	O
,	O
8926	O
,	O
612	O
(	O
2	O
,	O
810	O
up	O
,	O
3	O
,	O
803	O
down	O
)	O
1	O
,	O
959	O
(	O
834	O
up	O
,	O
1	O
,	O
125	O
down	O
)	O
1	O
,	O
549	O
(	O
697	O
up	O
,	O
852	O
down	O
)	O
3	O
,	O
104	O
(	O
1	O
,	O
279	O
up	O
,	O
1	O
,	O
825	O
down	O
)	O
Developmental	O
period	O
1	O
indicates	O
the	O
comparisons	O
between	O
stages	O
94	O
dpc	O
and	O
1	O
dpn	O
;	O
Developmental	O
period	O
2	O
indicates	O
the	O
comparisons	O
between	O
stages	O
1	O
dpc	O
and	O
28	O
dpn	O
;	O
Developmental	O
period	O
3	O
indicates	O
the	O
comparisons	O
between	O
stages	O
28	O
dpc	O
and	O
188	O
dpn	O
;	O
'	O
Up	O
'	O
indicates	O
higher	O
expression	O
values	O
of	O
later	O
stages	O
,	O
'	O
down	O
'	O
indicates	O
lower	O
expression	O
values	O
at	O
later	O
stages	O
.	O

However	B
,	O
certain	O
stages	O
in	O
development	O
and	O
cell	O
types	O
can	B
be	O
thought	B
of	I
as	O
particularly	B
sensitive	O
to	O
epigenetic	O
change	O
due	B
to	I
the	O
resulting	O
severity	O
of	O
the	O
outcome	O
for	O
the	O
individual	O
or	O
the	O
potential	B
for	O
affecting	B
multiple	O
generations	O
.	O

The	O
RT2	O
reactions	O
including	O
the	O
entire	O
RT1	O
reactions	O
,	O
mixed	O
with	O
5	O
µl	O
moloney	O
murine	O
leukemia	O
virus	O
reverse	O
transcriptase	O
(	O
M	O
-	O
MLV	O
)	O
5	O
×	O
buffer	O
(	O
250	O
mM	O
,	O
pH	O
=	O
8	O
.	O
3	O
)	O
Tris	O
–	O
HCl	O
,	O
15	O
mM	O
MgCl2	O
,	O
50	O
mM	O
dithiothreitol	O
and	O
375	O
mM	O
KCl	O
,	O
1	O
.	O
25	O
µl	O
of	O
10	O
mM	O
-	O
deoxyribonucleotide	O
tripho	O
-	O
sphate	O
,	O
1	O
µl	O
M	O
-	O
MLV	O
RNase	O
(	O
200	O
U	O
/	O
µl	O
)	O
and	O
0	O
.	O
5	O
µl	O
RNase	O
inhibitor	O
(	O
40	O
U	O
/	O
µl	O
).	O

Materials	O
and	O
Methods	O
2	O
.	O
1	O
.	O

This	O
creates	O
a	O
hat	O
trick	O
of	O
DNA	O
damage	O
:	O
Uranium	O
’	O
s	O
radioactive42and	O
chemical43properties	O
both	O
can	B
harm	O
DNA	O
,	O
and	O
the	O
presence	O
of	O
arsenic	O
may	B
prevent	O
cells	O
from	O
repairing	O
the	O
damage	O
.	O

Inspired	O
by	O
the	O
work	O
identifying	O
adult	O
enterotypes	O
by	O
Arumugam	O
et	O
al	O
.	O

It	O
should	O
be	O
noted	B
here	O
that	O
the	O
interactions	O
presented	O
in	O
the	O
networks	O
are	O
not	B
specific	I
for	O
porcine	O
liver	O
tissue	O
,	O
as	O
the	O
database	O
contains	O
literature	O
from	O
many	O
different	O
research	O
areas	O
.	O

The	O
serum	O
osmolality	O
was	O
356	O
mOsm	O
/	O
kg	O
;	O
urine	O
sodium	O
21	O
mEq	O
/	O
L	O
and	O
urine	O
osmolality	O
was	O
inappropriately	O
low	O
(	O
225	O
mOsm	O
/	O
kg	O
).	O

Early	O
life	O
Early	O
embryo	O
and	O
germ	O
line	O
development	O
can	B
be	O
affected	B
by	O
in	O
utero	O
exposures	O
.	O

For	O
a	O
second	O
filtering	O
step	O
standard	O
deviations	O
were	O
calculated	O
for	O
each	O
probe	O
-	O
set	O
over	O
all	O
subsets	O
of	O
arrays	O
of	O
the	O
particular	O
comparisons	O
.	O

Meconium	O
Aspiration	O
Syndrome	O
Meconium	O
aspiration	O
syndrome	O
,	O
which	O
occurs	O
when	O
a	O
fetus	O
who	O
is	O
under	O
stress	O
and	O
not	O
getting	O
enough	O
oxygen	O
inhales	O
waste	O
products	O
inside	O
the	O
womb	O
,	O
was	O
linked	B
to	O
a	O
sevenfold	O
increase	O
in	O
the	O
likelihood	B
that	O
a	O
child	O
would	B
later	O
develop	O
autism	O
.	O

Participant	O
Characteristics	O
Excluding	O
participants	O
with	O
miscarriages	O
(	O
n	O
=	O
6	O
)	O
and	O
GDM	O
(	O
n	O
=	O
32	O
),	O
363	O
mothers	O
(	O
177	O
overweight	O
/	O
obese	O
and	O
186	O
normal	O
weight	O
)	O
completed	O
the	O
baseline	O
assessment	O
,	O
which	O
occurred	O
between	O
10	O
and	O
16	O
weeks	O
of	O
pregnancy	O
(	O
13	O
weeks	O
on	O
average	O
).	O

Urinalysis	O
was	O
significant	O
for	O
a	O
specific	O
gravity	O
of	O
1	O
.	O
008	O
,	O
red	O
blood	O
cells	O
8	O
–	O
10	O
/	O
high	O
-	O
power	O
field	O
,	O
and	O
30	O
mg	O
/	O
dL	O
of	O
protein	O
.	O

Furthermore	O
,	O
metformin	O
can	B
promote	O
the	O
development	O
of	O
lactic	O
acidosis	O
,	O
which	O
surely	B
must	B
be	I
a	O
concern	B
in	O
situations	O
of	O
fetal	O
distress	O
.	O

Whether	B
women	O
treated	O
for	O
thyroid	O
cancer	O
should	B
become	O
pregnant	O
was	O
once	O
a	O
matter	O
of	O
concern	B
,	O
but	B
current	B
evidence	I
suggests	B
that	O
DTC	O
should	B
not	O
discourage	O
intended	O
pregnancy	O
,	O
with	O
the	O
usual	O
recommendation	B
to	O
postpone	O
it	O
to	O
at	B
least	I
6	O
months	O
after	O
radioiodine	O
therapy	O
.	O

A	O
self	O
-	O
report	O
,	O
food	O
frequency	O
questionnaire	O
was	O
used	O
,	O
which	O
is	O
useful	O
in	O
ranking	O
nutrient	O
intakes	O
of	O
individual	O
subjects	O
but	O
can	O
be	O
subject	O
to	O
bias	B
,	O
particularly	O
in	O
obese	O
individuals	O
[	O
52	O
].	O

Another	O
factor	O
that	O
should	B
be	I
considered	B
is	O
the	O
composition	O
of	O
fatty	O
acids	O
present	O
in	O
breast	O
milk	O
,	O
which	O
may	B
influence	B
the	O
immune	O
response	O
of	O
the	O
child	O
[	O
68	O
].	O

In	O
another	O
study	O
,	O
the	O
cold	O
-	O
induced	O
increase	O
in	O
thermogenesis	O
was	O
accompanied	B
by	O
a	O
decrease	O
in	O
body	O
weight	O
,	O
mainly	B
affecting	B
the	O
fat	O
mass	O
compartment	O
(	O
Yoneshiro	O
et	O
al	O
.,	O
2013	O
).	O

During	O
pregnancy	O
.	O

Variables	O
that	O
were	O
significant	O
or	O
approached	O
significance	O
(	O
P	O
<	O
0	O
.	O
10	O
)	O
within	O
each	O
category	O
in	O
the	O
stepwise	O
analyses	O
were	O
included	O
together	O
in	O
a	O
comprehensive	O
model	O
.	O

Most	O
women	O
(	O
96	O
.	O
0	O
%)	O
registered	O
their	O
pregnancy	O
with	O
their	O
general	O
practitioner	O
and	O
had	O
the	O
first	O
prenatal	O
visit	O
in	O
the	O
second	O
(	O
61	O
.	O
0	O
%)	O
or	O
the	O
third	O
(	O
19	O
.	O
0	O
%)	O
month	O
;	O
only	O
9	O
.	O
0	O
%	O
of	O
women	O
had	O
the	O
first	O
visit	O
in	O
the	O
fifth	O
month	O
.	O

Calbindin	O
is	O
strongly	O
induced	O
by	O
vitamin	O
D	O
[	O
29	O
],	O
and	O
thus	B
it	O
is	O
feasible	B
that	O
the	O
reduction	O
in	O
this	O
protein	O
may	B
be	I
a	O
consequence	O
of	O
the	O
early	O
life	O
reduction	O
in	O
vitamin	O
D	O
.	O
The	O
potential	B
links	B
between	O
vitamin	O
D	O
and	O
neuronal	O
calcium	O
binding	O
proteins	O
has	B
been	I
noted	O
in	O
a	O
recent	O
review	O
article	O
[	O
30	O
]	O
Two	O
members	O
of	O
the	O
dynamin	O
family	O
(	O
dynamin	O
1	O
and	O
dynamin	O
1	O
-	O
like	O
proteins	O
)	O
were	O
also	O
significantly	O
down	O
-	O
regulated	O
.	O

Wrote	O
the	O
paper	O
:	O
MO	O
KW	O
.	O

Litter	O
size	O
during	O
suckling	O
was	O
standardised	O
to	O
11	O
piglets	O
per	O
sow	O
.	O

Subsequent	O
analyses	O
were	O
performed	O
using	O
R	O
version	O
3	O
.	O
2	O
.	O
2	O
[	O
42	O
].	O

This	O
is	O
a	O
surprisingly	B
high	O
proportion	O
,	O
especially	O
when	O
there	O
is	O
no	O
strong	O
recommendation	B
for	O
the	O
use	O
of	O
multivitamins	O
in	O
Romania	O
or	O
internationally	O
.	O

The	O
results	O
of	O
this	O
study	O
to	O
address	O
these	O
hypotheses	O
are	O
presented	O
here	O
.	O

Table	O
1	O
shows	O
the	O
demographics	O
and	O
clinical	O
characteristics	O
of	O
the	O
133	O
children	O
participants	O
in	O
this	O
study	O
with	O
measurement	O
of	O
circulating	O
cathelicidin	O
.	O

Statistical	O
analyses	O
were	O
performed	O
using	O
SAS	O
9	O
.	O
3	O
.	O

Lewis	O
and	O
colleagues	O
surveyed	O
1	O
,	O
304	O
residents	O
,	O
obtaining	O
basic	O
demographic	O
information	O
,	O
mapping	O
the	O
locations	O
of	O
their	O
homes	O
,	O
and	O
taking	O
samples	O
from	O
the	O
wells	O
where	O
they	O
obtained	O
their	O
drinking	O
water	O
.	O

Materials	O
and	O
Methods	O
:	O
Forty	O
-	O
one	O
eligible	O
pregnant	O
women	O
in	O
their	O
first	O
trimester	O
were	O
divided	O
and	O
matched	O
in	O
terms	O
of	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
before	O
pregnancy	O
into	O
normal	O
and	O
higher	O
than	O
normal	O
BMI	O
groups	O
,	O
A	O
and	O
B	O
.	O
Serum	O
visfatin	O
levels	O
were	O
measured	O
during	O
6	O
-	O
12	O
and	O
15	O
-	O
20	O
weeks	O
of	O
gestation	O
using	O
ELISA	O
.	O

The	O
degree	O
of	O
risk	O
seems	B
to	O
be	O
directly	O
related	B
to	O
the	O
family	O
history	O
of	O
allergy	O
and	O
especially	O
to	O
maternal	O
atopy	O
,[	O
53	O
]	O
particularly	O
when	O
the	O
mother	O
has	O
diagnosed	O
atopic	O
eczema	O
and	O
has	O
elevated	O
IgE	O
levels	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Adjusted	O
relative	O
risks	O
(	O
aRR	O
)	O
of	O
pregnancy	O
complications	O
from	O
any	O
complication	O
,	O
preeclampsia	O
(	O
PE	O
),	O
gestational	O
hypertension	O
(	O
GH	O
),	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
),	O
spontaneous	O
preterm	O
birth	O
(	O
sPTB	O
)	O
and	O
small	O
-	O
for	O
-	O
gestational	O
age	O
(	O
SGA	O
)	O
according	O
to	O
vitamin	O
D	O
status	O
categorised	O
based	O
on	O
standardised	O
quartiles	O
and	O
clinical	O
definitions	O
of	O
vitamin	O
D	O
statusPregnancy	O
ComplicationsAll	O
womenAny	O
ComplicationPEGHGDMsPTBSGA	O
n	O
(%)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
Standardised	O
Quartiles	O
**	O
Low711	O
(	O
25	O
)	O
328	O
(	O
46	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
85	O
,	O
1	O
.	O
07	O
)	O
46	O
(	O
6	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
66	O
,	O
1	O
.	O
57	O
))	O
57	O
(	O
8	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
67	O
,	O
1	O
.	O
42	O
)	O
28	O
(	O
4	O
)	O
0	O
.	O
79	O
(	O
0	O
.	O
47	O
,	O
1	O
.	O
30	O
)	O
36	O
(	O
5	O
)	O
0	O
.	O
83	O
(	O
0	O
.	O
54	O
,	O
1	O
.	O
29	O
)	O
84	O
(	O
12	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
75	O
,	O
1	O
.	O
39	O
)	O
Low	O
-	O
Moderate755	O
(	O
27	O
)	O
318	O
(	O
42	O
)	O
1	O
.	O
00	O
(	O
0	O
.	O
90	O
,	O
1	O
.	O
12	O
)	O
42	O
(	O
6	O
)	O
1	O
.	O
07	O
(	O
0	O
.	O
69	O
,	O
1	O
.	O
64	O
)	O
65	O
(	O
9	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
74	O
,	O
1	O
.	O
52	O
)	O
25	O
(	O
3	O
)	O
0	O
.	O
67	O
(	O
0	O
.	O
39	O
,	O
1	O
.	O
16	O
)	O
33	O
(	O
4	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
56	O
,	O
1	O
.	O
3572	O
(	O
10	O
)	O
0	O
.	O
98	O
(	O
0	O
.	O
73	O
,	O
1	O
.	O
32	O
)	O
Moderate	O
-	O
High702	O
(	O
25	O
)	O
309	O
(	O
44	O
)	O
1	O
.	O
0	O
†	O
37	O
(	O
5	O
)	O
1	O
.	O
0	O
†	O
50	O
(	O
7	O
)	O
1	O
.	O
0	O
†	O
28	O
(	O
4	O
)	O
1	O
.	O
0	O
†	O
39	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
81	O
(	O
12	O
)	O
1	O
.	O
0	O
†	O
High630	O
(	O
23	O
)	O
258	O
(	O
41	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
82	O
,	O
1	O
.	O
06	O
)†	O
35	O
(	O
6	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
78	O
,	O
1	O
.	O
96	O
)	O
40	O
(	O
6	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
58	O
,	O
1	O
.	O
30	O
)	O
10	O
(	O
2	O
)	O
0	O
.	O
47	O
(	O
0	O
.	O
23	O
,	O
0	O
.	O
96	O
)	O
30	O
(	O
5	O
)	O
0	O
.	O
77	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
25	O
)	O
60	O
(	O
10	O
)	O
0	O
.	O
80	O
(	O
0	O
.	O
57	O
,	O
1	O
.	O
11	O
)	O
Vitamin	O
D	O
Status	O
<	O
25	O
nmol	O
/	O
L99	O
(	O
4	O
)	O
51	O
(	O
52	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
89	O
,	O
1	O
.	O
36	O
)	O
8	O
(	O
8	O
)	O
1	O
.	O
44	O
(	O
0	O
.	O
68	O
,	O
3	O
.	O
03	O
))	O
6	O
(	O
6	O
)	O
0	O
.	O
70	O
(	O
0	O
.	O
32	O
,	O
1	O
.	O
52	O
)	O
5	O
(	O
5	O
)	O
0	O
.	O
98	O
(	O
0	O
.	O
38	O
,	O
2	O
.	O
52	O
)	O
7	O
(	O
7	O
)	O
1	O
.	O
44	O
(	O
0	O
.	O
68	O
,	O
3	O
.	O
04	O
)	O
13	O
(	O
13	O
)	O
1	O
.	O
15	O
(	O
0	O
.	O
66	O
,	O
2	O
.	O
01	O
)	O
25	O
-	O
50	O
nmol	O
/	O
L673	O
(	O
24	O
)	O
301	O
(	O
45	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
83	O
,	O
1	O
.	O
03	O
)	O
45	O
(	O
7	O
)	O
1	O
.	O
18	O
(	O
0	O
.	O
80	O
,	O
1	O
.	O
75	O
)	O
59	O
(	O
9	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
71	O
,	O
1	O
.	O
34	O
)	O
26	O
(	O
4	O
)	O
0	O
.	O
89	O
(	O
0	O
.	O
54	O
,	O
1	O
.	O
47	O
)	O
29	O
(	O
4	O
)	O
0	O
.	O
75	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
16	O
)	O
74	O
(	O
11	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
69	O
,	O
1	O
.	O
24	O
)	O
>	O
50	O
-	O
75	O
nmol	O
/	O
L928	O
(	O
33	O
)	O
428	O
(	O
46	O
)	O
1	O
.	O
0	O
†	O
48	O
(	O
5	O
)	O
1	O
.	O
0	O
†	O
80	O
(	O
9	O
)	O
1	O
.	O
0	O
†	O
35	O
(	O
4	O
)	O
1	O
.	O
0	O
†	O
52	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
107	O
(	O
12	O
)	O
1	O
.	O
0	O
†	O
>	O
75	O
nmol	O
/	O
L1098	O
(	O
39	O
)	O
435	O
(	O
40	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
86	O
,	O
1	O
.	O
04	O
)	O
60	O
(	O
5	O
)	O
1	O
.	O
28	O
(	O
0	O
.	O
87	O
,	O
1	O
.	O
87	O
)	O
67	O
(	O
6	O
)	O
0	O
.	O
82	O
(	O
0	O
.	O
59	O
,	O
1	O
.	O
12	O
)†	O
26	O
(	O
2	O
)	O
0	O
.	O
78	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
28	O
)	O
51	O
(	O
5	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
59	O
,	O
1	O
.	O
26	O
)	O
104	O
(	O
9	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
67	O
,	O
1	O
.	O
12	O
)	O
*	O
Relative	O
risks	O
compared	O
to	O
all	O
women	O
were	O
adjusted	O
for	O
age	O
,	O
maternal	O
body	O
mass	O
index	O
,	O
ethnicity	O
(	O
non	O
Caucasian	O
vs	O
.	O
Caucasian	O
),	O
smoking	O
status	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
(	O
no	O
vs	O
.	O
yes	O
),	O
alcohol	O
consumption	O
at	O
15	O
±	O
1	O
weeks	O
’	O
(	O
no	O
vs	O
yes	O
),	O
recreational	O
walking	O
(	O
1	O
-	O
3	O
×/	O
week	O
and	O
≥	O
4	O
×/	O
week	O
vs	O
.	O
never	O
)	O
and	O
recruitment	O
site	O
(	O
Auckland	O
vs	O
.	O
Adelaide	O
)	O
**	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
standardised	O
for	O
month	O
that	O
serum	O
was	O
sampled	O
based	O
as	O
previously	O
described	O
[	O
34	O
]	O
†	O
Reference	O
category	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
,	O
pregnancy	O
outcome	O
and	O
fetal	O
sex	O
As	O
there	B
is	I
evidence	I
to	I
suggest	B
that	O
vitamin	O
D	O
metabolism	O
within	O
the	O
placenta	O
may	B
differ	B
with	O
respect	O
to	O
fetal	O
sex	O
[	O
35	O
]	O
thus	B
,	O
we	O
assessed	B
the	O
effect	B
of	O
“	O
standardised	O
”	O
vitamin	O
D	O
status	O
on	O
pregnancy	O
outcome	O
stratified	O
by	O
fetal	O
sex	O
(	O
Table	O
3	O
).	O

IUFD	O
was	O
defined	O
as	O
pregnancy	O
loss	O
at	O
gestational	O
week	O
≥	O
22	O
+	O
0	O
.	O

Apart	O
from	O
the	O
inconvenience	O
of	O
taking	O
time	O
to	O
answer	O
the	O
research	O
questionnaire	O
,	O
participants	O
were	O
not	O
exposed	O
to	O
undue	O
risk	O
.	O

Pregnancy	O
loss	O
before	O
gestational	O
week	O
22	O
was	O
based	O
on	O
self	O
-	O
report	O
data	O
and	O
medical	O
records	O
to	O
verify	O
miscarriage	O
were	O
not	B
available	I
.	O

In	O
cases	O
where	O
a	O
reduced	O
sensitization	O
to	O
food	O
was	O
found	B
,	O
this	O
protective	B
effect	B
was	O
short	O
-	O
lived	O
and	O
was	O
primarily	O
observed	O
during	O
the	O
first	O
year	O
of	O
life	O
.	O

The	O
rate	O
of	O
cockroach	O
sensitization	O
at	O
the	O
age	O
of	O
5	O
years	O
was	O
higher	O
for	O
winter	O
births	O
(	O
72	O
%),	O
than	O
for	O
spring	O
(	O
48	O
%),	O
summer	O
(	O
42	O
%)	O
and	O
fall	O
(	O
43	O
%)	O
births	O
[	O
70	O
].	O

However	B
,	O
we	O
plan	B
to	I
re	O
-	O
examine	O
this	O
hypothesis	B
in	O
another	O
birth	O
cohort	O
to	O
see	O
if	B
we	O
can	B
replicate	B
the	O
main	O
findings	O
.	O

The	O
potential	B
for	O
contamination	O
by	O
heavy	O
metals	O
,	O
as	O
well	O
as	O
risk	O
of	O
listeriosis	O
requires	B
careful	O
consideration	B
of	O
the	O
shaping	O
of	O
dietary	O
messages	O
related	B
to	O
fish	O
intake	O
during	O
pregnancy	O
.	O

We	O
computed	O
the	O
alternative	O
Mediterranean	O
diet	O
(	O
aMED	O
)	O
score	O
based	O
on	O
FFQ	O
-	O
derived	O
measures	O
of	O
daily	O
food	O
intake	O
,	O
following	O
the	O
method	O
of	O
Tobias	O
et	O
al	O
.	O

Methods	O
An	O
observational	O
analytic	O
cross	O
-	O
sectional	O
study	O
was	O
carried	O
out	O
amongst	O
pregnant	O
women	O
attending	O
selected	O
government	O
health	O
centres	O
in	O
the	O
Buea	O
Health	O
District	O
.	O

A	O
systematic	O
review	O
of	O
randomised	O
control	O
trials	O
examining	O
LC	O
n	O
-	O
3PUFA	O
supplementation	O
during	O
pregnancy	O
found	B
no	B
clear	I
association	O
between	O
supplement	O
use	O
and	O
infant	O
cognitive	O
outcomes	O
[	O
33	O
].	O

This	O
trial	O
of	O
100	O
000	O
IU	O
(	O
2	O
·	O
5	O
mg	O
)	O
vitamin	O
D3	O
(	O
cholecalciferol	O
)	O
supplementation	O
along	O
with	O
antibiotic	O
treatment	O
of	O
children	O
younger	O
than	O
3	O
years	O
with	O
clinically	O
diagnosed	O
pneumonia	O
in	O
Kabul	O
showed	O
no	O
difference	O
in	O
the	O
time	O
to	O
recovery	O
between	O
the	O
groups	O
.	O

Special	O
hypoallergenic	O
formula	O
(	O
extensively	O
hydrolyzed	O
,	O
not	O
soy	O
-	O
based	O
)	O
should	B
be	I
used	O
only	B
if	O
the	O
child	O
is	O
diagnosed	O
with	O
atopy	O
.	O

This	O
indicates	B
that	O
there	O
may	B
be	I
a	O
window	O
of	O
opportunity	O
during	O
fetal	O
development	O
in	O
which	O
allergic	O
manifestation	O
risk	O
may	B
be	I
altered	O
.	O

The	O
infant	O
is	O
weighed	O
on	O
a	O
calibrated	O
scale	O
with	O
minimum	O
of	O
clothing	O
,	O
namely	O
only	O
a	O
vest	O
,	O
and	O
without	O
a	O
nappy	O
;	O
and	O
recorded	O
to	O
the	O
nearest	O
5	O
g	O
.	O
Recumbent	O
length	O
of	O
the	O
infants	O
is	O
taken	O
by	O
means	O
of	O
an	O
infantometer	O
to	O
the	O
nearest	O
0	O
.	O
1	O
cm	O
.	O

Examples	O
of	O
such	O
proposed	O
adaptations	O
are	O
provided	O
within	O
the	O
OECD	O
Endocrine	O
Disruptor	O
Conceptual	O
Framework	O
(	O
Supplementary	O
Table	O
5	O
;	O
OECD2012	O
).	O

Maternal	O
intake	O
of	O
sugar	O
during	O
pregnancy	O
and	O
childhood	O
respiratory	O
and	O
atopic	O
outcomes	O
Abstract	O
The	O
possible	B
role	B
of	O
maternal	O
consumption	O
of	O
free	O
sugar	O
during	O
pregnancy	O
in	O
the	O
inception	O
of	O
respiratory	O
and	O
atopic	O
diseases	O
has	O
not	B
been	I
studied	I
.	O

In	O
this	B
review	I
,	O
the	O
authors	O
underline	B
that	O
regular	O
adjustment	O
of	O
levo	O
-	O
thyroxine	O
and	O
calcium	O
therapy	O
is	O
of	O
outmost	B
importance	I
for	O
both	O
maternal	O
and	O
foetal	O
well	O
-	O
being	O
and	O
offer	O
some	B
insight	B
,	O
very	O
interesting	B
from	O
a	O
practical	O
point	B
of	I
view	I
,	O
to	O
provide	O
a	O
clear	O
and	O
simple	O
pathway	O
for	O
the	O
management	O
of	O
pregnancy	O
-	O
associated	B
thyroid	O
cancer	O
.	O

Fructose	O
consumption	O
,	O
in	O
the	O
form	O
of	O
high	O
fructose	O
corn	O
syrup	O
(	O
ratio	O
of	O
fructose	O
/	O
glucose	O
60	O
/	O
40	O
%),	O
increased	O
from	O
near	O
0	O
%	O
to	O
near	O
30	O
%	O
of	O
per	O
capita	O
consumption	O
of	O
refined	O
sugars	O
in	O
the	O
USA	O
between	O
1970	O
and	O
2000	O
,	O
whereas	O
the	O
consumption	O
of	O
sucrose	O
and	O
glucose	O
declined	O
or	O
remained	O
constant	O
[	O
3	O
].	O

The	O
emulsifier	O
PROSOL	O
(	O
sodium	O
stearoyl	O
-	O
2	O
-	O
lactylate	O
)	O
increases	O
IMF	O
deposition	O
and	O
QG	O
in	O
Korean	O
cattle	O
[	O
108	O
].	O

The	O
capillaries	O
were	O
not	O
arranged	O
in	O
lobules	O
and	O
rather	O
were	O
dispersed	O
among	O
spicules	O
of	O
mineralized	O
bone	O
.	O

[	O
3	O
].	O

With	O
regards	O
to	O
pharmacokinetics	O
,	O
oral	O
dosing	O
produces	O
therapeutic	O
effects	O
within	O
3	O
-	O
5	O
days	O
.	O

Regarding	O
the	O
absence	O
of	O
hyperphagia	O
,	O
it	O
is	O
important	B
to	I
note	I
that	O
the	O
food	O
intake	O
has	B
been	I
associated	B
with	O
the	O
cannabinoid	O
activation	O
in	O
specific	O
hypothalamic	O
areas	O
(	O
Soria	O
-	O
Gomez	O
et	O
al	O
.,	O
2014	O
).	O

Furthermore	O
terbutaline	O
has	B
been	I
shown	I
to	O
increase	O
microglial	O
activation	O
associated	B
with	O
behavioral	O
abnormalities	O
akin	O
to	O
autism	O
.	O

Then	O
,	O
2	O
weeks	O
before	O
mating	O
(	O
Figure1	O
),	O
animals	O
were	O
weighed	O
(	O
average	O
weight	O
240	O
.	O
7	O
±	O
3	O
.	O
4	O
g	O
)	O
and	O
randomly	O
exposed	O
to	O
an	O
ad	O
libitum	O
access	O
of	O
a	O
standard	O
chow	O
(	O
control	O
group	O
;	O
n	O
=	O
9	O
)	O
or	O
a	O
restricted	O
access	O
of	O
the	O
same	O
standard	O
chow	O
(	O
caloric	O
restriction	O
group	O
;	O
n	O
=	O
15	O
).	O

Such	O
changes	O
may	B
still	B
prove	O
useful	O
for	O
regulatory	O
purposes	O
and	O
also	O
do	B
not	I
rule	I
out	I
the	O
possibility	B
of	O
later	O
onset	O
effects	B
.	O

Canaries	O
in	O
the	O
Uranium	O
Mines	O
The	O
arrival	O
of	O
prospectors	O
signified	O
the	O
Navajo	O
Nation	O
’	O
s	O
entrance	O
into	O
the	O
modern	O
wage	O
economy	O
.	O
7Some	O
welcomed	O
the	O
potential	O
income	O
.	O

For	O
example	O
,	O
certain	O
metals	O
and	O
environmental	O
chemicals	O
can	O
directly	O
bind	O
and	O
alter	O
the	O
activity	O
of	O
DNMTs	O
,	O
TETs	O
and	O
histone	O
modifiers	O
(	O
Chervona	O
&	O
Costa2012	O
;	O
Hou	O
et	O
al	O
.	O
2012	O
;	O
Wang	O
&	O
Wang2013	O
;	O
Ruiz	O
-	O
Hernandez	O
et	O
al	O
.	O
2015	O
).	O

†	O
Studies	O
validating	B
loss	O
of	O
both	O
epigenetic	O
change	O
(	O
s	O
)	O
and	O
adverse	O
effect	B
(	O
s	O
)	O
following	O
appropriate	O
inhibition	O
,	O
treatment	O
or	O
knock	O
out	O
/	O
down	O
.	O

For	B
this	I
reason	I
,	O
in	O
addition	O
to	O
calcitonin	O
-	O
gene	O
products	O
,	O
such	O
as	O
calcitonin	O
CGRP	O
(	O
calcitonin	O
-	O
generelated	O
-	O
peptide	O
)	O
and	O
C	O
-	O
CAP	O
(	O
katacalcin	O
),	O
MTC	O
cells	O
express	O
several	O
other	B
biochemical	O
markers	O
that	O
reflect	B
the	O
features	O
of	O
diffuse	O
neuroendocrine	O
system	O
,	O
implicated	B
in	O
the	O
pathogenesis	O
of	O
the	O
symptoms	O
(	O
flushing	O
,	O
diarrhoea	O
,	O
carcinoid	O
syndrome	O
or	O
Cushing	O
'	O
s	O
syndrome	O
)	O
that	O
may	B
occur	O
in	O
patients	O
with	O
advanced	O
disease	O
.	O

An	O
initial	O
diagnosis	O
of	O
autism	O
occurs	O
as	O
an	O
individual	O
is	O
noticeably	O
unable	O
to	O
achieve	O
certain	O
early	O
childhood	O
milestones	O
in	O
terms	O
of	O
communication	O
and	O
socialization	O
.	O

Univariate	O
associations	O
of	O
exposures	O
and	O
demographics	O
with	O
birth	O
weight	O
percentile	O
status	O
or	O
with	O
LINE	O
-	O
1	O
and	O
AluYb8	O
extent	O
were	O
examined	O
using	O
Kruskal	O
–	O
Wallis	O
tests	O
for	O
continuous	O
covariates	O
and	O
chi	O
-	O
square	O
tests	O
for	O
categorical	O
covariates	O
.	O

Although	B
previous	O
cross	O
-	O
sectional	O
studies	O
have	B
reported	I
a	O
positive	O
association	B
between	O
childhood	O
consumption	O
of	O
sugar	O
-	O
containing	O
drinks	O
,	O
including	O
fruit	O
juice	O
,	O
and	O
asthma	O
[	O
5	O
–	O
8	O
],	O
intake	O
of	O
free	O
sugar	O
in	O
early	O
childhood	O
in	O
our	O
study	O
was	O
not	O
associated	O
with	O
any	O
respiratory	O
or	O
atopic	O
outcome	O
.	O

The	O
risk	O
of	O
GDM	O
was	O
particularly	B
elevated	O
among	O
overweight	O
women	O
who	O
snored	O
.	O

The	O
first	O
sign	B
is	O
a	O
rise	O
in	O
the	O
ratio	O
of	O
calcium	O
to	O
creatinine	O
in	O
the	O
urine	O
,	O
which	O
precedes	O
hypercalcemia	O
.	O

An	O
intake	O
of	O
fish	O
may	B
reflect	B
a	O
health	O
conscious	O
diet	O
and	O
thus	B
the	O
positive	O
effects	B
may	B
not	O
be	O
directly	O
attributed	B
to	O
the	O
fish	O
but	O
rather	B
to	O
the	O
diet	O
as	O
a	O
whole	O
.	O

In	O
particular	O
,	O
stage	O
-	O
specific	O
feeding	O
programs	O
with	O
concentrate	O
-	O
based	O
diets	O
developed	O
by	O
Japan	O
and	O
Korea	O
are	O
described	O
in	O
this	O
article	O
.	O

The	O
intestinal	O
mucosa	O
is	O
renewed	O
every	O
5	O
to	O
6	O
days	O
and	O
will	O
absorb	O
as	O
much	O
iron	O
as	O
necessary	O
to	O
maintain	O
iron	O
balance	O
;	O
however	O
,	O
mature	O
cells	O
will	O
stop	O
absorbing	O
iron	O
entirely	O
if	O
they	O
are	O
flooded	O
with	O
it	O
,	O
even	B
if	O
there	O
is	O
an	O
iron	O
deficit	O
.	O

These	O
features	O
were	O
also	O
linked	B
to	O
an	O
impairment	O
of	O
the	O
browning	O
process	O
of	O
the	O
white	O
adipose	O
tissue	O
(	O
Geurts	O
et	O
al	O
.,	O
2015	O
).	O

[	O
6	O
]	O
sampled	O
women	O
in	O
gestational	O
week	O
26	O
–	O
28	O
,	O
and	O
found	B
a	O
higher	O
OR	O
for	O
SGA	O
than	O
the	O
two	O
studies	O
that	O
sampled	O
women	O
in	O
T1	O
.	O

Our	O
aim	B
was	O
to	B
evaluate	I
the	O
association	B
between	O
the	O
intake	O
of	O
different	O
fish	O
species	O
,	O
PUFA	O
and	O
vitamin	O
D	O
and	O
the	O
prevalence	O
of	O
psychotic	O
-	O
like	O
symptoms	O
in	O
a	O
population	O
-	O
based	O
study	O
among	O
Swedish	O
women	O
.	O

Methods	O
Study	O
population	O
This	O
study	O
utilised	O
data	O
collected	O
from	O
the	O
multi	O
-	O
centre	O
,	O
prospective	O
cohort	O
Screening	O
for	O
Pregnancy	O
Endpoints	O
(	O
SCOPE	O
)	O
study	O
[	O
28	O
].	O

The	O
association	O
between	O
fish	O
,	O
fatty	O
acids	O
or	O
vitamin	O
D	O
and	O
psychotic	O
-	O
like	O
symptoms	O
was	O
summarized	O
in	O
terms	O
of	O
relative	O
risk	O
ratios	O
(	O
RRRs	O
)	O
and	O
corresponding	O
95	O
%	O
confidence	O
intervals	O
,	O
and	O
it	O
was	O
evaluated	O
by	O
energy	O
-	O
adjusted	O
multinomial	O
logistic	O
regression	O
(	O
polytomous	O
logistic	O
regression	O
),	O
for	O
example	O
:	O
RRR	O
=	O
P	O
(	O
y	O
=	O
high	O
level	O
group	O
;	O
fish	O
intake	O
>	O
2	O
/	O
week	O
)/	O
P	O
(	O
y	O
=	O
low	O
level	O
group	O
;	O
fish	O
intake	O
>	O
2	O
/	O
week	O
)/	O
P	O
(	O
y	O
=	O
high	O
level	O
group	O
;	O
no	O
fish	O
intake	O
)/	O
P	O
(	O
y	O
=	O
low	O
level	O
group	O
;	O
no	O
fish	O
intake	O
).	O

Therefore	B
,	O
thyroxine	O
therapy	O
aims	B
at	O
suppressing	O
pituitary	O
secretion	O
of	O
TSH	O
,	O
as	B
indicated	B
by	O
serum	O
TSH	O
levels	O
below	O
0	O
.	O
05	O
mIU	O
/	O
L	O
.	O

These	O
conditions	O
were	O
maintained	O
for	O
six	O
weeks	O
prior	O
to	O
mating	O
and	O
throughout	O
gestation	O
.	O

The	O
number	O
of	O
children	O
lost	O
to	O
follow	O
-	O
up	O
was	O
low	O
and	O
many	O
children	O
lost	O
at	O
one	O
time	O
because	O
of	O
travel	O
rejoined	O
the	O
study	O
later	O
with	O
rates	O
being	O
similar	O
between	O
the	O
two	O
groups	O
(	O
figure	O
1	O
).	O

The	O
resulting	O
gene	O
lists	O
were	O
compared	O
between	O
LP	O
and	O
AP	O
offspring	O
at	O
the	O
corresponding	O
ontogenetic	O
periods	O
.	O

The	O
baby	O
had	O
been	O
on	O
cow	O
'	O
s	O
milk	O
since	O
birth	O
.	O

Many	B
studies	I
have	B
shown	I
that	O
increased	O
visfatin	O
levels	O
in	O
maternal	O
plasma	O
are	O
associated	B
with	O
small	O
-	O
for	O
-	O
gestantional	O
-	O
age	O
births	O
(	O
8	O
)	O
and	O
intrauterine	O
growth	O
restriction	O
(	O
9	O
).	O

We	O
collected	O
venous	O
blood	O
samples	O
from	O
randomly	O
selected	O
blocks	O
of	O
children	O
on	O
the	O
basis	O
of	O
the	O
assumption	O
that	O
each	O
block	O
had	O
an	O
equal	O
number	O
of	O
children	O
from	O
the	O
vitamin	O
D3and	O
placebo	O
groups	O
.	O

Consequently	B
,	O
there	O
is	O
worldwide	O
recognition	O
of	O
this	O
phenomenon	O
,	O
and	O
discussion	O
on	O
how	B
to	O
both	O
guide	O
further	B
scientific	I
research	I
towards	O
a	O
greater	O
mechanistic	O
understanding	O
of	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
humans	O
,	O
and	O
translate	O
relevant	B
research	O
outcomes	O
into	O
appropriate	O
regulatory	O
policies	O
for	O
effective	O
public	B
health	I
protection	O
.	O

The	O
UPBEAT	O
trial	O
evaluated	O
the	O
effect	O
of	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
among	O
obese	O
women	O
,	O
with	O
no	O
impact	O
on	O
infant	O
birth	O
weight	O
demonstrated	O
[	O
17	O
].	O

Obviously	O
,	O
this	O
initiates	O
an	O
immediate	O
recovery	O
of	O
the	O
activity	O
of	O
genes	O
to	O
'	O
normal	O
level	O
'	O
reflected	O
by	O
similar	O
expression	O
pattern	O
in	O
LP	O
and	O
AP	O
piglets	O
.	O

Adjusted	O
relative	O
risks	O
(	O
aRR	O
)	O
of	O
pregnancy	O
complications	O
from	O
any	O
complication	O
,	O
preeclampsia	O
(	O
PE	O
),	O
gestational	O
hypertension	O
(	O
GH	O
),	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
),	O
spontaeous	O
preterm	O
birth	O
(	O
sPTB	O
)	O
and	O
small	O
-	O
for	O
-	O
gestational	O
age	O
(	O
SGA	O
)	O
according	O
to	O
vitamin	O
D	O
status	O
and	O
stratified	O
by	O
fetal	O
sex	O
.	O

Vitamin	O
D	O
deficiency	O
is	O
a	O
widespread	O
global	B
problem	B
,	O
which	O
even	B
can	B
observe	O
in	O
the	O
countries	O
which	O
get	O
enough	O
sunlight	O
[	O
49	O
,	O
51	O
].	O

The	O
red	O
dashed	O
lines	O
represent	O
the	O
null	O
limits	O
for	O
the	O
permutation	O
distribution	O
of	O
regression	O
coefficient	O
t	O
-	O
statistics	O
(	O
t	O
-	O
stat	O
),	O
adjusted	O
for	O
multiple	O
comparisons	O
.	O

Because	O
subjects	O
were	O
selected	O
based	O
on	O
SGA	O
status	O
and	O
matched	O
to	O
non	O
-	O
SGA	O
infants	O
on	O
sex	O
,	O
gestational	O
age	O
,	O
and	O
maternal	O
age	O
,	O
we	O
observed	O
no	O
significant	O
differences	O
in	O
those	O
characteristics	O
among	O
birth	O
weight	O
groups	O
(	O
SGA	O
,	O
AGA	O
,	O
LGA	O
).	O

The	O
main	O
epigenetic	O
pathways	O
,	O
including	O
histone	O
modifications	O
,	O
DNA	O
methylation	O
and	O
sncRNAs	O
,	O
are	O
also	O
conserved	O
in	O
zebrafish	O
(	O
Mishima2012	O
;	O
Kamstra	O
et	O
al	O
.	O
2015	O
;	O
Williams	O
et	O
al	O
.	O
2014	O
).	O

The	O
average	O
intake	O
of	O
food	O
items	O
from	O
the	O
FFQ	O
were	O
converted	O
into	O
average	O
intake	O
of	O
energy	O
and	O
nutrients	O
by	O
linkage	O
to	O
the	O
database	O
of	O
nutrients	O
created	O
by	O
the	O
Swedish	O
National	O
Food	O
Administration	O
[	O
27	O
].	O

47	O
859	O
women	O
were	O
invited	O
to	O
complete	O
a	O
web	O
-	O
based	O
questionnaire	O
,	O
and	O
non	O
-	O
responders	O
received	O
a	O
paper	O
questionnaire	O
.	O

All	O
measurements	O
are	O
done	O
twice	O
and	O
recorded	O
to	O
the	O
nearest	O
0	O
.	O
05	O
kg	O
for	O
weight	O
,	O
0	O
.	O
1	O
cm	O
for	O
MUAC	O
and	O
height	O
.	O

Although	B
we	O
found	O
that	O
these	O
repetitive	O
element	O
indicators	O
are	O
weakly	O
to	O
moderately	O
correlated	B
,	O
they	O
have	O
their	O
own	O
unique	O
distributions	O
of	O
methylation	O
values	O
,	O
consistent	B
with	O
previous	O
comparisons	O
between	O
LINE	O
-	O
1	O
and	O
Alu	O
methylation	O
in	O
normal	O
blood	O
(	O
Jintaridth	O
and	O
Mutirangura	O
2010	O
).	O

While	B
fruit	O
is	O
considered	O
healthful	O
and	O
red	O
and	O
processed	O
meat	O
consumption	O
is	O
recommended	B
to	O
be	O
limited	O
,	O
OTUs	O
in	O
the	O
genus	O
Bifidobacterium	O
,	O
generally	O
recognized	O
as	O
a	O
beneficial	O
microbe	O
,	O
were	O
decreased	O
with	O
increasing	O
maternal	O
fruit	O
consumption	O
in	O
vaginally	O
born	O
infants	O
yet	B
increased	O
with	O
higher	O
maternal	O
red	O
and	O
processed	O
meat	O
consumption	O
in	O
those	O
born	O
by	O
Cesarean	O
section	O
.	O

In	O
contrast	O
,	O
backfat	O
thickness	O
,	O
which	O
is	O
a	O
negative	O
YG	O
factor	O
,	O
was	O
highest	O
in	O
winter	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Finally	O
,	O
Guinchat	O
et	O
al	O
.	O

Folate	O
deficiency	O
was	O
associated	B
with	O
an	O
increase	O
in	O
DNA	O
damage	O
in	O
spermatocytes	O
.	O

2003	O
;	O
Spanò	O
et	O
al	O
.	O

The	O
Shonjibon	O
study	O
area	O
will	O
consist	O
of	O
24	O
Upazilas	O
from	O
these	O
five	O
districts	O
(	O
Fig	O
.	O

We	O
are	O
presenting	O
a	O
case	O
of	O
gestational	O
diabetes	O
insipidus	O
in	O
a	O
patient	O
with	O
HELLP	O
syndrome	O
.	O

(	O
2012	O
)	O
*	O
Lifestyle	O
factors	O
Smoking	O
:	O
Cigarette	O
smokeAdulthood	O
LifetimeAdulthoodCOPD	O
Breast	O
and	O
lung	O
cancer	O
↓	O
lung	O
cancer	O
overall	O
survivalDNA	O
methylation	O
Epigenetic	O
machinery	O
miRNAsLin	O
et	O
al	O
.	O

Our	O
model	B
indicates	B
that	O
gestational	O
LP	O
diets	O
affected	B
the	O
hepatic	O
expression	O
profiles	O
in	O
an	O
acute	O
,	O
short	O
-	O
term	O
as	O
well	O
as	O
in	O
a	O
delayed	O
,	O
long	O
-	O
term	O
manner	O
in	O
LP	O
offspring	O
.	O

Upstream	O
signaling	O
events	O
of	O
'	O
mTOR	O
signaling	O
'	O
include	O
alterations	O
in	O
amino	O
acid	O
availability	O
,	O
abundance	O
of	O
hormones	O
,	O
AMP	O
and	O
growth	O
factors	O
[	O
32	O
].	O

01117961	O
)	O
[	O
16	O
].	O

¶	O
Studies	O
in	O
which	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
epigenetic	O
change	O
(	O
s	O
)	O
were	O
reported	B
in	O
separate	O
publications	O
but	O
were	O
performed	O
within	O
the	O
same	O
experimental	O
animals	O
.	O

Effective	O
interventions	O
directed	O
specifically	O
at	O
preventing	O
neonatal	O
deaths	O
are	O
required	B
to	O
improve	O
overall	O
child	O
survival	O
.	O

When	O
dividing	O
the	O
cohort	O
by	O
vitamin	O
D	O
sufficiency	O
status	O
for	O
additional	O
analyses	O
,	O
vitamin	O
D	O
deficiency	O
was	O
defined	O
as	O
<	O
20	O
ng	O
/	O
mL	O
(<	O
50	O
nmol	O
/	O
L	O
)).	O

Conclusions	O
In	O
conclusion	O
,	O
once	O
standardised	O
against	O
month	O
of	O
sampling	O
,	O
we	O
demonstrate	B
a	O
protective	B
effect	B
of	O
high	O
vitamin	O
D	O
with	O
GDM	O
.	O

Overall	O
,	O
a	O
woman	O
requires	B
about	O
2	O
–	O
2	O
.	O
8	O
mg	O
of	O
iron	O
per	O
day	O
during	O
pregnancy	O
[	O
17	O
].	O

Future	B
research	I
is	I
needed	I
to	O
determine	O
whether	B
differences	O
in	O
postnatal	O
feeding	O
behaviors	O
might	B
explain	O
differential	O
growth	O
rates	O
in	O
offspring	O
of	O
normal	O
weight	O
and	O
overweight	O
/	O
obese	O
mothers	O
.	O

Environmental	O
Risk	O
Factors	O
for	O
Atopy	O
The	O
causes	O
of	O
allergy	O
in	O
general	O
and	O
of	O
specific	O
sensitization	O
in	O
newborns	O
in	O
particular	O
have	O
not	B
yet	I
been	I
completely	O-
determined	I
.	O

This	O
adjunctive	O
therapy	O
is	O
supposed	B
to	I
destroy	O
occult	O
microscopic	O
carcinoma	O
within	O
the	O
thyroid	O
remnant	O
by	O
being	O
actively	O
trapped	O
both	O
by	O
normal	O
and	O
pathological	O
thyroid	O
cells	O
,	O
and	O
to	O
facilitate	O
follow	O
-	O
up	O
because	B
serum	O
thyroglobulin	O
(	O
HTG	O
)	O
measurements	O
are	O
more	O
reliable	B
after	O
the	O
destruction	O
of	O
residual	O
normal	O
thyroid	O
tissue	O
.	O

MTC	O
arises	O
from	O
C	O
cells	O
secreting	O
calcitonin	O
,	O
a	O
32	O
-	O
amino	O
acid	O
peptide	O
.	O

Nutrition	O
during	O
pregnancy	O
is	O
an	O
important	B
factor	O
associated	B
with	O
both	O
maternal	O
and	O
infant	O
health	O
outcomes	O
[	O
80	O
].	O

Birth	O
weight	O
is	O
an	O
independent	O
predictor	O
of	O
the	O
development	O
of	O
obesity	O
;	O
however	O
,	O
increases	O
in	O
weight	O
during	O
the	O
first	O
3	O
–	O
6	O
months	O
of	O
life	O
are	O
also	O
influential	B
on	O
long	O
-	O
term	O
increased	O
risk	O
of	O
obesity	O
[	O
47	O
,	O
48	O
].	O

The	O
higher	O
leptin	O
sensitivity	O
described	B
in	O
females	O
than	O
in	O
males	O
has	B
been	I
associated	B
with	O
gonadal	O
hormones	O
(	O
Clegg	O
et	O
al	O
.,	O
2003	O
,	O
2006	O
)	O
and	O
may	B
explain	B
in	B
part	I
the	O
higher	O
levels	O
of	O
leptin	O
found	B
in	O
the	O
plasma	O
of	O
male	O
offspring	O
.	O

Research	O
assistants	O
used	O
Harpenden	O
skin	O
-	O
fold	O
callipers	O
to	O
obtain	O
skinfold	O
thickness	O
measurements	O
,	O
and	O
received	O
ongoing	O
standardised	O
training	O
[	O
29	O
].	O

To	B
the	I
best	I
of	I
our	I
knowledge	I
no	B
one	I
has	O
evaluated	O
the	O
impact	B
of	O
sleep	O
duration	O
and	O
snoring	O
on	O
maternal	O
glucose	O
metabolism	O
in	O
pregnancy	O
.	O

For	O
patients	O
who	O
were	O
already	O
on	O
immunotherapy	O
before	O
the	O
pregnancy	O
,	O
maintenance	O
treatment	O
may	B
be	I
continued	O
safely	O
during	O
pregnancy	O
.	O

2004	O
;	O
Simon	O
and	O
Kingston	O
2009	O
).	O

Of	O
these	O
,	O
952	O
probe	O
-	O
sets	O
showed	O
higher	O
expression	O
and	O
1	O
,	O
132	O
probe	O
-	O
sets	O
showed	O
lower	O
expression	O
in	O
LP	O
than	O
in	O
AP	O
offspring	O
.	O

Methods	O
This	O
randomized	O
clinical	O
trial	O
was	O
done	O
in	O
pregnant	O
women	O
who	O
were	O
under	O
prenatal	O
care	O
in	O
a	O
teaching	O
hospital	O
in	O
Shiraz	O
,	O
Iran	O
.	O

We	O
identified	O
147	O
rodent	O
studies	O
within	O
PubMed	O
(	O
up	O
to	O
7	O
March	O
2016	O
)	O
demonstrating	B
both	O
adverse	O
phenotype	O
(	O
s	O
)	O
(	O
such	O
as	O
reduced	O
fertility	O
,	O
reproductive	O
,	O
developmental	O
or	O
other	O
organ	O
-	O
specific	O
abnormalities	O
,	O
or	O
adult	O
onset	O
diseases	O
(	O
cancer	O
,	O
diabetes	O
,	O
obesity	O
or	O
immune	O
disorders	O
))	O
and	O
epigenetic	O
change	O
(	O
s	O
)	O
(	O
histone	O
modification	O
,	O
DNA	O
methylation	O
,	O
epigenetic	O
machinery	O
or	O
miRNAs	O
)	O
following	O
exposure	O
to	O
environmental	O
factor	O
(	O
s	O
)	O
(	O
including	O
chemicals	O
,	O
radiation	O
or	O
lifestyle	O
factors	O
(	O
alcohol	O
,	O
nutrition	O
,	O
or	O
smoking	O
))	O
at	O
various	O
stages	O
of	O
development	O
(	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
,	O
neonatal	O
,	O
lactation	O
,	O
childhood	O
,	O
adolescence	O
and	O
adulthood	O
).	O

Visfatin	O
had	O
been	O
copiously	O
excreted	O
in	O
mother	O
’	O
s	O
milk	O
,	O
and	O
serum	O
visfatin	O
levels	O
were	O
100	O
times	O
higher	O
in	O
mothers	O
’	O
milk	O
than	O
in	O
their	O
blood	O
.	O

Thus	B
,	O
the	O
continuous	O
cycling	O
of	O
triglyceride	O
hydrolysis	O
coupled	O
to	O
resynthesis	O
,	O
which	O
requires	O
large	O
amounts	O
of	O
ATP	O
,	O
could	B
be	I
another	O
important	B
mechanism	O
to	O
increase	O
thermogenesis	O
in	O
BAT	O
,	O
in	O
addition	O
to	O
the	O
role	B
of	O
UCP1	O
activation	O
in	O
this	O
process	O
(	O
Mottillo	O
et	O
al	O
.,	O
2014	O
).	O

T1	O
25OHD	O
was	O
also	O
investigated	O
as	O
a	O
continuous	O
variable	O
as	O
there	O
were	O
few	O
cases	O
in	O
some	O
categories	O
.	O

Data	O
will	O
be	O
analysed	O
prospectively	O
to	O
determine	O
associations	O
between	O
variables	O
at	O
different	O
time	O
points	O
(	O
longitudinally	O
)	O
by	O
using	O
appropriate	O
statistical	O
methods	O
(	O
e	O
.	O
g	O
.	O

Restricting	O
the	O
definition	O
of	O
pneumonia	O
confirmed	O
with	O
chest	O
radiography	O
to	O
consolidation	O
only	O
,	O
gave	O
a	O
rate	O
of	O
0	O
·	O
011	O
per	O
child	O
per	O
year	O
(	O
95	O
%	O
CI	O
0	O
·	O
008	O
–	O
0	O
·	O
017	O
)	O
in	O
the	O
vitamin	O
D	O
group	O
and	O
0	O
·	O
008	O
(	O
0	O
·	O
005	O
–	O
0	O
·	O
013	O
)	O
in	O
the	O
placebo	O
group	O
;	O
this	O
difference	O
was	O
not	O
significant	O
RR	O
1	O
·	O
44	O
(	O
0	O
·	O
76	O
–	O
2	O
·	O
72	O
).	O

Thus	B
,	O
Korean	O
and	O
Japanese	O
beef	O
production	O
systems	O
have	O
focused	O
on	O
production	O
of	O
highly	O
marbled	O
beef	O
to	O
satisfy	O
their	O
customers	O
and	O
to	O
protect	O
their	O
beef	O
industry	O
against	O
imported	O
beef	O
that	O
has	O
relatively	O
low	O
MS	O
.	O
As	O
described	O
above	O
,	O
several	O
nutritional	O
factors	O
affect	B
IMF	O
deposition	O
,	O
and	O
these	O
factors	O
must	B
be	I
considered	B
to	O
prepare	O
a	O
proper	O
diet	O
to	O
improve	O
marbling	O
at	O
the	O
proper	O
time	O
in	O
the	O
life	O
cycle	O
.	O

Nutritional	O
programming	O
during	O
the	O
fetal	O
and	O
neonatal	O
periods	O
has	B
been	I
suggested	I
as	O
a	O
promising	B
method	O
to	O
manipulate	O
IMF	O
deposition	O
.	O

In	B
spite	I
of	O
the	O
theoretical	B
proliferative	O
stimulation	O
caused	O
by	O
HCG	O
and	O
placental	O
growth	O
factors	O
,	O
published	O
data	O
indicate	B
that	O
there	O
is	O
no	B
evidence	I
that	O
thyroid	O
cancer	O
can	B
be	O
influenced	B
by	O
pregnancy	O
.	O

The	O
lack	O
of	O
vitamin	O
A	O
supplementation	O
also	O
increased	O
marbling	O
compared	O
with	O
vitamin	O
A	O
supplementation	O
in	O
a	O
study	O
of	O
Angus	O
crossbred	O
steers	O
[	O
133	O
].	O

Data	O
were	O
entered	O
into	O
a	O
Microsoft	O
Access	O
database	O
(	O
version	O
2007	O
)	O
and	O
data	O
processing	O
and	O
analysis	O
was	O
done	O
in	O
STATA	O
(	O
version	O
11	O
.	O
0	O
).	O

The	O
females	O
with	O
caloric	O
restriction	O
were	O
fed	O
with	O
a	O
daily	O
amount	O
of	O
food	O
corresponding	O
to	O
the	O
80	O
%	O
of	O
the	O
calories	O
that	O
the	O
control	O
rats	O
were	O
fed	O
in	O
the	O
previous	O
day	O
of	O
the	O
experiment	O
,	O
according	O
to	O
the	O
body	O
weight	O
(	O
20	O
%	O
of	O
caloric	O
restriction	O
).	O

In	O
vivo	O
testing	O
should	B
generally	B
be	O
postponed	O
until	O
after	O
pregnancy	O
,	O
unless	O
diagnosis	O
for	O
therapeutic	O
intervention	O
is	O
urgently	B
needed	O
.	O

Characteristics	O
of	O
the	O
8956	O
mother	O
–	O
child	O
pairs	O
who	O
were	O
included	O
in	O
the	O
analyses	O
and	O
those	O
of	O
the	O
3122	O
mother	O
–	O
child	O
pairs	O
with	O
information	O
on	O
maternal	O
diet	O
who	O
were	O
excluded	O
because	B
of	O
incomplete	B
outcome	O-
data	I
are	O
compared	O
in	O
supplementary	O
table	O
E1	O
.	O

Tissue	O
-	O
specific	O
FGF21	O
regulation	O
was	O
shown	O
to	O
occur	O
in	O
response	O
to	O
chronic	O
cold	O
exposure	O
in	O
mice	O
(	O
Fisher	O
et	O
al	O
.,	O
2012	O
).	O

The	O
central	O
team	O
will	O
comprise	O
of	O
three	O
research	O
fellows	O
,	O
one	O
medical	O
officer	O
and	O
one	O
research	O
investigator	O
and	O
one	O
BRAC	O
national	O
manager	O
.	O

Maternal	O
mean	O
1	O
-	O
hour	O
plasma	O
glucose	O
concentrations	O
,	O
adjusted	O
for	O
age	O
and	O
race	O
/	O
ethnicity	O
,	O
were	O
highest	O
for	O
women	O
who	O
reported	O
habitual	O
sleep	O
duration	O
≤	O
4	O
hours	O
per	O
night	O
during	O
early	O
pregnancy	O
and	O
lowest	O
for	O
those	O
who	O
reported	O
sleeping	O
9	O
hours	O
per	O
night	O
on	O
average	O
.	O

The	O
intake	O
of	O
fatty	O
acids	O
and	O
vitamin	O
D	O
was	O
categorized	O
into	O
quartiles	O
,	O
with	O
the	O
lowest	O
quartile	O
as	O
the	O
reference	O
category	O
for	O
comparison	O
.	O

The	O
importance	B
of	O
effective	O
3	O
-	O
way	O
communication	O
among	O
the	O
patient	O
,	O
asthma	O
specialist	O
,	O
and	O
obstetrician	O
cannot	B
be	I
overemphasized	I
.	O

Interestingly	B
,	O
vitamin	O
D	O
status	O
at	O
T1	O
-	O
around	O
the	O
time	O
the	O
maternal	O
blood	O
flow	O
of	O
the	O
placenta	O
is	O
fully	O
developed	O
-	O
is	O
only	B
related	B
to	O
pregnancy	O
loss	O
.	O

In	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
,	O
we	O
identified	O
three	O
clusters	O
that	O
differed	O
slightly	O
from	O
vaginally	O
delivered	O
infants	O
,	O
which	O
were	O
characterized	O
by	O
a	O
high	O
abundance	O
of	O
Bifidobacterium	O
,	O
high	O
Clostridium	O
and	O
low	O
Streptococcus	O
and	O
Ruminococcus	O
genera	O
,	O
and	O
high	O
abundance	O
of	O
the	O
family	O
Enterobacteriaceae	O
.	O

Adequate	O
vitamin	O
D	O
intake	O
is	O
associated	B
with	O
a	O
lower	O
risk	O
of	O
cancer	O
[	O
7	O
],[	O
8	O
],[	O
9	O
],[	O
10	O
],[	O
11	O
],	O
cardiovascular	O
diseases	O
[	O
12	O
],	O
autoimmune	O
diseases	O
[	O
13	O
],	O
neurological	O
disorders	O
[	O
14	O
]	O
and	O
diabetes	O
[	O
15	O
].	O

1c	O
;	O
Additional	O
file	O
1	O
:	O
Table	O
S2a	O
).	O

The	O
remaining	O
95	O
–	O
99	O
%	O
of	O
the	O
genome	O
was	O
regarded	B
as	O
‘	O
junk	O
’	O
DNA	O
.	O

Nutrient	O
density	O
was	O
calculated	O
by	O
dividing	O
the	O
estimated	O
intake	O
of	O
fatty	O
acids	O
,	O
vitamin	O
D	O
and	O
other	O
nutrients	O
by	O
the	O
total	O
energy	O
intake	O
(	O
i	O
.	O
e	O
.,	O
the	O
multivariate	O
nutrient	O
density	O
model	O
)	O
[	O
28	O
].	O

Vitamin	O
D2	O
cannot	O
be	O
synthesized	O
endogenously	O
,	O
i	O
.	O
e	O
.,	O
it	O
is	O
an	O
exogenous	O
only	O
Vitamin	O
D	O
,	O
which	O
comes	O
from	O
artificially	O
synthesized	O
compounds	O
or	O
some	O
plant	O
foods	O
such	O
as	O
edible	O
mushroom	O
grown	O
in	O
natural	O
environment	O
.	O

Spearman	O
correlations	O
(	O
ρ	O
)	O
were	O
used	O
to	O
assess	O
the	O
association	O
between	O
each	O
child	O
’	O
s	O
cathelicidin	O
concentration	O
and	O
the	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
obtained	O
at	O
various	O
time	O
points	O
:	O
(	O
1	O
)	O
at	O
the	O
corresponding	O
follow	O
-	O
up	O
visit	O
;	O
(	O
2	O
)	O
at	O
delivery	O
;	O
(	O
3	O
)	O
maternal	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
D	O
throughout	O
pregnancy	O
(	O
using	O
the	O
area	O
under	O
the	O
curve	O
from	O
visit	O
3	O
to	O
visit	O
7	O
);	O
and	O
(	O
4	O
)	O
maternal	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
D	O
within	O
one	O
month	O
of	O
delivery	O
.	O

We	O
used	O
PyNAST	O
alignment	O
[	O
37	O
]	O
with	O
Greengenes	O
core	O
reference	O
[	O
38	O
,	O
39	O
]	O
to	O
build	O
OTU	O
tables	O
and	O
assign	O
taxonomy	O
[	O
39	O
,	O
40	O
].	O

To	B
study	I
the	O
Vitamin	O
D	O
nutritional	O
status	O
of	O
pregnant	O
women	O
with	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
in	O
the	O
middle	O
and	O
late	O
pregnancy	O
and	O
analyze	B
the	O
different	B
sources	O
of	O
Vitamin	O
D	O
intake	O
.	O

Regarding	O
female	O
offspring	O
,	O
two	O
-	O
way	O
ANOVA	O
indicated	B
a	O
main	O
effect	B
of	O
prenatal	O
diet	O
[	O
F	O
(	O
3	O
,	O
31	O
)=	O
7	O
.	O
517	O
,	O
P	O
<	O
0	O
.	O
05	O
]	O
and	O
an	O
almost	O
significant	O
effect	B
of	O
treatment	O
[	O
F	O
(	O
3	O
,	O
31	O
)=	O
3	O
.	O
928	O
,	O
P	O
=	O
0	O
.	O
056	O
]	O
on	O
chocolate	O
intake	O
(	O
Figure3G	O
).	O

Among	O
these	O
women	O
,	O
one	O
(	O
10	O
%)	O
had	O
25OHD	O
concentration	O
<	O
30	O
nmol	O
/	O
L	O
in	O
T1	O
.	O

It	O
can	O
be	O
observed	B
that	O
a	O
slight	O
increase	O
in	O
fT4	O
and	O
a	O
reduction	O
in	O
TSH	O
occur	O
between	O
the	O
9thand	O
12thweeks	O
of	O
gestation	O
;	O
subsequently	O
,	O
HCG	O
levels	O
decrease	O
and	O
TSH	O
reaches	O
normal	O
non	O
-	O
pregnant	O
levels	O
.	O

Studies	O
examining	O
the	O
impact	B
of	O
environmental	O
exposures	O
on	O
DNA	O
methylation	O
have	O
often	O
focused	O
on	O
the	O
global	O
extent	O
of	O
5	O
-	O
methylcytosine	O
,	O
using	O
various	O
approaches	O
(	O
Einstein	O
et	O
al	O
.	O

In	O
addition	O
,	O
specific	O
deletion	O
of	O
Pten	O
in	O
the	O
liver	O
in	O
LPTENKO	O
mice	O
induces	O
a	O
strong	O
hepatic	O
steatosis	O
(	O
Stiles	O
et	O
al	O
.,	O
2004	O
;	O
Peyrou	O
et	O
al	O
.,	O
2015	O
),	O
but	O
improves	O
the	O
overall	O
insulin	O
sensitivity	O
,	O
and	O
decreases	O
the	O
fat	O
mass	O
.	O

While	B
the	O
risk	O
factors	O
outlined	O
in	O
this	O
review	O
do	O
not	O
conflict	B
with	O
our	O
current	O
understanding	O
of	O
the	O
natural	O
history	O
of	O
cancer	O
or	O
glioma	O
specifically	O
,	O
the	O
evidence	O
in	O
support	B
of	O
a	O
causal	O
relationship	B
has	O
not	B
been	I
consistent	I
.	O

A	O
major	O
issue	B
in	O
sex	O
differences	O
is	O
the	O
need	I
for	O
control	O
the	O
estrous	O
phase	O
on	O
which	O
the	O
evaluations	O
were	O
performed	O
in	O
order	O
to	B
clarify	I
the	O
impact	B
of	O
sex	O
hormones	O
variations	B
in	O
the	O
female	O
.	O

We	O
conducted	O
the	O
key	O
informant	O
interviews	O
to	O
understand	O
the	O
community	O
norms	O
around	O
IFA	O
supplementation	O
,	O
and	O
challenges	O
and	O
successes	O
of	O
the	O
existing	O
programme	O
.	O

ANC	O
coverage	O
in	O
Cameroon	O
in	O
2007	O
stood	O
at	O
82	O
%	O
with	O
60	O
%	O
of	O
pregnant	O
women	O
having	O
four	O
or	O
more	O
visits	O
[	O
2	O
].	O

Normal	O
embryo	O
development	O
requires	O
a	O
maternal	O
and	O
paternal	O
contribution	O
,	O
generation	O
of	O
uniparental	O
embryos	O
by	O
pronuclear	O
transplantation	O
results	O
in	O
developmental	O
failure	O
(	O
Barton	O
et	O
al	O
.	O
1984	O
;	O
McGrath	O
&	O
Solter1984	O
).	O

As	O
a	O
part	O
of	O
the	O
capacity	O
building	O
efforts	O
,	O
the	O
Ministry	O
of	O
Women	O
&	O
Child	O
Development	O
has	O
recommended	B
policy	O
related	O
and	O
institutional	O
transformations	O
.	O

Educational	O
level	O
There	O
was	O
insignificant	O
difference	O
using	O
the	O
Fisher	O
'	O
s	O
exact	O
test	O
,	O
with	O
regards	O
to	O
all	O
the	O
service	O
ratings	O
when	O
different	O
educational	O
levels	O
were	O
compared	O
(	O
Table	O
3	O
).	O

PubMed	O
Central	O
:	O

Our	O
analysis	O
of	O
the	O
relationship	B
between	O
the	O
extent	O
of	O
methylation	O
at	O
these	O
elements	O
and	O
genomewide	O
gene	O
-	O
associated	O
methylation	O
was	O
aimed	B
to	O
better	O
characterize	O
the	O
similarities	O
and	O
differences	O
in	O
the	O
potential	B
functional	O
importance	B
of	O
these	O
markers	O
.	O

Hub	O
proteins	O
not	O
significantly	O
dysregulated	O
in	O
the	O
study	O
are	O
shown	O
as	O
clear	O
.	O

This	O
is	O
because	B
these	O
settings	O
are	O
characterized	O
by	O
poor	B
maternal	O
health	O
service	O
indicators	O
such	O
as	O
nonutilization	O
of	O
service	O
or	O
delayed	O
antenatal	O
visit	O
.	O

Since	O
1991	O
/	O
1992	O
,	O
688	O
women	O
were	O
deceased	O
,	O
and	O
491	O
women	O
had	O
emigrated	O
.	O

Few	B
case	O
reports	O
have	O
suggested	B
an	O
interaction	B
between	O
season	O
or	O
latitude	O
and	O
psychological	O
problems	B
[	O
28	O
,	O
29	O
].	O

Venous	O
blood	O
from	O
the	O
infant	O
(	O
3	O
ml	O
)	O
is	O
drawn	O
at	O
phases	O
6	O
,	O
7	O
and	O
8	O
.	O

Oral	O
antidiabetic	O
agents	O
in	O
gestational	O
diabetes	O
There	O
is	O
controversy	B
regarding	O
the	O
use	O
of	O
oral	O
hypoglycemic	O
agents	O
during	O
pregnancy	O
.	O

This	O
process	O
is	O
active	O
and	O
specific	O
,	O
much	O
like	O
the	O
process	O
of	O
sensitization	O
[	O
119	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Levels	O
of	O
adiposity	O
in	O
perirenal	O
,	O
perigonadal	O
and	O
abdominal	O
fat	O
of	O
rat	O
adult	O
offspring	O
at	O
postnatal	O
weeks	O
21	O
–	O
23	O
†	O
.	O
MaleFemaleTwo	O
-	O
way	O
ANOVACC	O
(	O
n	O
=	O
12	O
)	O
RC	O
(	O
n	O
=	O
15	O
)	O
CC	O
(	O
n	O
=	O
11	O
)	O
RC	O
(	O
n	O
=	O
17	O
)	O
InteractionPrenatal	O
dietSex	O
Perirenal	O
fat	O
(	O
g	O
)	O
8	O
.	O
90	O
±	O
0	O
.	O
4112	O
.	O
30	O
±	O
0	O
.	O
64	O
***	O
4	O
.	O
82	O
±	O
0	O
.	O
36	O
***	O
5	O
.	O
73	O
±	O
0	O
.	O
69	O
$$$	O
F	O
(	O
1	O
,	O
51	O
)=	O
4	O
.	O
214	O
,	O
P	O
=	O
0	O
.	O
045	O
F	O
(	O
1	O
,	O
51	O
)=	O
12	O
.	O
542	O
,	O
P	O
=	O
0	O
.	O
001	O
F	O
(	O
1	O
,	O
51	O
)=	O
76	O
.	O
281	O
,	O
P	O
<	O
0	O
.	O
001Perirenal	O
fat	O
/	O
BW	O
(%)	O
1	O
.	O
97	O
±	O
0	O
.	O
082	O
.	O
47	O
±	O
0	O
.	O
12	O
*	O
1	O
.	O
80	O
±	O
0	O
.	O
122	O
.	O
06	O
±	O
0	O
.	O
19	O
$	O
ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
6	O
.	O
106	O
,	O
P	O
=	O
0	O
.	O
017nsPerigonadal	O
fat	O
(	O
g	O
)	O
9	O
.	O
32	O
±	O
0	O
.	O
6111	O
.	O
32	O
±	O
0	O
.	O
70	O
*	O
6	O
.	O
14	O
±	O
0	O
.	O
67	O
**	O
7	O
.	O
2	O
±	O
0	O
.	O
49	O
$$$	O
ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
4	O
.	O
059	O
,	O
P	O
=	O
0	O
.	O
049	O
F	O
(	O
1	O
,	O
51	O
)=	O
34	O
.	O
261	O
,	O
P	O
<	O
0	O
.	O
001Perigonadal	O
fat	O
/	O
BW	O
(%)	O
2	O
.	O
06	O
±	O
0	O
.	O
122	O
.	O
27	O
±	O
0	O
.	O
132	O
.	O
29	O
±	O
0	O
.	O
212	O
.	O
66	O
±	O
0	O
.	O
14nsNs	O
F	O
(	O
1	O
,	O
51	O
)=	O
4	O
.	O
111	O
,	O
P	O
=	O
0	O
.	O
048Abdominal	O
fat	O
(	O
g	O
)	O
18	O
.	O
22	O
±	O
0	O
.	O
9423	O
.	O
63	O
±	O
1	O
.	O
14	O
**	O
10	O
.	O
96	O
±	O
0	O
.	O
96	O
***	O
12	O
.	O
95	O
±	O
1	O
.	O
11	O
$$$	O
ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
11	O
.	O
302	O
,	O
P	O
=	O
0	O
.	O
001	O
F	O
(	O
1	O
,	O
51	O
)=	O
66	O
.	O
545	O
,	O
P	O
<	O
0	O
.	O
001Abdominal	O
fat	O
/	O
BW	O
(%)	O
4	O
.	O
03	O
±	O
0	O
.	O
184	O
.	O
74	O
±	O
0	O
.	O
204	O
.	O
15	O
±	O
0	O
.	O
284	O
.	O
72	O
±	O
0	O
.	O
30ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
6	O
.	O
163	O
,	O
P	O
=	O
0	O
.	O
016ns	O
CC	O
,	O
offspring	O
from	O
control	O
-	O
fed	O
dams	O
;	O
RC	O
,	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
.	O

On	O
the	O
one	O
hand	O
,	O
this	O
matter	O
may	B
be	I
related	B
to	O
mitochondrial	O
impairments	O
which	O
may	B
happen	O
due	O
to	O
the	O
LP	O
diet	O
,	O
as	B
has	B
been	I
suggested	I
previously	B
[	O
57	O
,	O
58	O
].	O

In	O
a	O
term	O
fetus	O
,	O
amnion	O
and	O
decida	O
have	O
higher	O
levels	O
of	O
mRNA	O
of	O
the	O
visfatin	O
gene	O
(	O
4	O
).	O

All	O
experiments	O
were	O
carried	O
out	O
in	O
triplicate	O
.	O

Total	O
GWG	O
was	O
positively	O
predictive	O
of	O
higher	O
child	O
WFA	O
z	O
score	O
at	O
birth	O
(	O
beta	O
=.	O
41	O
;	O
t	O
=	O
4	O
.	O
9	O
;	O
P	O
=	O
.	O
0001	O
)	O
and	O
macrosomia	O
at	O
birth	O
(	O
OR	O
=	O
1	O
.	O
2	O
(	O
1	O
.	O
1	O
,	O
1	O
.	O
3	O
);	O
P	O
=	O
0	O
.	O
001	O
).	O

Autism	O
spectrum	O
disorders	O
in	O
childhood	O
have	B
also	O-
been	I
observed	O
and	O
diagnosed	O
more	O
frequently	O
among	O
children	O
born	O
to	O
women	O
with	O
metabolic	O
conditions	O
identified	O
during	O
pregnancy	O
,	O
including	O
diabetes	O
and	O
obesity	O
[	O
47	O
].	O

She	O
had	O
no	O
palpable	O
pedal	O
pulses	O
and	O
bilateral	O
1	O
+	O
edema	O
of	O
her	O
lower	O
extremities	O
.	O

The	O
authors	O
suggested	B
that	O
the	O
prepartum	O
maternal	O
dietary	O
energy	O
source	O
during	O
late	O
gestation	O
can	B
alter	O
the	O
development	O
of	O
fetal	O
adipose	O
tissue	O
,	O
affecting	B
IMF	O
deposition	O
in	O
progeny	O
.	O

Interestingly	B
,	O
we	O
found	B
a	O
lower	O
rate	O
of	O
psychotic	O
-	O
like	O
symptoms	O
with	O
increasing	O
vitamin	O
D	O
intake	O
.	O

For	O
example	O
,	O
birth	O
weights	O
in	O
agricultural	O
societies	O
are	O
highest	O
at	O
the	O
peak	O
of	O
the	O
dry	O
season	O
,	O
corresponding	O
to	O
the	O
time	O
of	O
harvesting	O
and	O
greatest	O
food	O
availability	O
[	O
174	O
].	O

Based	O
on	O
maternal	O
colostrum	O
visfatin	O
levels	O
,	O
the	O
aurors	O
were	O
able	O
to	O
predict	B
neonatal	O
weight	O
loss	O
in	O
the	O
first	O
three	O
days	O
of	O
birth	O
(	O
25	O
,	O
26	O
).	O

In	O
each	O
of	O
the	O
models	B
,	O
however	B
,	O
the	O
child	O
’	O
s	O
age	O
at	O
their	O
first	O
follow	O
-	O
up	O
visit	O
was	O
significantly	O
and	O
independently	B
positively	O
correlated	B
with	O
cathelicidin	O
.	O

These	O
speculations	B
relate	B
two	O
studies	O
in	O
which	O
supplementation	O
of	O
a	O
single	O
large	O
dose	O
(	O
300	O
00033or	O
500	O
00023IU	O
)	O
of	O
vitamin	O
D	O
for	O
reducing	O
fractures	O
in	O
elderly	O
women	O
led	O
to	O
an	O
increase	O
in	O
fractures	O
,	O
plus	O
similar	B
discrepancies	B
in	O
prostate	O
cancer	O
research	O
with	O
vitamin	O
D	O
.	O
22Our	B
findings	O
and	O
particularly	O
the	O
slightly	O
higher	O
repeat	O
episodes	O
of	O
pneumonia	O
in	O
the	O
vitamin	O
D	O
group	O
could	B
be	I
due	B
to	I
such	O
fluctuations	O
if	B
the	O
hypothesis	B
is	O
true	B
.	O

Therefore	B
,	O
current	O
studies	I
are	O
inconsistent	B
in	O
their	O
results	O
and	O
conclusions	O
on	O
the	O
effects	B
of	O
dietary	O
protein	O
levels	O
affect	B
IMF	O
deposition	O
.	O

Blood	O
samples	O
were	O
obtained	O
during	O
yearly	O
visits	O
from	O
133	O
children	O
,	O
ages	O
2	O
–	O
7	O
,	O
whose	O
mothers	O
had	O
participated	O
in	O
a	O
pregnancy	O
vitamin	O
D	O
supplementation	O
RCT	O
.	O

Ratios	O
range	O
from	O
0	O
to	O
1	O
:	O
β	O
=	O
1	O
indicates	O
complete	O
methylation	O
and	O
β	O
=	O
0	O
represents	O
no	O
methylation	O
.	O

It	O
cannot	B
,	I
however	I
,	I
correct	I
for	I
potential	B
bias	B
and	O
confounding	B
of	O
the	O
studies	O
included	O
;	O
we	O
addressed	O
this	O
issue	B
in	O
our	O
review	O
(	O
Martin	O
et	O
al	O
.	O

The	O
variations	O
of	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
with	O
seasons	O
reflect	B
the	O
changes	O
in	O
UVB	O
exposure	O
,	O
one	O
of	O
the	O
main	O
determinants	B
of	O
vitamin	O
D	O
status	O
in	O
many	O
European	O
countries	O
.	O

Although	B
,	O
a	O
56	O
%	O
decreased	O
risk	O
for	O
GDM	O
was	O
observed	O
in	O
those	O
with	O
low	O
-	O
moderate	O
levels	O
of	O
standardised	O
vitamin	O
D	O
when	O
compared	O
to	O
moderate	O
-	O
high	O
levels	O
for	O
women	O
carrying	O
a	O
female	O
fetus	O
(	O
aRR	O
:	O
0	O
.	O
44	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
20	O
,	O
0	O
.	O
97	O
).	O

Results	O
We	O
performed	O
a	O
longitudinal	O
holistic	O
study	O
of	O
the	O
hepatic	O
transcriptome	O
of	O
offspring	O
of	O
dams	O
fed	O
either	O
an	O
experimental	O
low	O
protein	O
diet	O
(	O
LP	O
)	O
or	O
an	O
adequate	O
protein	O
diet	O
(	O
AP	O
)	O
throughout	O
gestation	O
,	O
in	B
order	I
to	I
obtain	O
a	O
comprehensive	O
picture	O
of	O
genes	O
and	O
functional	O
networks	O
that	O
are	O
sensitive	O
to	O
fetal	O
nutritional	O
programming	O
using	O
a	O
porcine	O
model	B
.	O

This	O
study	O
is	O
critical	B
because	O
it	O
will	B
determine	O
if	B
antenatal	O
IFA	O
supplements	O
commenced	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
,	O
rather	B
than	O
later	O
,	O
will	B
significantly	O
reduce	O
neonatal	O
deaths	O
in	O
the	O
first	O
month	O
of	O
life	O
,	O
and	O
if	B
this	O
approach	O
is	O
cost	O
-	O
effective	O
.	O

DNA	O
methylation	O
also	O
alters	O
the	O
interaction	O
between	O
DNA	O
and	O
DNA	O
binding	O
proteins	O
to	O
regulate	O
gene	O
expression	O
.	O

It	O
has	B
long	O-
been	I
suggested	I
that	O
5mC	O
can	B
be	O
removed	O
by	O
both	O
passive	O
(	O
through	O
lack	O
of	O
maintenance	O
during	O
replication	O
)	O
and	O
active	O
(	O
enzymatic	O
)	O
mechanisms	O
.	O

Probe	O
-	O
sets	O
with	O
a	O
low	O
standard	O
deviation	O
(	O
s	O
≤	O
0	O
.	O
25	O
)	O
were	O
discarded	O
,	O
because	O
such	O
transcripts	O
are	O
not	O
likely	B
to	O
be	O
regulated	O
.	O

Nevertheless	B
,	O
such	O
work	O
provides	O
valuable	B
data	O
.	O

PubMed	O
Central	O
:	O

Factors	B
related	B
to	O
the	O
delivery	O
room	O
experience	O
may	B
be	I
associated	B
with	O
meconium	O
aspiration	O
syndrome	O
,	O
birth	O
weight	O
,	O
and	O
labor	O
time	O
.	O

Introduction	O
Thyroid	O
cancer	O
,	O
the	O
most	B
common	I
endocrine	O
malignancy	O
,	O
is	O
often	O
detected	O
in	O
young	O
patients	O
and	O
is	O
more	O
frequently	O
diagnosed	O
in	O
women	O
.	O

PTH	O
was	O
not	O
elevated	O
(	O
median	O
1	O
.	O
0pmol	O
/	O
L	O
[<	O
0	O
.	O
3	O
-	O
3	O
.	O
1	O
]),	O
urinary	O
calcium	O
:	O
creatinine	O
ratio	O
not	O
suppressed	O
(	O
median	O
2	O
.	O
3	O
,	O
[	O
0	O
.	O
4	O
-	O
9	O
]),	O
25OHVitD	O
low	O
-	O
normal	O
(	O
median	O
44nmol	O
/	O
L	O
[	O
17	O
-	O
218	O
])	O
and	O
1	O
,	O
25	O
(	O
OH	O
)	O
2VitD	O
elevated	O
(	O
median	O
232pmol	O
/	O
L	O
[	O
64	O
-	O
720	O
]),	O
in	O
keeping	O
with	O
an	O
abnormality	O
in	O
CYP24A1	O
.	O

Moreover	O
,	O
40	O
subjects	O
with	O
samples	O
from	O
two	O
subsequent	O
years	O
showed	O
a	O
highly	O
significant	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
increase	O
in	O
cathelicidin	O
concentration	O
from	O
visit	O
one	O
to	O
visit	O
two	O
.	O

In	O
previous	B
work	O
and	O
a	O
scoping	O
study	O
,	O
we	O
found	B
that	O
most	O
of	O
the	O
research	O
carried	O
out	O
in	O
relation	B
to	O
impaired	O
spermatogenesis	O
had	O
investigated	O
time	O
trends	O
rather	B
than	O
association	B
with	O
specific	O
risk	O
factors	O
(	O
Martin	O
et	O
al	O
.	O

They	O
were	O
suffering	O
from	O
vitamin	O
D	O
deficiency	O
based	B
on	I
new	B
perspective	B
towards	O
normal	O
serum	O
vitamin	O
D	O
concentration	O
[	O
46	O
].	O

While	B
association	B
between	O
β	O
2	O
adrenergic	O
receptor	O
agonists	O
and	O
autism	O
spectrum	O
disorders	O
is	O
not	B
strong	I
,	O
exposure	O
to	O
terbutaline	O
during	O
the	O
third	O
trimester	O
has	O
shown	O
to	O
increase	O
incidence	O
.	O

Synthetic	O
folic	O
acid	O
does	O
not	O
occur	O
naturally	O
and	O
is	O
distinct	O
from	O
naturally	O
occurring	O
folic	O
acid	O
[	O
1	O
,	O
4	O
,	O
5	O
].	O

Therefore	O
,	O
the	O
up	O
-	O
regulation	O
of	O
'	O
AMPK	O
signaling	O
'	O
in	O
developmental	O
periods	O
I	O
,	O
II	O
and	O
III	O
in	O
AP	O
offspring	O
accounts	O
for	O
metabolic	O
health	O
in	O
AP	O
offspring	O
,	O
but	O
not	O
in	O
LP	O
offspring	O
.	O

Therefore	B
,	O
an	O
average	O
daily	O
dose	O
of	O
4	O
–	O
6	O
mg	O
of	O
iron	O
is	O
required	B
in	O
the	O
second	O
and	O
third	O
trimesters	O
of	O
pregnancy	O
[	O
14	O
].	O

This	O
interpretation	B
also	O
agrees	B
with	I
the	O
down	O
-	O
regulation	O
of	O
the	O
endocannabinoid	O
metabolism	O
in	O
peripheral	O
tissues	O
.	O

However	B
,	O
diets	O
are	O
often	O
stable	O
,	O
and	O
a	O
mid	O
-	O
pregnancy	O
food	O
frequency	O
questionnaire	O
(	O
FFQ	O
)-	O
assessment	O
is	O
likely	B
to	O
be	O
sufficiently	O
representative	O
of	O
late	O
pregnancy	O
and	O
lactation	O
diet	O
in	O
a	O
high	O
proportion	O
of	O
individuals	O
[	O
25	O
,	O
26	O
].	O

For	O
41	O
.	O
7	O
%	O
of	O
the	O
women	O
this	O
was	O
their	O
first	O
pregnancy	O
(	O
unknown	O
for	O
0	O
.	O
4	O
%	O
of	O
the	O
women	O
),	O
while	O
for	O
45	O
.	O
6	O
%	O
of	O
the	O
women	O
this	O
would	O
be	O
their	O
first	O
child	O
(	O
status	O
not	O
known	O
for	O
1	O
.	O
4	O
%	O
of	O
the	O
women	O
).	O

Procedures	O
We	O
chose	O
a	O
quarterly	O
supplementation	O
regimen	O
because	O
in	O
routine	O
programme	O
conditions	O
a	O
quarterly	O
regimen	O
is	O
likely	B
to	O
have	O
better	O
adherence	O
than	O
a	O
daily	O
regimen	O
,	O
13	O
,	O
14and	O
has	B
been	I
shown	O
to	O
be	O
effective	O
at	O
maintaining	O
the	O
serum	O
vitamin	O
D	O
concentration	O
within	O
normal	O
ranges	O
for	O
2	O
–	O
3	O
months	O
in	O
a	O
French	O
high	O
-	O
risk	O
infant	O
population	O
.	O
16The	O
syringes	O
containing	O
vitamin	O
D	O
or	O
placebo	O
were	O
stored	O
in	O
conditions	O
recommended	O
by	O
the	O
manufacturer	O
—	O
a	O
dry	O
cool	O
environment	O
—	O
between	O
2	O
and	O
24	O
weeks	O
before	O
administration	O
.	O

SIRTs	O
have	O
an	O
important	B
role	B
in	O
the	O
process	O
of	O
synapse	O
promotion	O
and	O
modulation	O
of	O
their	O
strength	O
,	O
which	O
is	O
important	B
for	O
memory	O
formation	O
.	O

The	O
effect	B
of	O
maternal	O
diet	O
on	O
child	O
leukemia	O
risk	O
has	B
not	I
been	I
rigorously	O-
studied	I
;	O
the	O
few	B
studies	I
that	O
have	B
been	I
done	O
have	O
focused	O
on	O
specific	O
dietary	O
factors	O
,	O
and	O
the	O
results	O
have	B
been	I
mixed	B
.	O

For	O
each	O
animal	O
,	O
two	O
gels	O
were	O
averaged	O
.	O

Results	O
Study	O
population	O
Characteristics	O
of	O
the	O
study	O
population	O
are	O
summarized	O
in	O
Table	O
1	O
(	O
n	O
=	O
145	O
).	O

Intervention	O
From	O
the	O
formative	O
study	O
,	O
we	O
identified	O
culturally	O
appropriate	O
and	O
feasible	O
ways	O
of	O
implementing	O
the	O
intervention	O
[	O
14	O
].	O

Little	B
,	I
however	B
,	O-
is	I
known	I
about	O
the	O
consequences	B
of	O
insufficient	O
sleep	O
and	O
poor	O
sleep	O
quality	O
during	O
pregnancy	O
on	O
glucose	O
tolerance	O
and	O
gestational	O
diabetes	O
.	O

As	B
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
are	O
related	B
to	O
preeclampsia	O
;	O
these	O
results	O
are	O
consistent	B
with	O
the	O
current	O
findings	B
.	O

They	O
reported	O
that	O
the	O
average	O
breed	O
type	O
list	O
included	O
purebred	O
or	O
crossbred	O
Angus	O
,	O
Brahman	O
,	O
Simmental	O
,	O
Charolais	O
,	O
Hereford	O
,	O
Jersey	O
,	O
Korean	O
Brown	O
cattle	O
,	O
Maine	O
Anjou	O
,	O
Pinzgauer	O
,	O
Sahiwal	O
,	O
Salers	O
,	O
and	O
South	O
Devon	O
with	O
estimates	B
MS	O
heritability	O
of	O
0	O
.	O
37	O
(	O
range	O
0	O
.	O
30	O
to	O
0	O
.	O
57	O
).	O

The	O
MS	O
and	O
IMF	O
content	O
in	O
Angus	O
steers	O
increases	O
in	O
a	O
linear	O
fashion	O
with	O
increasing	O
HCW	O
from	O
208	O
to	O
380	O
kg	O
[	O
72	O
].	O

Food	O
items	O
similar	O
in	O
nutrient	O
profile	O
were	O
combined	O
into	O
33	O
predefined	O
food	O
groups	O
(	O
Table	O
1	O
).	O

Vitamin	O
D	O
status	O
(	O
measured	O
as	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25OHD	O
))	O
of	O
pregnant	O
women	O
has	O
been	I
inversely	O
associated	B
with	O
adverse	O
gestational	O
outcomes	O
and	O
associated	B
with	O
uteroplacental	O
dysfunction	O
[	O
2	O
].	O

Medline	O
,	O
Scopus	O
,	O
Web	O
of	O
Science	O
,	O
ScienceDirect	O
and	O
the	O
Cochrane	O
Library	O
were	O
searched	O
using	O
the	O
search	O
terms	O
:	O
pregnant	O
,	O
neurodevelopment	O
,	O
cognition	O
,	O
fish	O
and	O
seafood	O
.	O

We	O
will	O
use	O
physician	O
-	O
certified	O
verbal	O
autopsy	O
method	O
to	O
identify	O
cases	O
of	O
death	O
related	O
to	O
preterm	O
delivery	O
and	O
birth	O
asphyxia	O
using	O
the	O
hierarchical	O
assignment	O
of	O
causes	O
of	O
death	O
.	O

A	O
potential	B
limitation	B
of	O
our	O
follow	O
-	O
up	O
study	O
is	O
the	O
risk	O
of	O
selection	O
bias	B
,	O
with	O
only	B
82	O
%	O
of	O
the	O
available	O
cohort	O
contributing	O
data	O
at	O
6	O
-	O
month	O
follow	O
-	O
up	O
assessments	O
.	O

The	O
recall	O
is	O
done	O
chronologically	O
unless	O
the	O
participant	O
wishes	O
to	O
recall	O
randomly	O
.	O

The	O
median	O
was	O
used	O
as	O
the	O
measure	O
of	O
central	O
tendency	O
.	O

Fetuses	O
were	O
killed	O
by	O
i	O
.	O
v	O
.	O

We	O
will	O
also	O
exclude	O
three	O
Upazilas	O
from	O
Gazipur	O
because	O
of	O
the	O
high	O
number	O
of	O
garment	O
industries	O
,	O
which	O
would	B
have	O
high	O
numbers	O
of	O
working	O
women	O
and	O
would	B
be	I
difficult	B
to	O
follow	O
-	O
up	O
and	O
eight	O
Upazilas	O
from	O
Mymensingh	O
because	O
of	O
the	O
high	O
prevalence	O
of	O
malaria	O
and	O
kalazar	O
.	O

Daily	O
consumption	O
of	O
vegetables	O
,	O
fruits	O
,	O
legumes	O
,	O
soy	O
,	O
and	O
nuts	O
,	O
whole	O
grains	O
,	O
fish	O
and	O
seafood	O
,	O
and	O
monounsaturated	O
to	O
saturated	O
fat	O
ratio	O
(	O
MUFA	O
:	O
SFA	O
)	O
above	O
the	O
median	O
is	O
considered	O
healthful	O
and	O
confers	O
1	O
point	O
to	O
the	O
aMED	O
score	O
.	O

Further	O
filtering	O
based	O
on	O
the	O
variability	O
of	O
expression	O
of	O
probe	O
-	O
sets	O
revealed	O
7	O
,	O
937	O
probe	O
-	O
sets	O
for	O
further	O
analysis	O
at	O
stage	O
94	O
dpc	O
(	O
1	O
dpn	O
:	O
9	O
,	O
099	O
;	O
28	O
dpn	O
:	O
8	O
,	O
250	O
;	O
188	O
dpn	O
:	O
8	O
,	O
943	O
).	O

Despite	B
considerable	B
efforts	I
to	O
unravel	B
the	O
etiologic	O
basis	O
for	O
this	O
cancer	O
and	O
attempts	O
to	O
find	O
a	O
cure	O
,	O
gliomas	O
largely	O
remain	O
refractory	O
to	O
treatment	O
.	O

When	O
adjusting	O
for	O
the	O
other	O
variables	O
in	O
the	O
models	O
,	O
no	O
significant	O
relationship	O
between	O
any	O
of	O
the	O
25	O
(	O
OH	O
)	O
D	O
measurements	O
and	O
cathelicidin	O
was	O
found	O
.	O

Within	O
the	O
significantly	O
different	O
spots	O
,	O
three	O
calcium	O
binding	O
proteins	O
(	O
calbindin1	O
,	O
calbindin2	O
and	O
hippocalcin	O
)	O
were	O
altered	O
.	O

A	O
previous	B
study	I
in	O
Romania	O
reported	B
that	O
supplemental	O
iron	O
was	O
taken	O
by	O
53	O
.	O
3	O
%	O
of	O
women	O
during	O
pregancy	O
[	O
14	O
].	O

Epidemiological	O
data	O
were	O
obtained	O
from	O
children	O
with	O
autism	O
,	O
including	O
residential	O
history	O
of	O
the	O
mother	O
,	O
which	O
was	O
compared	O
to	O
the	O
traffic	O
-	O
related	O
air	O
pollution	O
assigned	O
to	O
each	O
location	O
using	O
measures	O
from	O
the	O
Environmental	O
Protection	O
Agency	O
'	O
s	O
Air	O
Quality	O
System	O
data	O
.	O

These	O
effects	B
are	O
partly	B
interrelated	B
,	O
but	O
can	O
also	O
be	O
dissociated	O
and	O
exerted	O
by	O
different	O
UCP1	O
-	O
expressing	O
types	O
of	O
adipocytes	O
(	O
i	O
.	O
e	O
.,	O
brown	O
and	O
“	O
brite	O
”	O
adipocytes	O
).	O

After	O
all	O
,	O
we	O
know	B
that	O
insulin	O
therapy	O
is	O
safe	B
and	O
usually	B
effective	O
.	O

Thus	B
,	O
preeclampsia	O
does	O
not	O
seem	B
to	O
mediate	B
the	O
associations	B
between	O
vitamin	O
D	O
status	O
trajectory	O
and	O
neonatal	O
birth	O
size	O
or	O
preterm	O
birth	O
.	O

Using	O
a	O
data	O
-	O
driven	O
recursively	O
partitioned	O
mixture	O
model	O
(	O
RPMM	O
),	O
these	O
CpG	O
loci	O
were	O
clustered	O
into	O
16	O
methylation	O
classes	O
based	O
on	O
like	O
methylation	O
pattern	O
obtained	O
from	O
the	O
array	O
results	O
,	O
pruning	O
the	O
model	O
after	O
four	O
splits	O
to	O
maintain	O
power	O
(	O
Houseman	O
et	O
al	O
.	O

The	O
visfatin	O
regulation	O
mechanism	O
in	O
human	O
fetal	O
blood	O
circulation	O
is	O
unknown	B
(	O
12	O
).	O

In	O
such	O
patients	O
,	O
IL	O
-	O
6	O
is	O
preferentially	O
secreted	O
from	O
visceral	O
rather	O
than	O
from	O
subcutaneous	O
adipocytes	O
and	O
may	B
participate	O
in	O
the	O
prevailing	O
increase	O
in	O
sympathetic	O
outflow	O
by	O
exerting	O
central	O
effects	B
(	O
Wallenius	O
et	O
al	O
.,	O
2002	O
;	O
Fain	O
et	O
al	O
.,	O
2004	O
).	O

Curiously	B
,	O
it	O
has	B
been	I
shown	O
that	O
calcium	O
concentration	O
is	O
an	O
important	B
modulator	O
of	O
thimet	O
oligopeptidase	O
activity	O
[	O
41	O
],	O
thus	B
the	O
disruption	O
of	O
this	O
protein	O
may	B
also	O
be	O
down	O
-	O
stream	O
consequence	O
of	O
altered	O
calcium	O
buffering	O
.	O

They	O
represent	O
the	O
most	O
common	O
malignant	O
brain	O
tumors	O
[	O
1	O
].	O

Manipulating	O
dietary	O
fat	O
digestion	O
and	O
absorption	O
in	O
the	O
small	O
intestine	O
may	B
enhance	O
MS	O
.	O
Emulsifying	O
fat	O
may	B
affect	B
the	O
digestion	O
and	O
absorption	O
of	O
fat	O
.	O

This	O
view	B
of	O
epigenetically	O
mediated	B
phenotypic	O
plasticity	O
falls	O
into	O
the	O
realms	O
of	O
Lamarckian	O
inheritance	O
,	O
the	O
idea	B
that	O
an	O
organism	O
can	B
pass	O
on	O
acquired	O
characteristics	O
to	O
future	B
offspring	O
.	O

Eligibility	O
Criteria	O
Articles	O
published	O
in	O
peer	O
-	O
reviewed	O
journals	O
between	O
January	O
2000	O
and	O
March	O
2014	O
were	O
included	O
in	O
this	O
review	O
.	O

All	O
analyses	O
were	O
performed	O
using	O
Stata	O
9	O
.	O
0	O
statistical	O
software	O
(	O
Stata	O
,	O
College	O
Station	O
,	O
TX	O
).	O

The	O
incidence	O
of	O
left	O
-	O
handedness	O
is	O
disproportionately	B
higher	O
among	O
males	O
[	O
202	O
],	O
a	O
finding	O
which	O
is	O
consistently	B
observed	O
across	O
species	O
[	O
201	O
,	O
209	O
–	O
212	O
].	O

All	O
data	O
were	O
anonymised	O
to	O
maintain	O
participant	O
confidentiality	O
.	O

Assuming	O
a	O
crude	O
birth	O
rate	O
of	O
23	O
per	O
1000	O
people	O
,	O
10	O
%	O
loss	O
of	O
pregnancies	O
before	O
birth	O
and	O
15	O
%	O
loss	O
to	O
follow	O
up	O
each	O
cluster	O
will	O
yield	O
300	O
births	O
over	O
15	O
months	O
,	O
and	O
this	O
will	B
be	O
sufficient	O
to	O
reach	O
the	O
desired	O
sample	O
size	O
.	O

There	O
was	O
no	O
statistical	O
significance	O
observed	O
when	O
respondents	O
’	O
maritalstatus	O
and	O
age	O
were	O
compared	O
with	O
the	O
satisfaction	O
of	O
the	O
different	O
services	O
in	O
the	O
health	O
centres	O
using	O
the	O
Fisher	O
'	O
s	O
exact	O
test	O
(	O
Table	O
3	O
).	O

The	O
intra	O
-	O
and	O
inter	O
-	O
assay	O
CV	O
were	O
5	O
%.	O

Numerous	O
individual	O
nutrients	O
consumed	O
by	O
the	O
mother	O
during	O
pregnancy	O
have	B
been	I
suggested	I
as	O
being	O
preventive	O
for	O
development	O
of	O
atopic	O
diseases	O
in	O
the	O
child	O
;	O
these	O
include	O
apples	O
or	O
fish	O
,[	O
80	O
]	O
vitamin	O
D	O
,[	O
107	O
]	O
vitamin	O
E	O
,[	O
108	O
]	O
and	O
various	O
probiotics	O
,	O
the	O
latter	O
having	B
been	I
shown	I
to	O
be	O
effective	O
in	O
mouse	O
models	B
[	O
109	O
]	O
and	O
human	O
studies	O
[	O
110	O
].	O

,	O
2007	O
[	O
20	O
]	O
Gale	O
et	O
al	O
.	O

In	O
the	O
USA	O
excessive	O
GWG	O
remains	B
of	O
predominant	O
concern	B
,	O
as	O
60	O
%	O
of	O
obese	O
women	O
gain	O
more	O
than	O
recommended	O
.	O

For	B
this	I
reason	I
,	O
a	O
large	O
amount	O
of	O
concentrate	O
is	O
fed	O
during	O
the	O
fattening	O
period	O
in	O
Japanese	O
Wagyu	O
and	O
Korean	O
beef	O
cattle	O
[	O
95	O
,	O
96	O
].	O

Several	B
studies	I
have	B
shown	I
that	O
fetal	O
nutritional	O
programming	O
affects	B
growth	O
and	O
/	O
or	O
beef	O
quality	O
,	O
including	O
marbling	O
.	O

However	B
,	O
meta	O
-	O
analysis	O
of	O
the	O
4	O
case	O
-	O
control	O
studies	O
revealed	B
a	O
significantly	O
increased	O
risk	O
of	O
oral	O
clefts	O
in	O
infants	O
of	O
corticosteroid	O
-	O
treated	O
mothers	O
(	O
odds	O
ratio	O
,	O
3	O
.	O
35	O
;	O
confidence	O
interval	O
1	O
.	O
97	O
-	O
5	O
.	O
69	O
)	O
[	O
12	O
].	O

Factors	O
known	O
to	O
influence	B
the	O
development	O
of	O
asthma	O
include	O
race	O
[	O
80	O
,	O
81	O
],	O
low	O
yearly	O
family	O
income	O
[	O
81	O
],	O
less	O
than	O
a	O
high	O
school	O
education	O
[	O
81	O
],	O
residence	O
in	O
high	O
poverty	O
areas	O
[	O
81	O
],	O
exposure	O
to	O
urban	O
air	O
pollution	O
[	O
64	O
]	O
and	O
childhood	O
viral	O
infections	O
[	O
64	O
,	O
82	O
].	O

These	O
results	O
are	O
similar	B
to	I
other	O
studies	I
of	O
patient	O
satisfaction	O
;	O
(	O
96	O
.	O
5	O
%)	O
in	O
Ibadan	O
,	O
Nigeria	O
[	O
7	O
]	O
and	O
86	O
.	O
4	O
%	O
in	O
Ogun	O
State	O
,	O
Nigeria	O
[	O
25	O
].	O

Due	B
to	I
this	O
heterogeneity	B
a	O
qualitative	O
rather	B
than	O
quantitative	O
approach	O
was	O
deemed	O
appropriate	O
for	O
comparison	O
and	O
presentation	O
of	O
findings	O
.	O

Frequent	O
regular	O
follow	O
-	O
up	O
visits	O
to	O
or	O
by	O
health	O
professionals	O
skilled	O
in	O
managing	O
asthma	O
are	O
essential	B
to	O
ensure	O
optimal	O
success	O
and	O
safety	O
of	O
asthma	O
management	O
during	O
pregnancy	O
.	O

PubMed	O
Central	O
:	O

Management	O
of	O
these	O
patients	O
and	O
providing	O
evidencebased	B
advice	B
are	O
obviously	B
extremely	B
difficult	B
tasks	I
.	O

To	B
assess	I
the	O
potential	B
problem	B
of	O
multicollinearity	O
we	O
used	O
Pearsons	O
correlation	O
coefficient	O
or	O
Cramers	O
V	O
(	O
for	O
paired	O
categorical	O
variables	O
).	O

It	O
is	O
probably	B
regulated	O
by	O
glucose	O
and	O
insulin	O
(	O
6	O
),	O
and	O
increases	O
with	O
gradual	O
degradation	O
of	O
B	O
-	O
cell	O
and	O
progress	O
of	O
insulin	O
-	O
resistance	O
and	O
maternal	O
weight	O
(	O
7	O
).	O

These	O
studies	O
do	O
not	B
necessarily	I
rule	B
out	I
an	O
epigenetic	O
mechanism	O
of	O
toxicity	O
per	O
se	O
,	O
but	B
they	O
do	O
exclude	B
a	O
link	B
between	O
the	O
specific	O
epigenetic	O
,	O
exposure	O
and	O
/	O
or	O
adverse	O
endpoints	O
/	O
markers	O
investigated	O
.	O

The	O
highest	O
profit	O
in	O
this	O
steer	O
group	O
was	O
for	O
a	O
slaughter	O
age	O
of	O
31	O
months	O
.	O

PubMed	O
Central	O
:	O

Sex	O
affects	B
IMF	O
content	O
in	O
the	O
LM	O
.	O

Allergies	O
or	O
hyperreactivities	O
have	B
been	I
classified	O
by	O
Gells	O
and	O
Coombs	O
into	O
types	O
I	O
through	O
IV	O
,	O
with	O
types	O
I	O
,	O
II	O
,	O
and	O
III	O
being	O
mediated	O
by	O
antibodies	O
or	O
immune	O
complexes	O
and	O
type	O
IV	O
reactions	O
as	O
well	O
as	O
chronic	O
stages	O
of	O
allergic	O
diseases	O
being	O
mediated	O
by	O
T	O
cells	O
[	O
1	O
].	O

Abbreviations	O
AA	O
:	O
arachidonic	O
acid	O
;	O
BMI	O
:	O
body	O
mass	O
index	O
;	O
CAPE	O
:	O
community	O
assessment	O
of	O
psychic	O
experiences	O
;	O
CI	O
:	O
confidence	O
intervals	O
;	O
DHA	O
:	O
docosahexaenoic	O
acid	O
;	O
DPA	O
:	O
docosapentaenoic	O
acid	O
;	O
EPA	O
:	O
eicosapentaenoic	O
acid	O
;	O
FFQ	O
:	O
food	O
-	O
frequency	O
questionnaire	O
;	O
PCB	O
:	O
polychlorinated	O
biphenyls	O
;	O
PUFA	O
:	O
polyunsaturated	O
fatty	O
acids	O
;	O
RR	O
:	O
relative	O
risk	O
;	O
SD	O
:	O
standard	O
deviation	O
.	O

However	B
,	O
in	O
a	O
recent	B
study	I
,	O
the	O
role	B
of	O
diabetes	O
during	O
gestation	O
on	O
such	O
adverse	O
long	O
-	O
term	O
metabolic	O
consequences	O
has	B
been	I
seriously	O
questioned	B
,	O
as	B
they	O
seem	B
to	O
relate	B
more	O
on	O
known	O
confounders	B
,	O
such	O
as	O
the	O
BMI	O
of	O
either	O
one	O
of	O
the	O
parents	O
(	O
Donovan	O
and	O
Cundy	O
,	O
2014	O
).	O

Frequent	O
monitoring	O
and	O
adjustment	O
of	O
L	O
-	O
T4	O
dosages	O
are	O
very	O
important	B
because	B
of	O
large	O
fluctuations	O
of	O
T4	O
metabolism	O
during	O
pregnancy	O
;	O
calcium	O
and	O
D	O
vitamin	O
supplementation	O
,	O
often	B
indispensable	B
,	O
must	B
be	I
carefully	O
tailored2324	O
.	O

There	O
are	O
two	O
major	O
forms	O
of	O
active	O
Vitamin	O
D	O
,	O
Vitamin	O
D2	O
(	O
ergocalciferol	O
)	O
and	O
Vitamin	O
D3	O
(	O
cholecalciferol	O
).	O

Compared	O
with	O
lean	O
women	O
who	O
did	O
not	O
snore	O
,	O
those	O
who	O
were	O
overweight	O
and	O
snored	O
had	O
a	O
6	O
.	O
9	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
(	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
6	O
).	O

Participants	O
were	O
classified	O
into	O
three	O
predefined	O
levels	O
:	O
low	O
,	O
middle	O
and	O
high	O
frequency	O
of	O
symptoms	O
.	O

After	O
expert	O
review	O
,	O
the	O
final	O
questionnaire	O
used	O
had	O
29	O
items	O
(	O
see	O
Additional	O
file1	O
).	O

Although	O
essential	O
amino	O
acids	O
are	O
needed	O
for	O
growth	O
,	O
anabolic	O
and	O
developmental	O
processes	O
,	O
transcriptional	O
levels	O
of	O
genes	O
leading	O
to	O
degradation	O
of	O
those	O
dietary	O
valuable	O
compounds	O
is	O
forced	O
during	O
postnatal	O
development	O
in	O
LP	O
offspring	O
.	O

Podolian	O
bulls	O
fed	O
grazing	O
pasture	O
and	O
fed	O
a	O
high	O
protein	O
(	O
15	O
%	O
CP	O
,	O
DM	O
basis	O
)	O
supplement	O
had	O
higher	O
IMF	O
content	O
in	O
the	O
LM	O
than	O
did	O
animals	O
grazing	O
pasture	O
and	O
fed	O
a	O
low	O
protein	O
(	O
12	O
%	O
CP	O
)	O
supplement	O
[	O
126	O
].	O

Total	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
and	O
chocolate	O
preference	O
(	O
calculated	O
as	O
the	O
percentage	O
of	O
chocolate	O
eaten	O
on	O
overall	O
intake	O
)	O
were	O
evaluated	O
at	O
adolescence	O
(	O
postnatal	O
weeks	O
8	O
–	O
9	O
)	O
and	O
reevaluated	O
at	O
adulthood	O
(	O
postnatal	O
weeks	O
12	O
–	O
13	O
)	O
in	O
all	O
experimental	O
groups	O
.	O

As	O
mentioned	O
earlier	O
,	O
there	O
are	O
a	O
number	O
of	O
loci	O
within	O
PGCs	O
that	O
escape	O
the	O
two	O
global	O
DNA	O
demethylation	O
re	O
-	O
programing	O
events	O
.	O

vitamins	O
C	O
,	O
D	O
and	O
E	O
)	O
protect	O
against	O
AM	O
.	O

There	O
are	O
two	O
known	B
factors	B
which	O
contribute	B
to	O
development	O
of	O
iron	O
deficiency	O
anaemia	O
(	O
IDA	O
)	O
in	O
pregnancy	O
;	O
the	O
first	O
is	O
the	O
woman	O
'	O
s	O
iron	O
stores	O
at	O
the	O
time	O
of	O
conception	O
and	O
the	O
second	O
is	O
the	O
amount	O
of	O
iron	O
absorbed	O
during	O
gestation	O
.	O

The	O
lower	O
SEI	O
of	O
the	O
Adelaide	O
women	O
could	B
therefore	B
make	O
them	O
more	O
susceptible	O
to	O
lower	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
because	O
of	O
factors	O
relating	B
to	O
disadvantage	O
.	O

High	O
birth	O
weight	O
is	O
an	O
important	B
predictor	O
of	O
adult	O
obesity	O
[	O
171	O
],	O
and	O
a	O
higher	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
has	B
been	I
linked	B
to	O
greater	O
risk	O
for	O
adult	O
-	O
onset	O
glioma	O
[	O
172	O
].	O

The	O
research	O
team	O
took	O
written	O
approval	O
for	O
the	O
study	O
from	O
Directorate	O
General	O
of	O
Health	O
Service	O
(	O
DGHS	O
)	O
under	O
Ministry	O
of	O
Health	O
&	O
Family	O
Welfare	O
before	O
allocating	O
the	O
clusters	O
to	O
a	O
treatment	O
group	O
or	O
the	O
trial	O
interventions	O
begin	O
.	O

Iron	O
fortification	O
of	O
foods	O
might	B
be	O
particularly	B
useful	O
and	O
cost	O
effective	O
in	O
settings	O
where	O
the	O
logistics	O
of	O
oral	O
iron	O
supplementation	O
among	O
pregnant	O
women	O
are	O
highly	O
challenging	B
.	O

Such	O
differences	B
are	O
largely	B
driven	I
by	I
diverse	O
genetic	O
backgrounds	O
.	O

OR	O
#-	O
adjusted	O
for	O
the	O
interaction	O
effect	O
(	O
PC	O
*	O
E	O
).	O

Part	O
2	O
:	O
Prevention	O
of	O
Asthma	O
and	O
Allergies	O
in	O
Early	O
Life	O
Infants	O
With	O
High	O
-	O
Risk	O
of	O
Allergy	O
The	O
potential	B
risk	O
for	O
the	O
development	O
of	O
atopy	O
among	O
newborns	O
is	O
high	O
.	O

Furthermore	O
,	O
multivitamin	O
supplements	O
available	O
during	O
the	O
study	O
period	O
contained	O
very	O
little	O
(	O
maximum	O
50	O
IU	O
),	O
if	O
any	O
,	O
vitamin	O
D	O
and	O
thus	B
are	O
an	O
unlikely	B
source	O
of	O
variation	O
within	O
the	O
population	O
.	O

Infant	O
anthropometric	O
measurements	O
Infant	O
growth	O
is	O
assessed	O
at	O
each	O
postnatal	O
visit	O
.	O

E1	O
–	O
education	O
:	O
>	O
12	O
years	O
;	O
E2	O
–	O
9	O
–	O
12	O
years	O
;	O
reference	O
category	O
-	O
≤	O
8	O
years	O
.	O

The	O
effect	B
is	O
characterised	O
by	O
a	O
programming	O
of	O
the	O
genome	O
that	O
leads	O
to	O
different	O
responsiveness	O
and	O
adaptability	O
of	O
the	O
gene	O
expression	O
machinery	O
to	O
chronic	O
and	O
acute	O
environmental	O
stimuli	O
,	O
i	O
.	O
e	O
.	O

Considering	B
the	O
possible	B
losses	O
,	O
the	O
sample	O
size	O
was	O
set	O
at	O
74	O
people	O
in	O
each	O
group	O
finally	O
.	O

There	O
is	O
also	O
evidence	B
of	O
a	O
relationship	B
between	O
engagement	O
with	O
prenatal	O
care	O
and	O
use	O
of	O
multivitamin	O
supplements	O
,	O
the	O
adequacy	O
of	O
prenatal	O
care	O
being	O
assessed	O
according	O
to	O
Adequacy	O
of	O
Prenatal	O
Care	O
Utilisation	O
Index	O
,	O
which	O
takes	O
into	O
account	O
the	O
month	O
of	O
initiation	O
of	O
care	O
and	O
the	O
proportion	O
of	O
recommended	O
visits	O
adjusted	O
for	O
the	O
gestational	O
age	O
at	O
initiation	O
of	O
care	O
and	O
gestational	O
age	O
at	O
delivery	O
[	O
27	O
].	O

Thirty	O
-	O
six	O
hours	O
after	O
birth	O
,	O
the	O
lightest	O
and	O
the	O
heaviest	O
piglet	O
within	O
one	O
litter	O
were	O
killed	O
by	O
i	O
.	O
m	O
.	O

In	O
this	O
study	O
only	B
183	O
autistic	O
children	O
were	O
considered	O
and	O
medical	O
conditions	O
of	O
the	O
mother	O
based	B
on	I
a	O
maternal	O
self	O
-	O
report	O
[	O
18	O
].	O

However	B
,	O
we	O
were	O
not	B
able	O
take	O
environmental	O
factors	B
and	O
geographic	O
area	O
into	O
account	O
,	O
because	B
the	O
study	O
questionnaire	O
did	B
not	I
assess	O
the	O
origin	O
of	O
fish	O
,	O
such	O
as	O
the	O
Baltic	O
Sea	O
or	O
the	O
Atlantic	O
Ocean	O
.	O

Higher	O
endocannabinoid	O
levels	O
as	B
a	O
result	O
of	O
a	O
lower	O
expression	O
of	O
the	O
eCBs	O
-	O
degrading	O
enzymes	O
FAAH	O
and	O
MAGL	O
in	O
liver	O
can	B
be	O
associated	B
with	O
alterations	O
in	O
the	O
lipid	O
and	O
cholesterol	O
metabolism	O
(	O
Dinh	O
et	O
al	O
.,	O
2002	O
;	O
Osei	O
-	O
Hyiaman	O
et	O
al	O
.,	O
2005	O
;	O
Di	O
Marzo	O
and	O
MacCarrone	O
,	O
2008	O
),	O
due	O
to	I
the	O
fact	O
that	O
both	O
eCBs	O
anandamide	O
(	O
AEA	O
)	O
and	O
2	O
-	O
AG	O
can	O
inhibit	O
the	O
gene	O
expression	O
of	O
apolipoprotein	O
A1	O
,	O
the	O
primary	O
protein	O
component	O
of	O
HDL	O
,	O
through	O
the	O
activation	O
of	O
CB1	O
receptors	O
in	O
hepatocytes	O
(	O
Haas	O
et	O
al	O
.,	O
2012	O
).	O

Schizophrenia	O
in	O
adulthood	O
is	O
often	B
preceded	O
by	O
milder	O
symptoms	O
and	O
delusions	O
during	O
adolescence	O
.	O

DNA	O
methylation	O
patterns	O
are	O
essential	O
for	O
the	O
growth	O
and	O
maintenance	O
of	O
tissue	O
-	O
specific	O
expression	O
profiles	O
in	O
different	O
cell	O
types	O
during	O
development	O
,	O
and	O
these	O
patterns	O
become	O
set	O
during	O
in	O
utero	O
development	O
(	O
Hajkova	O
et	O
al	O
.	O

The	O
drop	O
-	O
outs	O
had	O
a	O
slightly	O
higher	O
BMI	O
,	O
lower	O
education	O
and	O
were	O
more	O
often	O
smokers	O
and	O
born	O
outside	O
of	O
the	O
Nordic	O
countries	O
.	O

Thyroxin	O
therapy	O
should	B
be	I
started	O
immediately	O
after	O
surgery	O
because	B
untreated	O
hypothyroidism	O
may	B
expose	O
the	O
mother	O
to	O
a	O
higher	O
risk	O
of	O
disease	O
recurrence	O
and	O
may	B
have	O
an	O
adverse	O
effect	B
on	O
cognitive	O
function	O
and	O
regular	O
growth	O
of	O
the	O
offspring	O
.	O

Although	B
there	O
are	O
contradicting	B
epidemiological	O
and	O
experimental	O
results	O
regarding	O
the	O
direct	O
influence	B
of	O
smoking	O
on	O
total	O
and	O
specific	O
IgE	O
production	O
,[	O
97	O
,	O
98	O
]	O
smoking	O
should	B
nevertheless	B
be	O
avoided	O
for	O
obvious	O
reasons	O
,	O
such	O
as	O
carcinogenic	O
smoke	O
constituents	O
and	O
the	O
vasoconstrictive	O
effect	B
of	O
nicotine	O
.	O

The	O
result	O
was	O
that	O
196	O
participants	O
will	O
be	O
required	O
.	O

The	O
infant	O
assessment	O
includes	O
HIV	O
status	O
history	O
and	O
a	O
general	O
,	O
ear	O
,	O
nose	O
and	O
throat	O
,	O
respiratory	O
,	O
cardiovascular	O
,	O
abdominal	O
and	O
neurological	O
examination	O
as	O
well	O
as	O
any	O
current	O
complaints	O
.	O

These	O
cohorts	O
often	B
have	O
limited	B
availability	O
of	O
appropriate	O
biosample	O
at	O
appropriate	O
collection	O
windows	O
(	O
Bakulski	O
&	O
Fallin2014	O
).	O

Furthermore	O
,	O
we	O
manually	O
examined	O
the	O
bibliography	O
of	O
the	O
papers	O
that	O
were	O
identified	O
electronically	O
.	O

In	O
women	O
belonging	O
to	O
the	O
high	O
level	O
symptoms	O
group	O
,	O
the	O
RRs	O
with	O
increasing	O
quartiles	O
of	O
omega	O
-	O
6	O
intake	O
were	O
:	O
0	O
.	O
67	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
55	O
-	O
0	O
.	O
82	O
),	O
0	O
.	O
66	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
54	O
-	O
0	O
.	O
81	O
),	O
0	O
.	O
78	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
64	O
-	O
0	O
.	O
97	O
).	O

Exposure	O
to	O
such	O
an	O
intra	O
-	O
uterine	O
environment	O
potentially	B
creates	O
a	O
vicious	O
cycle	O
in	O
which	O
the	O
propensity	O
to	O
obesity	O
is	O
perpetuated	O
,	O
with	O
major	O
adverse	O
public	O
health	O
implications	O
[	O
11	O
,	O
12	O
],	O
and	O
implications	B
for	O
the	O
health	O
of	O
successive	O
generations	O
[	O
13	O
].	O

Conclusion	O
After	O
a	O
careful	O
review	O
of	O
previous	B
studies	I
on	O
visfatin	O
and	O
pregnancy	O
,	O
we	O
can	O
claim	B
the	O
present	B
study	I
is	O
the	O
first	B
in	O
Iran	O
to	O
have	O
specifically	O
addressed	O
the	O
relationship	B
between	O
maternal	O
visfatin	O
levels	O
and	O
infant	O
’	O
s	O
anthropometric	O
indicators	O
up	O
to	O
a	O
year	O
after	O
birth	O
.	O

For	O
the	O
24	O
-	O
HR	O
all	O
portion	O
sizes	O
are	O
converted	O
to	O
grams	O
per	O
day	O
per	O
food	O
item	O
.	O

Significantly	O
dysregulated	O
proteins	O
were	O
examined	O
in	O
bioinformatic	O
pathways	O
analysis	O
(	O
Ingenuity	O
Pathway	O
Analysis	O
[	O
IPA	O
];	O
Ingenuity	O
Systems	O
,	O
Mountain	O
View	O
,	O
CA	O
).	O

If	O
there	O
were	O
two	O
types	O
of	O
infection	O
during	O
a	O
single	O
visit	O
to	O
the	O
physician	O
or	O
hospital	O
,	O
that	O
event	O
was	O
counted	O
as	O
a	O
single	O
event	O
.	O

b	O
.	O

The	O
IMF	O
of	O
Angus	O
steers	O
grown	O
in	O
South	O
Dakota	O
(	O
USA	O
)	O
increased	O
linearly	O
with	O
increasing	O
HCW	O
from	O
189	O
to	O
368	O
kg	O
(	O
live	O
weight	O
from	O
340	O
to	O
591	O
kg	O
)	O
[	O
73	O
].	O

More	B
research	B
in	I
this	I
area	I
is	I
required	B
to	O
draw	O
sound	O
conclusions	O
.	O

In	O
those	O
studies	O
,	O
25OHD	O
was	O
used	O
as	O
a	O
categorical	O
variable	O
.	O

Lineage	O
-	O
tracing	O
studies	O
showed	O
that	O
brown	O
adipocytes	O
in	O
classic	O
BAT	O
areas	O
derive	O
from	O
myogenic	O
factor	O
5	O
(	O
Myf	O
5	O
+)-	O
positive	O
progenitor	O
cells	O
,	O
similarly	O
to	O
skeletal	O
myocytes	O
(	O
Timmons	O
et	O
al	O
.,	O
2007	O
).	O

Unlike	B
the	O
previously	B
published	O
data	O
on	O
vitamin	O
D	O
in	O
the	O
Auckland	O
cohort	O
[	O
20	O
],	O
serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
measured	O
using	O
the	O
IDS	O
-	O
iSYS	O
chemiluminescent	O
-	O
based	O
assay	O
(	O
Abacus	O
,	O
ALS	O
)	O
as	O
per	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O

),	O
and	O
World	O
Food	O
Program	O
(	O
viz	O
.	O

When	O
compared	O
to	O
normal	O
weight	O
women	O
,	O
the	O
chance	O
of	O
developing	O
the	O
disease	O
steadily	O
increases	O
in	O
those	O
who	O
are	O
overweight	O
,	O
obese	O
and	O
severely	O
obese	O
.	O

Vitamin	O
D	O
deficiency	O
was	O
found	B
in	O
at	O
least	O
one	O
fourth	O
of	O
children	O
living	O
in	O
rural	O
areas	O
.	O

Vitamin	O
D	O
deficiency	O
has	O
previously	B
been	O
associated	B
with	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
given	O
its	O
role	B
in	O
supporting	O
insulin	O
secretion	O
and	O
pancreatic	O
β	O
-	O
cell	O
function	O
[	O
42	O
].	O

Just	O
about	O
a	O
mile	O
and	O
a	O
half	O
from	O
Bell	O
-	O
Jefferson	O
’	O
s	O
home	O
,	O
a	O
dam	O
broke	O
at	O
the	O
United	O
Nuclear	O
Corporation	O
mill	O
,	O
where	O
workers	O
processed	O
ore	O
from	O
the	O
nearby	O
Northeast	O
Church	O
Rock	O
uranium	O
mine	O
.	O

Retinoic	O
acid	O
positively	O
regulates	O
growth	O
hormone	O
gene	O
expression	O
[	O
135	O
]	O
and	O
decreases	O
fat	O
deposition	O
and	O
IMF	O
in	O
steers	O
[	O
136	O
].	O

Increasing	O
propionate	O
production	O
for	O
glucose	O
synthesis	O
is	O
also	O
important	B
for	O
IMF	O
deposition	O
,	O
especially	O
during	O
the	O
fattening	O
period	O
.	O

However	B
,	O
factors	O
including	O
ethnicity	O
,	O
paternal	O
intelligence	O
,	O
the	O
home	O
environment	O
,	O
drug	O
use	O
,	O
dietary	O
patterns	O
,	O
supplement	O
use	O
and	O
maternal	O
responsiveness	O
were	O
not	B
always	I
measured	I
.	O

Other	O
mitigating	O
factors	O
may	B
include	O
a	O
greater	O
intake	O
of	O
saturated	O
fat	O
in	O
the	O
form	O
of	O
milk	O
and	O
butter	O
,	O
as	O
well	O
as	O
a	O
greater	O
number	O
of	O
older	O
siblings	O
living	O
at	O
home	O
in	O
rural	O
/	O
farm	O
communities	O
[	O
116	O
].	O

Some	B
studies	I
investigated	O
the	O
effect	B
of	O
reduced	O
exposure	O
of	O
infants	O
to	O
allergen	O
-	O
provoking	O
food	O
.	O

Following	O
fertilization	O
epigenetic	O
marks	O
are	O
removed	O
to	O
generate	O
a	O
totipotent	O
zygote	O
,	O
capable	O
of	O
producing	O
all	O
the	O
different	O
cell	O
types	O
required	O
to	O
form	O
a	O
new	O
individual	O
.	O

2012	O
[	O
29	O
],	O
excluding	O
alcohol	O
consumption	O
to	O
adapt	O
the	O
score	O
to	O
a	O
pregnant	O
cohort	O
.	O

Also	O
,	O
postpregnancy	O
dietary	O
habits	O
and	O
choices	O
may	B
be	I
different	O
compared	O
with	O
prepregnancy	O
.	O

Sampling	O
and	O
laboratory	O
analyses	O
have	O
been	O
described	O
previously	O
[	O
3	O
].	O

Issues	B
specific	O
to	O
pre	O
-	O
existing	O
diabetes	O
in	O
pregnancy	O
include	O
tight	O
glycemic	O
control	O
and	O
adequate	O
folate	O
supplementation	O
.	O
53	O
,	O
54Additionally	O
,	O
post	O
partum	O
evaluation	O
and	O
management	O
of	O
reversible	O
cardiovascular	O
risk	O
factors	O
such	O
as	O
smoking	O
,	O
obesity	O
,	O
hypertension	O
,	O
and	O
hyperlipidemia	O
should	B
be	I
undertaken	O
.	O

The	O
dissected	O
hypothalamic	O
blocks	O
contained	O
preoptic	O
,	O
supraoptic	O
,	O
paraventricular	O
,	O
anterior	O
,	O
suprachiasmatic	O
,	O
dorsomedial	O
,	O
ventromedial	O
,	O
arcuate	O
,	O
mammillary	O
,	O
posterior	O
and	O
lateral	O
complex	O
nuclei	O
.	O

It	O
has	B
been	I
shown	I
that	O
mice	O
fed	O
post	O
-	O
weaning	O
a	O
high	O
fat	O
diet	O
(	O
60	O
%	O
calories	O
from	O
fat	O
)	O
had	O
lower	O
expression	O
of	O
the	O
μ	O
-	O
opioid	O
receptor	O
gene	O
which	O
influences	B
reward	O
circuitry	O
in	O
the	O
ventral	O
tegmental	O
area	O
,	O
nucleus	O
accumbens	O
and	O
prefrontal	O
cortex	O
.	O
37	O
In	O
conclusion	B
,	O
the	O
obesogenic	O
phenotype	O
in	O
offspring	O
from	O
HV	O
fed	O
dams	O
may	B
be	I
a	O
consequence	B
of	O
altered	O
hypothalamic	O
control	O
of	O
feeding	O
behavior	O
but	B
can	B
be	O
prevented	O
by	O
feeding	O
them	O
HV	O
or	O
HFol	O
pup	O
diets	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
calorict	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
Ppar	O
α	O
and	O
Ppar	O
γ	O
in	O
liver	O
and	O
perirenal	O
adipose	O
tissue	O
of	O
adult	O
offspring	O
Gene	O
expression	O
of	O
relevant	O
transcription	O
factors	O
(	O
Ppar	O
α	O
,	O
Ppar	O
γ	O
)	O
regulating	O
the	O
expression	O
of	O
genes	O
implicated	O
in	O
lipid	O
and	O
carbohydrate	O
metabolism	O
was	O
also	O
evaluated	O
in	O
the	O
liver	O
and	O
the	O
PAT	O
(	O
Figure6	O
).	O

The	O
new	O
study	O
appears	O
in	O
the	O
July	O
2006	O
issue	O
of	O
Archives	O
of	O
Medical	O
Research	O
.	O

Anaphylaxis	O
The	O
exact	O
prevalence	O
of	O
anaphylaxis	O
during	O
pregnancy	O
is	O
unknown	B
,	O
but	O
it	O
is	O
extremely	O
uncommon	B
[	O
30	O
].	O

One	O
trial	O
in	O
schoolchildren28	O
(	O
measuring	O
influenza	O
A	O
antigen	O
from	O
swabs	O
)	O
found	B
a	O
statistically	O
significant	O
reduced	O
incidence	O
in	O
the	O
intervention	O
group	O
(	O
RR	O
0	O
·	O
58	O
,	O
95	O
%	O
CI	O
0	O
·	O
34	O
–	O
0	O
·	O
99	O
).	O

The	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
deficiency	O
rate	O
of	O
Summer	O
is	O
zero	O
in	O
both	O
groups	O
,	O
but	O
is	O
high	O
of	O
other	O
three	O
seasons	O
(	O
Fig	O
.	O

At	O
the	O
end	O
of	O
the	O
test	O
,	O
animals	O
were	O
returned	O
to	O
their	O
original	O
cages	O
and	O
standard	O
diet	O
.	O

Omnibus	O
tests	O
for	O
the	O
overall	O
association	O
between	O
each	O
repetitive	O
methylation	O
and	O
class	O
methylation	O
were	O
obtained	O
by	O
permutation	O
test	O
,	O
using	O
a	O
test	O
analogous	O
to	O
a	O
Kolmogorov	O
–	O
Smirnov	O
test	O
.	O

Of	B
note	I
,	O
brain	O
tumors	O
are	O
known	O
to	O
contain	O
sex	O
steroid	O
receptors	O
(	O
e	O
.	O
g	O
.,	O
estrogen	O
,	O
androgen	O
,	O
progestin	O
)	O
[	O
198	O
],	O
and	O
sex	O
hormones	O
have	B
been	I
shown	I
to	O
promote	O
brain	O
tumors	O
in	O
animal	O
studies	O
[	O
199	O
,	O
200	O
].	O

Here	B
we	O
provide	O
accompanying	O
data	O
about	O
the	O
expression	O
of	O
hepatic	O
miRNAs	O
targeting	O
porcine	O
GR	O
3	O
′	O
UTR	O
in	O
the	O
neonatal	O
piglets	O
.	O

Vitamin	O
D3	O
also	O
comes	O
from	O
endogenous	O
sources	O
where	O
it	O
can	O
be	O
synthesized	O
by	O
skin	O
when	O
exposed	O
to	O
ultraviolet	O
irradiation	O
.	O

This	O
may	B
therefore	B
be	O
affecting	B
the	O
number	O
of	O
these	O
elements	O
in	O
the	O
genome	O
and	O
the	O
functional	O
relevance	O
of	O
their	O
methylation	O
,	O
particularly	O
in	O
the	O
placenta	O
.	O

We	O
also	O
found	B
a	O
sex	O
effect	B
on	O
the	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Cnr2	O
,	O
and	O
Faah	O
in	O
liver	O
and	O
PAT	O
,	O
Mgll	O
in	O
hypothalamus	O
and	O
PAT	O
,	O
Napepld	O
in	O
liver	O
,	O
and	O
Dagl	O
α	O
and	O
Dagl	O
β	O
in	O
PAT	O
.	O

The	O
associations	B
of	O
other	O
maternal	O
dietary	O
factors	O
with	O
specific	O
infant	O
gut	O
microbes	O
were	O
also	O
somewhat	O
unexpected	B
,	O
namely	O
for	O
red	O
and	O
processed	O
meat	O
and	O
for	O
fruit	O
consumption	O
.	O

[	O
14	O
]	O
Soontrapa	O
et	O
al	O
.	O

Concerning	O
hyperphagia	O
,	O
several	B
studies	I
have	B
reported	I
this	O
feeding	O
alteration	O
after	O
the	O
exposure	O
to	O
undernutrition	O
in	O
critical	B
windows	O
of	O
development	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
;	O
Desai	O
et	O
al	O
.,	O
2005	O
;	O
Breton	O
et	O
al	O
.,	O
2009	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
;	O
Manuel	O
-	O
Apolinar	O
et	O
al	O
.,	O
2014	O
),	O
so	O
it	O
has	B
been	I
proposed	B
as	O
an	O
important	B
contributor	O
of	O
the	O
excessive	O
body	O
weight	O
.	O

Fish	O
consumption	O
is	O
generally	B
recommended	B
as	O
healthful	O
due	O
to	O
its	O
DHA	O
and	O
EPA	O
content	O
despite	B
the	O
exposure	O
to	O
heavy	O
metals	O
and	O
other	O
contaminants	O
that	O
may	B
be	I
detrimental	O
to	O
health	O
[	O
12	O
].	O

The	O
role	B
of	O
paternal	O
nutrition	O
on	O
epigenetically	O
linked	B
heritable	O
diseases	O
such	O
as	O
cardiovascular	O
and	O
obesity	O
have	B
been	I
suggested	B
in	O
epidemiological	O
studies	O
[	O
10	O
].	O

The	O
dams	O
were	O
housed	O
individually	O
in	O
ventilated	O
plastic	O
transparent	O
cages	O
with	O
bedding	O
in	O
a	O
12	O
:	O
12	O
h	O
light	O
-	O
dark	O
cycle	O
(	O
lights	O
on	O
at	O
0700	O
at	O
22	O
±	O
1	O
°	O
C	O
).	O

Serum	O
25	O
-	O
hydroxyvitamin	O
D	O
was	O
measured	O
with	O
the	O
Chemiluminescence	O
immunoassay	O
(	O
CLIA	O
)	O
method	O
[	O
45	O
].	O

DNA	O
methylation	O
and	O
in	O
utero	O
exposures	O
.	O

Oka	O
et	O
al	O
[	O
134	O
]	O
recommended	B
selective	O
restriction	O
of	O
dietary	O
vitamin	O
A	O
from	O
14	O
to	O
22	O
or	O
25	O
months	O
of	O
age	O
to	O
improve	O
MS	O
and	O
QG	O
without	O
adverse	O
health	O
effects	B
(	O
blindness	O
,	O
arthritis	O
,	O
and	O
muscular	O
edema	O
),	O
given	O
the	O
effect	B
of	O
vitamin	O
A	O
restriction	O
from	O
23	O
months	O
of	O
age	O
in	O
improving	O
MS	O
is	O
minimal	O
.	O

Neuronal	O
membranes	O
are	O
largely	O
made	O
up	O
of	O
phospholipids	O
,	O
and	O
the	O
brain	O
phospholipids	O
are	O
rich	O
in	O
polyunsaturated	O
fatty	O
acids	O
(	O
PUFA	O
).	O

Parents	O
and	O
other	O
individuals	O
track	O
dust	O
and	O
dirt	O
into	O
the	O
home	O
,	O
on	O
shoes	O
and	O
clothes	O
,	O
after	O
working	O
on	O
the	O
farm	O
.	O

The	O
order	O
of	O
introduction	O
seems	B
to	O
have	O
little	O
effect	O
on	O
AM	O
.	O

Therefore	B
,	O
the	O
participants	O
’	O
honesty	O
was	O
one	O
of	O
this	O
research	O
limits	B
.	O

The	O
initial	O
intervention	O
usually	O
entails	O
dietary	O
advice	O
,	O
individualized	O
if	O
possible	O
,	O
and	O
given	O
by	O
a	O
dietitian	O
.	O

Two	O
-	O
way	O
ANOVA	O
and	O
Bonferrroni	O
post	O
-	O
hoc	O
test	O
:	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
males	O
;	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
females	O
;	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
RC	O
males	O
;	O
ns	O
,	O
non	O
-	O
significant	O
.	O

We	O
tested	O
the	O
contribution	O
of	O
maternal	O
dietary	O
measures	O
(	O
as	O
continuous	O
variables	O
)	O
to	O
the	O
infant	O
microbiome	O
at	O
6	O
weeks	O
using	O
the	O
adonis	O
function	O
in	O
the	O
R	O
package	O
vegan	O
[	O
45	O
]	O
with	O
10	O
,	O
000	O
permutations	O
.	O

Further	B
well	O-
designed	O-
studies	B
are	O
required	B
to	O
strengthen	B
the	O
evidence	B
base	I
regarding	O
the	O
type	O
and	O
quantity	O
of	O
maternal	O
fish	O
consumption	O
during	O
pregnancy	O
and	O
associated	B
neurodevelopmental	O
outcomes	O
in	O
the	O
offspring	O
,	O
while	B
considering	B
the	O
contribution	B
of	O
mercury	O
from	O
fish	O
-	O
containing	O
diets	O
.	O

Glyburide	O
(	O
Glibenclamide	O
)	O
American	O
authors	O
have	O
stated	B
that	O
glyburide	O
has	O
replaced	O
insulin	O
as	O
first	B
line	I
pharmacological	O
treatment	O
of	O
GDM	O
in	O
many	O
practices	O
.	O
56This	O
has	O
largely	O
occurred	O
on	B
the	I
basis	I
of	I
a	O
randomized	O
controlled	O
trial	O
where	O
404	O
women	O
with	O
GDM	O
were	O
treated	O
with	O
glyburide	O
(	O
up	O
to	O
20	O
mg	O
/	O
day	O
)	O
or	O
insulin57In	O
this	O
study	O
,	O
the	O
level	O
of	O
glycemic	O
control	O
achieved	O
was	O
the	O
same	O
in	O
both	O
groups	O
(	O
mean	O
glucose	O
concentration	O
during	O
treatment	O
with	O
glyburide	O
5	O
.	O
9	O
±	O
0	O
.	O
9	O
mmol	O
/	O
L	O
compared	O
to	O
5	O
.	O
9	O
±	O
1	O
.	O
0	O
mmol	O
/	O
L	O
in	O
insulin	O
group	O
).	O

There	O
was	O
no	O
association	O
with	O
eczema	O
,	O
hay	O
fever	O
,	O
total	O
IgE	O
,	O
FEV1	O
,	O
FVC	O
or	O
FEF25	O
–	O
75	O
(	O
table	O
2and	O
supplementary	O
table	O
E2	O
).	O

Thus	B
,	O
all	O
the	O
machinery	O
involved	B
in	O
these	O
pathways	O
,	O
including	O
DNA	O
and	O
RNA	O
binding	O
and	O
modifying	O
proteins	O
,	O
are	O
epigenetically	O
important	B
.	O

Inhibitory	O
processes	O
are	O
shown	O
in	O
red	O
and	O
positive	O
in	O
green	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
and	O
number	O
of	O
positive	O
skin	O
prick	O
tests	O
(	O
SPTs	O
)#	O
Free	O
sugar1	O
positive	O
SPT	O
¶≥	O
2	O
positive	O
SPTs	O
+	O
Adjusted	O
OR	O
§(	O
95	O
%	O
CI	O
)	O
p	O
-	O
trendAdjusted	O
OR	O
§(	O
95	O
%	O
CI	O
)	O
p	O
-	O
trendQuintile	O
1	O
1	O
.	O
001	O
.	O
00	O
Quintile	O
2	O
0	O
.	O
87	O
(	O
0	O
.	O
68	O
–	O
1	O
.	O
12	O
)	O
1	O
.	O
17	O
(	O
0	O
.	O
87	O
–	O
1	O
.	O
57	O
)	O
Quintile	O
3	O
1	O
.	O
07	O
(	O
0	O
.	O
83	O
–	O
1	O
.	O
37	O
)	O
1	O
.	O
14	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
56	O
)	O
Quintile	O
4	O
1	O
.	O
09	O
(	O
0	O
.	O
83	O
–	O
1	O
.	O
43	O
)	O
1	O
.	O
37	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
90	O
)	O
Quintile	O
5	O
1	O
.	O
19	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
63	O
)	O
1	O
.	O
73	O
(	O
1	O
.	O
18	O
–	O
2	O
.	O
52	O
)	O
Per	O
quintile	O
1	O
.	O
06	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
121	O
.	O
13	O
(	O
1	O
.	O
03	O
–	O
1	O
.	O
23	O
)	O
0	O
.	O
006	O
#:	O
no	O
positive	O
SPT	O
was	O
considered	O
as	O
baseline	O
category	O
(	O
n	O
=	O
4797	O
);¶:	O
n	O
=	O
783	O
;+:	O
n	O
=	O
531	O
;§:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

Unplanned	O
pregnancy	O
was	O
more	O
frequent	O
in	O
the	O
vitamin	O
D	O
group	O
than	O
the	O
control	O
group	O
.	O

We	O
will	O
use	O
Cox	O
proportional	O
hazards	O
mixed	O
models	O
for	O
mortality	O
outcomes	O
and	O
include	O
groundwater	O
iron	O
level	O
as	O
an	O
interaction	O
term	O
in	O
the	O
mortality	O
model	O
.	O

Using	O
a	O
new	B
assessment	O
technique	O
,	O
we	O
investigated	B
Vitamin	O
D	O
nutritional	O
status	O
among	O
outpatients	O
with	O
GDM	O
in	O
our	O
hospital	O
,	O
and	O
analyzed	O
Vitamin	O
D	O
sources	O
and	O
its	O
association	B
with	O
dietary	O
pattern	B
.	O

Fewer	O
neonates	O
in	O
the	O
treatment	O
group	O
were	O
large	O
for	O
gestational	O
age	O
,	O
and	O
there	O
was	O
no	O
difference	O
in	O
the	O
incidence	O
of	O
small	O
for	O
gestational	O
age	O
infants	O
.	O

2	O
.	O

The	O
sequences	O
of	O
all	O
the	O
porcine	O
miRNAs	O
were	O
acquired	O
from	O
miRBase	O
(	O
http	O
://	O
www	O
.	O
mirbase	O
.	O
org	O
/).	O

The	O
results	O
demonstrated	B
that	O
terbutaline	O
increased	O
microglial	O
activation	O
in	O
the	O
subjects	O
'	O
cerebral	O
cortex	O
,	O
cerebellar	O
,	O
and	O
cerebrocortical	O
white	O
matter	O
[	O
23	O
].	O

In	O
pooled	O
data	O
of	O
different	O
sexes	O
(	O
cows	O
,	O
bulls	O
,	O
and	O
steers	O
)	O
of	O
Korean	O
cattle	O
,	O
MS	O
and	O
LM	O
area	O
increased	O
with	O
increasing	O
carcass	O
weight	O
from	O
143	O
to	O
536	O
kg	O
[	O
39	O
].	O

Methods	O
Design	O
and	O
study	O
population	O
We	O
conducted	O
a	O
cross	O
-	O
sectional	O
study	O
during	O
August	O
and	O
September	O
2010	O
on	O
a	O
sample	O
of	O
400	O
consecutive	O
women	O
who	O
had	O
given	O
birth	O
in	O
a	O
regional	O
specialist	O
obstetric	O
centre	O
,	O
the	O
Cuza	O
-	O
Vodă	O
Clinical	O
Hospital	O
in	O
Iaşi	O
,	O
Romania	O
.	O

Among	O
the	O
SGA	O
cases	O
defined	O
by	O
length	O
only	O
,	O
most	O
were	O
close	O
to	O
also	O
meeting	O
the	O
SGA	O
definition	O
for	O
birth	O
weight	O
.	O

After	O
separating	O
the	O
serum	O
from	O
blood	O
sample	O
,	O
the	O
serum	O
was	O
kept	O
under	O
−	O
20	O
°	O
C	O
temperature	O
until	O
the	O
laboratory	O
test	O
was	O
done	O
.	O

Interestingly	B
,	O
epidemiological	O
studies	O
in	O
women	O
showed	O
that	O
maternal	O
malnutrition	O
during	O
pregnancy	O
can	B
result	O
in	O
fetal	O
growth	O
retardation	O
[	O
11	O
,	O
12	O
].	O

Furthermore	O
,	O
the	O
dietary	O
modifications	O
led	O
to	O
regulation	O
of	O
the	O
'	O
Wnt	O
signaling	O
'	O
pathway	O
,	O
which	O
is	O
involved	B
in	O
various	O
aspects	O
of	O
embryogenesis	O
,	O
including	O
cell	O
differentiation	O
and	O
cell	O
proliferation	O
[	O
38	O
].	O

Those	O
who	O
participated	O
gave	O
written	O
informed	O
consent	O
.	O

Fatty	O
acid	O
metabolism	O
,	O
Biosynthesis	O
of	O
steroids	O
,	O
Synthesis	O
and	O
degradation	O
of	O
ketone	O
bodies	O
,	O
FA	O
elongation	O
in	O
mitochondria	O
,	O
Bile	O
acid	O
synthesis	O
)	O
and	O
cell	O
cycle	O
regulation	O
(	O
e	O
.	O
g	O
.	O

Alternately	B
,	O
any	O
reduction	O
in	O
cellular	O
energetics	O
within	O
this	O
region	O
may	B
delay	O
the	O
integration	O
of	O
cortical	O
and	O
/	O
or	O
sub	O
-	O
cortical	O
inputs	O
.	O

In	O
two	O
separate	O
studies	O
,	O
early	O
-	O
weaned	O
steers	O
(	O
weaned	O
at	O
177	O
d	O
[	O
study	O
1	O
]	O
and	O
158	O
d	O
[	O
study	O
2	O
]	O
of	O
age	O
and	O
placed	O
on	O
a	O
finishing	O
diet	O
)	O
increased	O
MS	O
and	O
body	O
weight	O
gain	O
,	O
improved	O
feed	O
efficiency	O
,	O
and	O
improved	O
QG	O
of	O
the	O
beef	O
compared	O
with	O
normally	O
weaned	O
steers	O
or	O
normally	O
weaned	O
steers	O
supplemented	O
with	O
grain	O
[	O
51	O
].	O

The	O
findings	O
of	O
the	O
formative	O
study	O
suggested	B
that	O
introduction	O
of	O
IFA	O
supplements	O
early	O
in	O
pregnancy	O
is	O
feasible	B
with	O
support	O
from	O
BRAC	O
or	O
government	O
community	O
health	O
workers	O
.	O

Data	O
analysis	O
The	O
bioinformatic	O
analysis	O
was	O
done	O
in	O
R	O
[	O
65	O
].	O

We	O
analyzed	O
maternal	O
plasma	O
glucose	O
concentrations	O
1	O
hour	O
after	O
a	O
50	O
-	O
gram	O
oral	O
glucose	O
challenge	O
as	O
part	O
of	O
routine	O
mid	O
-	O
pregnancy	O
screening	O
for	O
GDM	O
.	O

The	O
strategy	B
is	O
to	O
develop	O
Anganwadi	O
as	O
a	O
“	O
vibrant	O
early	O
childhood	O
development	O
centre	O
”	O
by	O
giving	O
greater	O
focus	O
on	O
under	O
three	O
years	O
children	O
,	O
strengthening	O
early	O
childhood	O
education	O
,	O
and	O
by	O
ensuring	O
care	O
and	O
counseling	O
of	O
mothers	O
and	O
family	O
.	O

Meanwhile	O
,	O
the	O
least	O
attended	O
were	O
Bonakanda	O
and	O
Bova	O
health	O
centres	O
(	O
0	O
.	O
5	O
%	O
and	O
0	O
.	O
3	O
%	O
respectively	O
).	O

Identifying	O
modifiable	O
,	O
prenatal	O
causes	O
of	O
childhood	O
obesity	O
will	B
inform	O
future	B
interventions	I
targeting	O
pregnancy	O
as	O
a	O
“	O
teachable	O
moment	O
”	O
for	O
primary	O
and	O
secondary	O
obesity	O
prevention	O
.	O

SSRIs	O
Selective	O
serotonin	O
reuptake	O
inhibitors	O
(	O
SSRIs	O
)	O
are	O
a	O
class	O
of	O
drugs	O
currently	O
and	O
increasingly	O
prescribed	O
for	O
anxiety	O
disorders	O
and	O
depression	O
.	O

Gestational	O
diabetes	O
in	O
humans	O
is	O
a	O
situation	O
of	O
increased	O
nutrient	O
supply	O
that	O
,	O
together	O
with	O
the	O
high	O
maternal	O
body	O
mass	O
index	O
,	O
can	B
be	O
accompanied	O
by	O
enhanced	O
birth	O
-	O
weight	O
and	O
adverse	O
long	O
-	O
term	O
metabolic	O
consequences	O
,	O
as	O
described	O
by	O
the	O
World	O
Health	O
Organization	O
(	O
2003	O
),	O
as	O
well	O
as	O
in	O
several	O
publications	O
(	O
Larsson	O
et	O
al	O
.,	O
1986	O
;	O
Dabelea	O
et	O
al	O
.,	O
2000	O
;	O
Singh	O
et	O
al	O
.,	O
2006	O
).	O

As	O
described	O
previously	O
[	O
24	O
],	O
16S	O
rDNA	O
V4	O
-	O
V5	O
amplicons	O
were	O
generated	O
from	O
purified	O
genomic	O
DNA	O
samples	O
using	O
fusion	O
primers	O
.	O

In	O
the	O
studies	O
conducted	O
to	O
date	O
,	O
risk	O
estimates	O
and	O
p	O
-	O
values	O
for	O
the	O
association	B
between	O
season	O
of	O
birth	O
and	O
glioma	O
risk	O
have	B
been	I
nominal	O
to	O
borderline	O
in	O
strength	O
.	O

In	O
2009	O
,	O
functional	O
human	O
BAT	O
was	O
identified	O
in	O
adults	O
by	O
a	O
combination	O
of	O
CT	O
scans	O
and	O
fluorodeoxyglucose	O
positron	O
emission	O
tomography	O
(	O
FDG	O
-	O
PET	O
)	O
(	O
Cypess	O
et	O
al	O
.,	O
2009	O
;	O
van	O
Marken	O
Lichtenbelt	O
et	O
al	O
.,	O
2009	O
;	O
Virtanen	O
et	O
al	O
.,	O
2009	O
).	O

“	O
But	O
what	O
we	O
will	B
end	O
up	O
with	O
is	O
that	O
we	O
now	O
will	B
be	O
able	O
to	O
study	O
three	O
successive	O
generations	O
of	O
Navajos	O
that	O
have	B
been	I
exposed	O
.”	O
Although	B
the	O
literature	O
on	O
chronic	O
low	O
-	O
level	O
uranium	O
exposure	O
is	O
still	B
quite	O
small	B
,	O
by	O
2003	O
researchers	O
knew	O
that	O
the	O
dangers	O
these	O
exposures	O
posed	O
were	O
due	B
not	B
to	I
uranium	O
’	O
s	O
radioactivity	O
but	B
to	O
its	O
chemical	O
toxicity	O
.	O
24Both	O
animal25and	O
human26studies	O
have	O
found	B
uranium	O
to	O
be	O
primarily	B
toxic	O
to	O
the	O
kidneys	O
.	O

However	B
,	O
there	O
was	O
no	O
difference	O
in	O
sperm	O
tail	O
DNA	O
fragmentation	O
,	O
tail	O
length	O
,	O
or	O
motility	O
(	O
p	O
>	O
0	O
.	O
05	O
).	O

This	O
is	O
especially	O
important	B
for	O
pregnant	O
asthmatic	O
patients	O
,	O
in	O
whom	O
smoking	O
-	O
related	O
morbidity	O
is	O
independent	O
of	O
--	O
and	O
adds	O
to	O
--	O
the	O
morbidity	O
resulting	O
from	O
asthma	O
[	O
96	O
].	O

Decades	O
of	O
uranium	O
mining	O
have	O
dotted	O
the	O
landscape	O
across	O
the	O
Navajo	O
Nation	O
with	O
piles	O
of	O
contaminated	O
mine	O
waste	O
.	O

Smoking	O
status	O
was	O
categorised	O
as	O
the	O
maximum	O
exposure	O
during	O
pregnancy	O
(	O
never	O
,	O
passive	O
smoking	O
only	O
,	O
1	O
–	O
9	O
,	O
10	O
–	O
19	O
and	O
≥	O
20	O
cigarettes	O
per	O
day	O
).	O

Maternal	O
iron	O
deficiency	O
and	O
anemia	O
early	O
in	O
gestation	O
can	O
result	O
in	O
premature	O
birth	O
and	O
low	O
birth	O
weight	O
.	O

Drug	O
Allergy	O
There	O
is	O
a	O
lack	B
of	I
data	I
on	O
the	O
prevalence	O
of	O
adverse	O
drug	O
reactions	O
during	O
pregnancy	O
.	O

For	O
this	O
reason	O
—	O
although	B
we	O
did	O
mention	O
impaired	O
spermatogenesis	O
as	O
one	O
of	O
the	O
end	O
points	O
encompassed	O
by	O
the	O
testicular	O
dysgenesis	O
syndrome	O
—	O
it	O
was	O
necessary	O
to	O
exclude	O
this	O
end	O
point	O
from	O
our	O
analysis	O
.	O

Increasing	O
digestion	O
of	O
rumen	O
-	O
bypassed	O
starch	O
in	O
the	O
small	O
intestine	O
helps	O
increase	O
the	O
glucose	O
supply	O
.	O

Multiple	O
regression	O
(	O
for	O
continuous	O
outcomes	O
)	O
and	O
logistic	O
regression	O
(	O
for	O
categorical	O
outcomes	O
)	O
were	O
used	O
to	O
examine	O
predictors	O
of	O
infant	O
macrosomia	O
,	O
and	O
WFA	O
z	O
-	O
scores	O
at	O
birth	O
and	O
6	O
months	O
,	O
and	O
changes	O
in	O
WFA	O
z	O
-	O
scores	O
,	O
adjusting	O
for	O
treatment	O
group	O
,	O
infant	O
sex	O
,	O
recruitment	O
clinic	O
,	O
weeks	O
of	O
gestation	O
at	O
delivery	O
,	O
and	O
breastfeeding	O
(	O
in	O
6	O
-	O
month	O
analyses	O
).	O

Conclusions	O
In	B
summary	I
,	O
20	O
.	O
4	O
%	O
pregnant	O
women	O
with	O
GDM	O
in	O
their	O
middle	O
and	O
late	O
pregnancy	O
are	O
deficient	O
in	O
Vitamin	O
D	O
,	O
though	B
their	O
Vitamin	O
D	O
levels	O
were	O
higher	O
than	O
the	O
general	O
population	O
.	O

Our	O
results	O
indicates	B
that	O
25OHD	O
at	O
T3	O
but	B
not	I
at	O
T1	O
is	O
associated	B
with	O
SGA	O
and	O
LBW	O
,	O
despite	B
better	B
statistical	O
power	O
at	O
T1	O
due	B
to	I
more	O
25OHD	O
samples	O
and	O
subsequently	O
more	O
cases	O
of	O
SGA	O
,	O
LBW	O
and	O
preterm	O
birth	O
.	O

Bonferroni	O
analysis	O
indicated	B
a	O
significant	O
increase	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Cnr2	O
in	O
the	O
hypoyhalamus	O
of	O
RC	O
male	O
offspring	O
compared	O
to	O
CC	O
ones	O
(	O
Figure4A	O
).	O

Strengths	O
of	O
this	B
study	I
are	O
that	O
the	O
GraviD	O
cohort	O
is	O
representative	O
of	O
the	O
general	O
pregnant	O
population	O
in	O
terms	O
of	O
origin	O
,	O
education	O
,	O
parity	O
,	O
BMI	O
and	O
tobacco	O
use	O
[	O
25	O
],	O
which	O
increases	O
the	O
external	O
validity	B
of	O
the	O
findings	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Repeat	O
element	O
methylation	O
markers	O
grouped	O
by	O
in	O
utero	O
exposures	O
.	O
Group	O
mean	O
±	O
SDExposure	O
n	O
LINE	O
-	O
1AluYb8Array	O
-	O
based	O
methylationSexMale19051	O
.	O
7	O
±	O
4	O
.	O
465	O
.	O
3	O
±	O
3	O
.	O
30	O
.	O
238	O
±	O
0	O
.	O
012Female19051	O
.	O
7	O
±	O
4	O
.	O
964	O
.	O
6	O
±	O
3	O
.	O
30	O
.	O
237	O
±	O
0	O
.	O
013	O
p	O
-	O
Value0	O
.	O
900	O
.	O
040	O
.	O
28Maternal	O
ethnicityCaucasian21751	O
.	O
4	O
±	O
4	O
.	O
564	O
.	O
9	O
±	O
3	O
.	O
30	O
.	O
239	O
±	O
0	O
.	O
013Non	O
-	O
Caucasian16352	O
.	O
0	O
±	O
4	O
.	O
865	O
.	O
1	O
±	O
3	O
.	O
30	O
.	O
236	O
±	O
0	O
.	O
011	O
p	O
-	O
Value0	O
.	O
210	O
.	O
470	O
.	O
17Maternal	O
tobacco	O
use	O
during	O
pregnancyYes3652	O
.	O
9	O
±	O
4	O
.	O
766	O
.	O
2	O
±	O
2	O
.	O
30	O
.	O
240	O
±	O
0	O
.	O
011No34351	O
.	O
6	O
±	O
4	O
.	O
664	O
.	O
8	O
±	O
3	O
.	O
40	O
.	O
237	O
±	O
0	O
.	O
012	O
p	O
-	O
Value0	O
.	O
10	O
<	O
0	O
.	O
010	O
.	O
31Maternal	O
alcohol	O
use	O
during	O
pregnancyYes355	O
.	O
0	O
±	O
1	O
.	O
066	O
.	O
0	O
±	O
3	O
.	O
40	O
.	O
230	O
±	O
0	O
.	O
001No37751	O
.	O
7	O
±	O
4	O
.	O
665	O
.	O
0	O
±	O
3	O
.	O
30	O
.	O
238	O
±	O
0	O
.	O
012	O
p	O
-	O
Value0	O
.	O
020	O
.	O
660	O
.	O
51Maternal	O
prenatal	O
vitamin	O
use	O
during	O
pregnancyYes31451	O
.	O
8	O
±	O
4	O
.	O
665	O
.	O
0	O
±	O
3	O
.	O
30	O
.	O
238	O
±	O
0	O
.	O
012No6651	O
.	O
3	O
±	O
4	O
.	O
764	O
.	O
6	O
±	O
3	O
.	O
40	O
.	O
238	O
±	O
0	O
.	O
014	O
p	O
-	O
Value0	O
.	O
500	O
.	O
290	O
.	O
80	O
p	O
-	O
Values	O
obtained	O
from	O
Kruskal	O
–	O
Wallis	O
tests	O
.	O

Conclusion	O
In	O
this	O
study	O
39	O
%	O
of	O
women	O
reported	O
using	O
herbs	O
during	O
pregnancy	O
,	O
a	O
higher	O
frequency	O
than	B
reported	I
in	I
other	I
studies	I
.	O

Although	B
many	O
proteins	O
were	O
found	B
to	I
be	I
significantly	O
altered	O
in	O
DVD	O
-	O
deficient	O
adults	O
,	O
the	O
fold	O
-	O
change	O
level	O
was	O
insufficient	B
for	O
confirmation	O
analysis	O
by	O
western	O
blot	O
.	O

Previous	B
studies	I
on	O
pregnant	O
Australian	O
and	O
New	O
Zealand	O
women	O
have	B
reported	I
that	O
while	B
circulating	O
25	O
(	O
OH	O
)	O
D	O
was	O
significantly	O
lower	O
in	O
women	O
with	O
PE	O
,	O
sPTB	O
,	O
GDM	O
and	O
those	O
who	O
delivered	O
a	O
small	O
-	O
for	O
gestational	O
age	O
(	O
SGA	O
)	O
infant	O
,	O
no	O
association	O
between	O
vitamin	O
D	O
deficiency	O
and	O
these	O
pregnancy	O
complications	B
was	O
found	O
after	O
adjusting	O
for	O
covariates	O
[	O
18	O
–	O
20	O
].	O

Of	O
total	O
participants	O
92	O
(	O
60	O
.	O
1	O
%)	O
mothers	O
were	O
nulliparous	O
and	O
61	O
(	O
39	O
.	O
9	O
%)	O
were	O
multiparous	O
women	O
.	O

Maternal	O
“	O
diabetes	O
”	O
was	O
not	O
associated	O
with	O
any	O
respiratory	O
or	O
atopic	O
outcome	O
,	O
but	O
was	O
associated	B
with	O
higher	O
birthweight	O
.	O

It	O
is	O
important	B
to	O
continue	O
supplementing	O
non	O
-	O
human	O
models	B
with	O
human	O
-	O
derived	O
data	O
,	O
incorporating	O
new	B
technologies	O
to	O
maximize	O
data	O
collection	O
,	O
and	O
updating	O
and	O
re	O
-	O
evaluating	O
current	O
conclusions	B
as	O
novel	B
information	B
becomes	O
available	O
.	O

No	O
current	O
medical	O
illness	O
;	O
4	O
).	O

Among	O
the	O
regulators	O
that	O
may	B
link	B
the	O
maternal	O
diet	O
during	O
gestation	O
with	O
the	O
metabolic	O
outcome	O
of	O
the	O
offspring	O
,	O
leptin	O
is	O
one	O
of	O
the	O
main	O
candidates	B
.	O

Epigenetic	O
programing	O
via	O
DNA	O
methylation	O
,	O
histone	O
modifications	O
and	O
non	O
-	O
coding	O
RNAs	O
then	O
redirects	O
and	O
drives	O
development	O
of	O
the	O
zygote	O
through	O
embryogenesis	O
and	O
ultimately	O
into	O
a	O
mature	O
adult	O
.	O

Stimulation	O
of	O
BAT	O
activity	O
and	O
/	O
or	O
recruitment	O
of	O
UCP1	O
-	O
positive	O
cells	O
are	O
therefore	B
relevant	B
targets	B
for	O
the	O
treatment	O
of	O
obesity	O
/	O
type	O
2	O
diabetes	O
in	O
humans	O
.	O

Maternal	O
household	O
food	O
insufficiency	O
and	O
insecurity	O
The	O
level	O
of	O
the	O
participating	O
women	O
’	O
s	O
household	O
food	O
insufficiency	O
and	O
insecurity	O
is	O
assessed	O
at	O
phase	O
1	O
in	O
pregnancy	O
and	O
again	O
at	O
phases	O
6	O
and	O
8	O
postnatally	O
.	O

In	O
particular	O
,	O
the	O
degradation	O
of	O
essential	O
,	O
branch	O
-	O
chained	O
amino	O
acids	O
like	O
valine	O
,	O
leucine	O
and	O
isoleucine	O
was	O
found	O
to	I
be	I
regulated	O
,	O
which	O
may	B
illustrate	O
the	O
LP	O
offspring	O
'	O
s	O
efforts	O
to	O
mimic	O
prenatal	O
experiences	O
in	O
terms	O
of	O
dietary	O
supply	O
during	O
postnatal	O
development	O
in	O
the	O
face	O
of	O
richer	O
conditions	O
.	O

Recently	B
,	O
investigators	O
reported	B
that	O
mild	O
sleep	O
restriction	O
induces	O
marked	O
reduction	O
in	O
basal	O
glucagon	O
concentrations	O
[	O
19	O
].	O

Our	B
findings	I
provide	O
further	B
support	B
for	O
the	O
hypothesis	B
that	O
an	O
aberration	O
in	O
lipid	O
metabolism	O
may	B
be	I
involved	B
in	O
the	O
biochemical	O
basis	O
for	O
psychiatric	O
disorders	O
[	O
13	O
].	O

The	O
study	O
was	O
conducted	O
with	O
steer	O
of	O
three	O
genotypes	O
(	O
Angus	O
,	O
Hereford	O
and	O
Wagyu	O
×	O
Angus	O
):	O
Angus	O
was	O
targeting	O
high	O
IMF	O
and	O
high	O
subcutaneous	O
fat	O
,	O
Hereford	O
was	O
targeting	O
low	O
IMF	O
and	O
high	O
subcutaneous	O
fat	O
,	O
and	O
Wagyu	O
sires	O
Angus	O
dams	O
were	O
targeting	O
high	O
IMF	O
and	O
lower	O
subcutaneous	O
fat	O
.	O

Maternal	O
diet	O
during	O
pregnancy	O
is	O
related	B
with	O
the	O
infant	O
stool	O
microbiome	O
in	O
a	O
delivery	O
mode	O
-	O
dependent	O
manner	O
Abstract	O
Background	O
The	O
gut	O
microbiome	O
has	O
an	O
important	B
role	B
in	O
infant	O
health	O
and	O
immune	O
development	O
and	O
may	B
be	I
affected	B
by	O
early	O
-	O
life	O
exposures	O
.	O

Any	O
drug	O
may	B
carry	O
a	O
small	O
risk	O
that	O
must	B
be	I
balanced	O
against	O
the	O
benefits	O
of	O
keeping	O
the	O
mother	O
and	O
baby	O
healthy	O
.	O

2010	O
).	O

Abstract	O
:	O
SHORT	O
Higher	O
maternal	O
intake	O
of	O
sugar	O
in	O
pregnancy	O
may	B
increase	O
the	O
risk	O
of	O
allergy	O
and	O
allergic	O
asthma	O
in	O
the	O
offspring	O
http	O
://	O
ow	O
.	O
ly	O
/	O
zehc30bFswP	O
Introduction	O
There	O
has	B
been	O
considerable	B
interest	B
in	O
the	O
role	B
of	O
maternal	O
diet	O
in	O
pregnancy	O
in	O
the	O
aetiology	O
of	O
childhood	O
asthma	O
and	O
atopy	O
[	O
1	O
].	O

Radioimmunoassay	O
and	O
ELISA	O
were	O
performed	O
to	O
analyze	O
25	O
(	O
OH	O
)	O
D	O
and	O
cathelicidin	O
,	O
respectively	O
.	O

of	O
regulated	O
genesGenes	O
involved	O
in	O
pathway94	O
dpc	O
vs	O
.	O
1	O
dpn	O
AP	O
AMPK	O
signalingup6	O
.	O
96	O
*	O
E	O
-	O
38AKT2	O
,	O
INSR	O
,	O
PIK3C2A	O
,	O
PIK3R1	O
,	O
PPM1B	O
,	O
PRKAA1	O
,	O
PRKACB	O
,	O
RAC1	O
AP	O
Mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinasedown3	O
.	O
25	O
*	O
E	O
-	O
47CCNB1	O
,	O
CCNB2	O
,	O
CDC25B	O
,	O
CHEK2	O
,	O
KIF11	O
,	O
PLK4	O
,	O
PTTG1	O
AP	O
Pyrimidine	O
metabolismdown2	O
.	O
52	O
*	O
E	O
-	O
310CAD	O
,	O
DCTD	O
,	O
DKC1	O
,	O
POLQ	O
,	O
POLR3E	O
,	O
POLR3K	O
,	O
RFC5	O
,	O
RRM1	O
,	O
TYMS	O
,	O
UCK2	O
AP	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulationdown2	O
.	O
04	O
*	O
E	O
-	O
46CCNB1	O
,	O
CCNB2	O
,	O
CDC25B	O
,	O
CHEK2	O
,	O
UBC	O
,	O
YWHAE	O
LP	O
Purine	O
metabolismup9	O
.	O
20	O
*	O
E	O
-	O
312DDX39	O
,	O
PNPT1	O
,	O
POLA2	O
,	O
POLE2	O
,	O
POLR1B	O
,	O
POLR1C	O
,	O
POLR2I	O
,	O
RFC3	O
,	O
RRM2	O
,	O
RRM2B	O
,	O
RUVBL1	O
,	O
RUVBL2	O
LP	O
Pyrimidine	O
metabolismup6	O
.	O
15	O
*	O
E	O
-	O
714CTPS	O
,	O
PNPT1	O
,	O
POLA2	O
,	O
POLE2	O
,	O
POLR1B	O
,	O
POLR1C	O
,	O
POLR2I	O
,	O
PUS1	O
,	O
RFC3	O
,	O
RRM2	O
,	O
RRM2B	O
,	O
TXNRD1	O
,	O
TYMS	O
,	O
UCK2	O
LP	O
Mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinaseup7	O
.	O
55	O
*	O
E	O
-	O
57ANAPC4	O
,	O
CDC27	O
,	O
CDK1	O
,	O
ESPL1	O
,	O
FZR1	O
,	O
PPP2R1B	O
,	O
PTTG1	O
LP	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulationup3	O
.	O
09	O
*	O
E	O
-	O
23CDK1	O
,	O
CHEK1	O
,	O
YWHAZ	O
LP	O
Wnt	O
signalingdown4	O
.	O
02	O
*	O
E	O
-	O
29AKT3	O
,	O
FZD5	O
,	O
MMP7	O
,	O
NLK	O
,	O
SOX4	O
,	O
TCF3	O
,	O
TCF4	O
,	O
TCF7L2	O
,	O
WNT5A1	O
dpn	O
vs	O
.	O
28	O
dpn	O
AP	O
AMPK	O
signalingup4	O
.	O
26	O
*	O
E	O
-	O
38AK1	O
,	O
CPT1A	O
,	O
EIF4EBP1	O
,	O
HMGCR	O
,	O
MAPK14	O
,	O
NOS3	O
,	O
PRKAA2	O
,	O
PRKAB2	O
AP	O
mTOR	O
signalingup1	O
.	O
89	O
*	O
E	O
-	O
27EIF3F	O
,	O
EIF3G	O
,	O
EIF4EBP1	O
,	O
FNBP1	O
,	O
GNB1L	O
,	O
PRKAA2	O
,	O
PRKAB2	O
AP	O
Val	O
,	O
Leu	O
,	O
Ile	O
degradationdown6	O
.	O
40	O
*	O
E	O
-	O
36ACAD8	O
,	O
ACADL	O
,	O
ACADSB	O
,	O
BCAT1	O
,	O
DBT	O
,	O
MCCC2	O
LP	O
Val	O
,	O
Leu	O
,	O
Ile	O
degradationup7	O
.	O
12	O
*	O
E	O
-	O
811ACADSB	O
,	O
ACAT1	O
,	O
ACAT2	O
,	O
ALDH1A1	O
,	O
AUH	O
,	O
BCKDHB	O
,	O
GCDH	O
,	O
HMGCL	O
,	O
HMGCS1	O
,	O
MCCC2	O
,	O
MCEE	O
LP	O
Fatty	O
acid	O
metabolismup3	O
.	O
23	O
*	O
E	O
-	O
38ACADSB	O
,	O
ACAT1	O
,	O
ACAT2	O
,	O
ALDH1A1	O
,	O
AUH	O
,	O
CYP51A1	O
,	O
GCDH	O
,	O
PECI	O
LP	O
Synthesis	O
and	O
degradation	O
of	O
ketone	O
bodiesup1	O
.	O
76	O
*	O
E	O
-	O
65ACAT1	O
,	O
ACAT2	O
,	O
BDH2	O
,	O
HMGCL	O
,	O
HMGCS1	O
LP	O
Biosynthesis	O
of	O
steroidsup3	O
.	O
27	O
*	O
E	O
-	O
45CYP24A1	O
,	O
FDPS	O
,	O
HMGCR	O
,	O
IDI1	O
,	O
SC5DL	O
LP	O
Glucocorticoid	O
receptor	O
signalingup3	O
.	O
57	O
*	O
E	O
-	O
312CDKN1C	O
,	O
CXCL3	O
,	O
IL10	O
,	O
MAP3K1	O
,	O
NCOA2	O
,	O
NFKBIB	O
,	O
NR3C1	O
,	O
POLR2B	O
,	O
PRKACB	O
,	O
RRAS2	O
,	O
SLPI	O
,	O
SMARCA4	O
LP	O
G1	O
/	O
S	O
checkpoint	O
regulationdown2	O
.	O
22	O
*	O
E	O
-	O
24CCNE1	O
,	O
CDC25A	O
,	O
CDKN1A	O
,	O
E2F328	O
dpn	O
vs	O
.	O
188	O
dpn	O
AP	O
AMPK	O
signalingup1	O
.	O
50	O
*	O
E	O
-	O
310INSR	O
,	O
MAPK12	O
,	O
PPAT	O
,	O
PPM1A	O
,	O
PPP2CA	O
,	O
PPP2R3A	O
,	O
PRKAA2	O
,	O
SMARCA2	O
,	O
SRC	O
,	O
STK11	O
AP	O
Fatty	O
acid	O
metabolismup1	O
.	O
28	O
*	O
E	O
-	O
28ACADSB	O
,	O
ALDH1A1	O
,	O
CYP1B1	O
,	O
CYP2D6	O
,	O
CYP3A4	O
,	O
CYP4A11	O
,	O
CYP4B1	O
,	O
PECI	O
AP	O
Mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinasedown8	O
.	O
33	O
*	O
E	O
-	O
37ANAPC5	O
,	O
CDK1	O
,	O
PLK1	O
,	O
PLK2	O
,	O
PPP2R1B	O
,	O
SLK	O
,	O
WEE1	O
AP	O
VEGF	O
signalingdown7	O
.	O
3	O
*	O
E	O
-	O
39AKT3	O
,	O
BCL2	O
,	O
KDR	O
,	O
NOS3	O
,	O
PRKCB	O
,	O
RAC2	O
,	O
RRAS	O
,	O
VCL	O
,	O
VEGFC	O
LP	O
Val	O
,	O
Leu	O
,	O
Ile	O
degradationup1	O
.	O
07	O
*	O
E	O
-	O
27ACAA1	O
,	O
ACAT1	O
,	O
ALDH1B1	O
,	O
AUH	O
,	O
ECH1	O
,	O
IVD	O
,	O
IWS1	O
LP	O
Fatty	O
acid	O
elongation	O
in	O
mitochondriaup2	O
.	O
05	O
*	O
E	O
-	O
23ACAA1	O
,	O
AUH	O
,	O
ECH1	O
LP	O
mTOR	O
signalingup2	O
.	O
65	O
*	O
E	O
-	O
210AKT3	O
,	O
DDIT4	O
,	O
EIF4B	O
,	O
EIF4G3	O
,	O
PPP2R1B	O
,	O
PRKAB2	O
,	O
PRKAG1	O
,	O
PRKAG2	O
,	O
TSC1	O
,	O
VEGFA	O
LP	O
Actin	O
cytoskeleton	O
signalingdown7	O
.	O
99	O
*	O
E	O
-	O
524ACTB	O
,	O
ACTR2	O
,	O
ARPC4	O
,	O
ARPC1A	O
,	O
CD14	O
,	O
CFL1	O
,	O
F2R	O
,	O
FGD1	O
,	O
LBP	O
,	O
MAP2K1	O
,	O
MYH9	O
,	O
NCKAP1	O
,	O
PAK2	O
,	O
PIK3C3	O
,	O
PIK3C2A	O
,	O
PIK3R4	O
,	O
PIKFYVE	O
,	O
PPP1R12A	O
,	O
RDX	O
,	O
ROCK1	O
,	O
ROCK2	O
,	O
TMSB4X	O
,	O
TMSL3	O
,	O
WASF1	O
LP	O
RhoA	O
signalingdow5	O
.	O
05	O
*	O
E	O
-	O
3n12ACTB	O
,	O
ACTR2	O
,	O
ARHGAP1	O
,	O
ARPC4	O
,	O
ARPC1A	O
,	O
CFL1	O
,	O
PIKFYVE	O
,	O
PPP1R12A	O
,	O
RDX	O
,	O
ROCK1	O
,	O
ROCK2	O
,	O
WASF1	O
LP	O
Rac	O
signalingdown4	O
.	O
34	O
*	O
E	O
-	O
312ACTR2	O
,	O
ARPC4	O
,	O
ARPC1A	O
,	O
CFL1	O
,	O
MAP2K1	O
,	O
NCKAP1	O
,	O
PAK2	O
,	O
PIK3C3	O
,	O
PIK3C2A	O
,	O
PIK3R4	O
,	O
PIKFYVE	O
,	O
WASF1	O
LP	O
Complement	O
systemdown2	O
.	O
17	O
*	O
E	O
-	O
25C2	O
,	O
C7	O
,	O
C9	O
,	O
CFB	O
,	O
MBL2	O
The	O
comparison	O
between	O
the	O
dietary	O
gestational	O
protein	O
diets	O
(	O
LP	O
vs	O
.	O
AP	O
)	O
is	O
shown	O
in	O
dependence	O
of	O
the	O
regulatory	O
direction	O
(	O
up	O
or	O
down	O
).	O

Schizophrenia	O
is	O
a	O
multifactorial	B
disorder	O
with	O
strong	O
genetic	O
vulnerability	O
and	O
the	O
vulnerability	O
might	B
include	O
metabolic	O
aberrations	O
.	O

Furthermore	O
,	O
the	O
high	O
frequency	O
of	O
gastrointestinal	O
side	O
effects	B
experienced	O
by	O
people	O
with	O
type	O
2	O
diabetes	O
suggests	B
that	O
any	O
future	B
role	B
of	O
acarbose	O
,	O
even	B
if	B
subsequent	B
studies	I
confirm	B
safety	O
,	O
will	B
be	I
limited	B
.	O

The	O
results	O
of	O
imputed	O
analyses	O
were	O
compared	O
with	O
those	O
from	O
complete	O
-	O
case	O
analyses	O
,	O
and	O
further	O
sensitivity	O
analyses	O
were	O
also	O
conducted	O
for	O
the	O
primary	O
outcome	O
on	O
the	O
assumption	O
that	O
data	O
were	O
Missing	O
Not	O
At	O
Random	O
(	O
MNAR	O
).	O

Anaphylaxis	O
associated	B
with	O
folic	O
acid	O
:	O
domestic	O
case	O
review	O
Background	O
Synthetic	O
folic	O
acid	O
has	B
been	I
shown	I
to	O
cause	O
serious	O
,	O
potentially	B
life	O
-	O
threatening	O
IgE	O
mediated	O
anaphylaxis	O
[	O
1	O
-	O
3	O
].	O

Also	O
,	O
vitamin	O
D	O
supplements	O
were	O
used	O
by	O
almost	O
half	O
of	O
the	O
women	O
but	O
most	O
(	O
88	O
%)	O
used	O
multivitamins	O
containing	O
5	O
–	O
10	O
μg	O
of	O
vitamin	O
D3	O
.	O

Therefore	O
,	O
these	O
three	O
subjects	O
were	O
included	O
in	O
the	O
analysis	O
.	O

This	O
experiment	O
was	O
conducted	O
over	O
8	O
replicates	O
and	O
offspring	O
of	O
a	O
subset	O
of	O
4	O
sows	O
(	O
2	O
per	O
diet	O
per	O
replicate	O
)	O
with	O
a	O
minimum	O
of	O
11	O
live	O
born	O
piglets	O
(	O
median	O
litter	O
size	O
=	O
13	O
)	O
were	O
used	O
.	O

Furthermore	O
,	O
male	O
gender	O
was	O
significantly	O
associated	B
with	O
increased	O
cathelicidin	O
concentrations	O
.	O

Secondary	O
study	O
outcomes	O
included	O
a	O
range	O
of	O
infant	O
anthropometric	O
measures	O
,	O
neurodevelopment	O
,	O
general	O
health	O
,	O
and	O
infant	O
feeding	O
.	O

The	O
origins	O
of	O
many	O
childhood	O
and	O
adult	O
malignancies	O
are	O
believed	B
to	O
be	O
determined	O
during	O
a	O
finite	O
perinatal	O
window	O
.	O

However	B
,	O
thyroid	O
cancer	O
detected	O
during	O
pregnancy	O
may	B
cause	O
anxiety	O
about	O
the	O
optimal	O
timing	O
of	O
recommended	B
treatments	O
and	O
about	O
both	O
maternal	O
and	O
neonatal	O
morbidity	O
,	O
as	O
weel	O
as	O
pregnancy	O
following	O
a	O
diagnosis	O
of	O
thyroid	O
cancer	O
obviously	B
needs	B
both	O
maternal	O
and	O
foetal	O
management	O
.	O

Results	O
Analyses	O
of	O
the	O
hepatic	O
gene	O
expression	O
of	O
the	O
offspring	O
at	O
prenatal	O
(	O
94	O
dies	O
post	O
conceptionem	O
,	O
dpc	O
)	O
and	O
postnatal	O
stages	O
(	O
1	O
,	O
28	O
,	O
188	O
dies	O
post	O
natum	O
,	O
dpn	O
)	O
included	O
comparisons	O
between	O
dietary	O
groups	O
within	O
stages	O
as	O
well	O
as	O
comparisons	O
between	O
ontogenetic	O
stages	O
within	O
diets	O
to	O
separate	O
diet	O
-	O
specific	O
transcriptional	O
changes	O
and	O
maturation	O
processes	O
.	O

Arsenic	O
is	O
chemically	O
very	O
similar	O
to	O
zinc	O
and	O
can	O
replace	O
zinc	O
in	O
proteins	O
that	O
are	O
important	O
in	O
DNA	O
repair	O
.	O
41	O
“	O
Arsenic	O
goes	O
in	O
and	O
kicks	O
zinc	O
out	O
,	O
but	O
the	O
arsenic	O
doesn	O
’	O
t	O
replace	O
the	O
function	O
of	O
zinc	O
.	O

Indeed	O
,	O
resistance	O
to	O
the	O
development	O
of	O
obesity	O
has	O
at	B
least	I
partly	B
been	O
attributed	O
to	O
elevated	O
recruitment	O
of	O
brown	O
adipocytes	O
in	O
skeletal	O
muscle	O
or	O
WAT	O
(	O
Guerra	O
et	O
al	O
.,	O
1998	O
;	O
Almind	O
et	O
al	O
.,	O
2007	O
;	O
Veyrat	O
-	O
Durebex	O
et	O
al	O
.,	O
2009	O
;	O
Harms	O
and	O
Seale	O
,	O
2013	O
).	O

Re	O
-	O
establishment	O
of	O
new	O
epigenetic	O
marks	O
then	O
redirects	O
and	O
drives	O
development	O
of	O
the	O
zygote	O
through	O
embryogenesis	O
and	O
ultimately	O
into	O
a	O
mature	O
adult	O
.	O

Moreover	O
,	O
the	O
expression	O
of	O
the	O
catalytic	O
subunits	O
of	O
AMPK	O
,	O
PRKAA1	O
and	O
PRKAA2	O
was	O
found	O
to	O
be	O
decreased	O
in	O
LP	O
offspring	O
compared	O
to	O
AP	O
offspring	O
at	O
stage	O
188	O
dpn	O
,	O
which	O
may	B
contribute	O
to	O
an	O
imbalanced	O
cellular	O
metabolism	O
.	O

In	O
this	O
subgroup	O
analysis	O
,	O
after	O
adjusting	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
,	O
a	O
1	O
-	O
hour	O
increase	O
in	O
nightly	O
sleep	O
was	O
associated	B
with	O
a	O
15	O
%	O
reduction	O
in	O
GDM	O
risk	O
(	O
RR	O
=	O
0	O
.	O
85	O
;	O
95	O
%	O
CI	O
0	O
.	O
69	O
-	O
1	O
.	O
05	O
);	O
though	B
this	O
association	B
was	O
not	O
statistically	O
significant	O
.	O

The	O
respective	O
biological	O
effects	B
of	O
omega	O
-	O
3	O
fatty	O
acids	O
and	O
omega	O
-	O
6	O
fatty	O
acids	O
on	O
the	O
etiology	O
of	O
psychiatric	O
symptoms	O
could	B
very	O
well	I
differ	B
and	O
the	O
balance	O
between	O
the	O
intakes	O
of	O
these	O
fatty	O
acids	O
might	B
be	O
of	O
importance	B
.	O

All	O
reported	O
p	O
-	O
values	O
are	O
two	O
-	O
tailed	O
.	O

Calcium	O
binding	O
proteins	O
are	O
central	O
to	O
a	O
wide	B
range	I
of	O
cellular	O
functions	O
,	O
of	O
which	O
calcium	O
sequestration	O
and	O
buffering	O
are	O
particularly	O
important	B
for	O
neurons	O
.	O

Interestingly	B
,	O
recent	B
studies	I
have	O
documented	O
epigenetic	O
modifications	O
or	O
affectation	B
of	O
adrenocortical	O
growth	O
in	O
offspring	O
after	O
maternal	O
dietary	O
restriction	O
around	O
the	O
time	O
of	O
conception	O
(	O
Nicholas	O
et	O
al	O
.,	O
2013	O
;	O
Zhang	O
et	O
al	O
.,	O
2013	O
),	O
pointing	B
out	O
the	O
importance	B
of	O
the	O
periconceptional	O
window	O
in	O
the	O
metabolic	O
programming	O
.	O

The	O
mean	O
depression	O
scores	O
in	O
the	O
nulliparous	O
and	O
multiparous	O
women	O
were	O
8	O
.	O
58	O
±	O
3	O
.	O
53	O
and	O
8	O
.	O
48	O
±	O
4	O
.	O
29	O
,	O
respectively	O
with	O
no	O
significant	O
difference	O
(	O
p	O
=	O
0	O
.	O
86	O
).	O

Thus	B
,	O
animals	O
with	O
low	O
genetic	O
potential	O
for	O
QG	O
are	O
not	O
recommended	B
for	O
a	O
long	O
fattening	O
stage	O
,	O
which	O
would	B
result	O
in	O
low	O
feed	O
efficiency	O
.	O

In	O
response	O
,	O
the	O
Chinese	O
government	O
invested	O
US	O
$	O
100	O
million	O
in	O
2007	O
to	O
launch	O
the	O
collection	O
of	O
data	O
from	O
industrial	O
,	O
agricultural	O
,	O
and	O
residential	O
sources	O
at	O
sites	O
throughout	O
China	O
,	O
beginning	O
in	O
February	O
2008	O
.	O

(	O
Arrows	O
between	O
boxes	O
show	O
direction	O
of	O
the	O
comparison	O
;	O
small	O
arrows	O
indicate	O
up	O
and	O
down	O
regulation	O
,	O
respectively	O
).	O

Dietary	O
Reference	O
Intakes	O
for	O
macronutrients	O
Institute	O
of	O
Medicine	O
,	O
National	O
Academic	O
Press	O
,	O
Washington	O
:	O
2005	O
).	O

Nevertheless	B
,	O
there	O
was	O
a	O
higher	O
(	O
adequate	O
level	O
)	O
mean	O
serum	O
concentration	O
of	O
calcifediol	O
at	O
the	O
end	O
of	O
first	O
supplementation	O
period	O
in	O
the	O
intervention	O
group	O
compared	O
with	O
the	O
lower	O
(	O
not	O
adequate	O
)	O
mean	O
concentrations	O
in	O
the	O
placebo	O
group	O
(	O
data	O
not	O
shown	O
).	O

[	O
21	O
]	O
reported	O
differences	B
in	O
outcomes	O
associated	B
with	O
oily	O
fish	O
intake	O
and	O
total	O
fish	O
intake	O
in	O
early	O
compared	O
to	O
late	O
pregnancy	O
.	O

For	O
example	O
,	O
we	O
have	B
shown	I
that	O
DVD	O
-	O
deficient	O
rats	O
have	O
enhanced	O
locomotion	O
in	O
response	O
to	O
the	O
psychomimetic	O
agents	O
such	O
as	O
NMDA	O
antagonist	O
MK	O
-	O
801	O
[	O
10	O
],[	O
12	O
].	O

The	O
potential	B
for	O
such	O
adaptations	O
is	O
already	B
acknowledged	B
at	O
the	O
OECD	O
,	O
but	B
more	O
applied	O
development	O
of	O
key	O
markers	O
and	O
subsequent	B
validation	B
work	O
is	I
needed	I
to	O
formally	O
incorporate	O
epigenetic	O
endpoints	O
into	O
TGs	O
.	O

Lifestyle	O
measures	O
can	B
provide	O
adequate	O
control	O
in	O
the	O
majority	O
of	O
cases	O
.	O

The	O
experiment	O
comprises	O
a	O
valuable	O
model	B
especially	O
for	O
'	O
fetal	O
'	O
programming	O
,	O
because	O
cross	O
-	O
fostering	O
enabled	O
assessment	O
of	O
solely	O
the	O
nutritional	O
effects	B
during	O
gestation	O
.	O

However	B
,	O
if	B
the	O
mother	O
is	O
already	O
allergic	O
or	O
if	B
there	O
is	O
a	O
family	O
history	O
of	O
atopy	O
or	O
allergy	O
,	O
food	O
comprising	O
potential	B
allergens	O
should	B
be	I
avoided	O
.	O

ADP	O
,	O
ON	O
,	O
LM	O
,	O
and	O
MG	O
contributed	O
to	O
the	O
study	O
conceptualization	O
and	O
design	O
,	O
acquisition	O
of	O
data	O
,	O
analysis	O
and	O
interpretation	O
of	O
data	O
and	O
writing	O
of	O
article	O
.	O

In	O
view	B
of	O
the	O
foregoing	O
,	O
a	O
review	O
of	O
effectiveness	O
of	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
was	O
conducted	O
;	O
furthermore	O
,	O
constraints	B
were	O
highlighted	B
and	O
suggestions	B
for	O
improvement	O
were	O
provided	O
.	O

Without	O
sufficient	O
Vitamin	O
D	O
,	O
bones	O
can	O
become	O
thin	O
and	O
brittle	O
.	O

Furthermore	O
,	O
during	O
pregnancy	O
,	O
nasal	O
congestion	O
can	B
worsen	O
,	O
although	B
the	O
exact	O
mechanism	O
for	O
this	O
is	O
not	B
defined	I
.	O

of	O
regulated	O
genesGenes	O
involved	O
in	O
pathway94	O
dpcWnt	O
signalingup1	O
.	O
20	O
*	O
E	O
-	O
29ACVR1	O
,	O
CSNK1G3	O
,	O
FZD4	O
,	O
FZD6	O
,	O
MAP3K7	O
,	O
MMP7	O
,	O
TCF4	O
,	O
TCF7L2	O
,	O
WNT5AMitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinasedown5	O
.	O
15	O
*	O
E	O
-	O
811CCNB1	O
,	O
CCNB2	O
,	O
CDC23	O
,	O
CDC25B	O
,	O
CDK1	O
,	O
FZR1	O
,	O
SP90AA1	O
,	O
KIF11	O
,	O
PLK1	O
,	O
PPP2R1B	O
,	O
PTTG1G1	O
/	O
S	O
checkpoint	O
regulationdown2	O
.	O
76	O
*	O
E	O
-	O
58CCND2	O
,	O
CCND3	O
,	O
CCNE1	O
,	O
CDK4	O
,	O
E2F1	O
,	O
E2F4	O
,	O
RB1	O
,	O
TFDP1G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulationdown1	O
.	O
53	O
*	O
E	O
-	O
35CCNB1	O
,	O
CCNB2	O
,	O
CDC25B	O
,	O
CDK1	O
,	O
PLK11	O
dpn	O
-----	O
28	O
dpnComplement	O
systemup2	O
.	O
07	O
*	O
E	O
-	O
55C4B	O
,	O
C5	O
,	O
C6	O
,	O
C9	O
,	O
CD55G1	O
/	O
S	O
checkpoint	O
regulationdown2	O
.	O
49	O
*	O
E	O
-	O
23CDKN1B	O
,	O
HDAC11	O
,	O
TGFB3188	O
dpnVEGF	O
signalingup2	O
.	O
80	O
*	O
E	O
-	O
412ACTA2	O
,	O
AKT3	O
,	O
BCL2	O
,	O
EIF2B1	O
,	O
KDR	O
,	O
MAPK1	O
,	O
MRAS	O
,	O
PIK3R3	O
,	O
PRKCB	O
,	O
RRAS2	O
,	O
VCL	O
,	O
VEGFCmTOR	O
signalingup6	O
.	O
29	O
*	O
E	O
-	O
313AKT3	O
,	O
EIF3B	O
,	O
EIF4B	O
,	O
MAPK1	O
,	O
MRAS	O
,	O
PIK3R3	O
,	O
PPP2CB	O
,	O
PRKAB2	O
,	O
PRKCB	O
,	O
RHOJ	O
,	O
RRAS2	O
,	O
TSC1	O
,	O
VEGFCSynthesis	O
and	O
degradation	O
of	O
ketone	O
bodiesup1	O
.	O
18	O
*	O
E	O
-	O
34ACAA1	O
,	O
BDH1	O
,	O
HADHA	O
,	O
HADHBBile	O
acid	O
synthesisup3	O
.	O
33	O
*	O
E	O
-	O
37ACAA1	O
,	O
ADH5	O
,	O
ADHFE1	O
,	O
ALDH7A1	O
,	O
HADHA	O
,	O
HADHB	O
,	O
LIPAFatty	O
acid	O
elongation	O
in	O
mitochondriaup4	O
.	O
81	O
*	O
E	O
-	O
34ACAA1	O
,	O
AUH	O
,	O
HADHA	O
,	O
HADHBGlucocorticoid	O
receptor	O
signalingup3	O
.	O
99	O
*	O
E	O
-	O
217AKT3	O
,	O
BCL2	O
,	O
CCL2	O
,	O
GTF2A2	O
,	O
GTF2B	O
,	O
GTF2E2	O
,	O
HSP90AB1	O
,	O
HSPA1B	O
,	O
IL1RN	O
,	O
MAPK1	O
,	O
MRAS	O
,	O
NCOR1	O
,	O
PBX1	O
,	O
PIK3R3	O
,	O
RRAS2	O
,	O
TAF4	O
,	O
VCAM1Val	O
,	O
Leu	O
,	O
Ile	O
degradationup8	O
.	O
32	O
*	O
E	O
-	O
38ACAA1	O
,	O
ACAD10	O
,	O
ALDH7A1	O
,	O
AUH	O
,	O
BCKDHB	O
,	O
HADHA	O
,	O
HADHB	O
,	O
HIBADHBiosynthesis	O
of	O
steroidsdown7	O
.	O
65	O
*	O
E	O
-	O
35CYP24A1	O
,	O
CYP7B1	O
,	O
DHCR7	O
,	O
FDFT1	O
,	O
MVD	O
The	O
comparison	O
between	O
the	O
dietary	O
gestational	O
protein	O
diets	O
(	O
LP	O
vs	O
.	O
AP	O
)	O
is	O
shown	O
in	O
dependence	O
of	O
the	O
regulatory	O
direction	O
(	O
up	O
or	O
down	O
).	O

Statistical	O
analyses	O
We	O
compared	O
the	O
distributions	O
of	O
child	O
and	O
maternal	O
variables	O
across	O
maternal	O
free	O
sugar	O
intake	O
quintiles	O
using	O
F	O
-	O
statistics	O
for	O
differences	O
in	O
continuous	O
variables	O
and	O
Chi	O
-	O
squared	O
tests	O
for	O
differences	O
in	O
categorical	O
variables	O
.	O

Snoring	O
that	O
is	O
infrequent	O
or	O
non	O
-	O
habitual	O
has	O
not	O
been	O
shown	O
to	O
be	O
a	O
useful	O
screen	O
for	O
sleep	O
disordered	O
breathing	O
in	O
large	O
epidemiologic	O
studies	O
[	O
41	O
,	O
42	O
].	O

The	O
eight	O
eligible	O
studies	O
were	O
graded	O
as	O
negative	O
,	O
neutral	O
or	O
positive	O
overall	O
based	O
on	O
NHMRC	O
guidelines	O
for	O
scientific	O
literature	O
reviews	O
[	O
16	O
].	O

Thus	O
,	O
genes	O
and	O
pathways	O
identified	O
as	O
regulated	O
in	O
one	O
offspring	O
group	O
were	O
either	O
unregulated	O
or	O
showed	O
an	O
opposite	O
direction	O
of	O
regulation	O
in	O
the	O
corresponding	O
ontogenetic	O
period	O
within	O
the	O
other	O
dietary	O
group	O
.	O

To	O
ensure	O
the	O
absence	O
of	O
a	O
DNA	O
contamination	O
within	O
the	O
isolated	O
RNA	O
a	O
PCR	O
amplification	O
with	O
the	O
porcine	O
glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
(	O
GAPDH	O
)	O
gene	O
was	O
done	O
(	O
Forward	O
primer	O
:	O
aagcagggatgatgttctgg	O
;	O
Reverse	O
primer	O
:	O
atgcctcctgtaccaccaac	O
).	O

suggested	B
that	O
more	O
accurate	O
clinical	O
trials	O
are	O
required	B
to	O
reach	O
a	O
conclusion	B
about	O
the	O
effectiveness	O
of	O
vitamin	O
D	O
on	O
depression	O
[	O
31	O
].	O

Nutritional	O
intervention	O
is	O
important	B
for	O
the	O
control	O
of	O
GDM	O
,	O
as	O
it	O
provides	O
benefits	O
to	O
mother	O
and	O
fetal	O
health	O
.	O

RNA	O
isolation	O
and	O
real	O
-	O
time	O
quantitative	O
PCR	O
analysis	O
We	O
performed	O
real	O
-	O
time	O
qPCR	O
(	O
TaqMan	O
,	O
Life	O
Technologies	O
)	O
as	O
described	O
previously	O
(	O
Decara	O
et	O
al	O
.,	O
2012	O
).	O

Measurement	O
of	O
infant	O
skinfold	O
thickness	O
[	O
36	O
,	O
37	O
]	O
and	O
bio	O
-	O
impedance	O
are	B
considered	B
reliable	I
and	O
relatively	O
non	O
-	O
invasive	O
methods	O
of	O
assessing	O
fat	O
distribution	O
,	O
both	O
of	O
which	O
have	B
been	I
correlated	B
with	O
more	O
invasive	O
measures	O
[	O
36	O
,	O
38	O
–	O
40	O
].	O

Biochemical	O
analyses	O
Haemoglobin	O
is	O
determined	O
on	O
site	O
in	O
whole	O
blood	O
(	O
20	O
μL	O
)	O
using	O
HemoCue	O
(	O
Hb	O
201	O
+,	O
Ängelholm	O
,	O
Sweden	O
).	O

However	B
,	O
only	B
four	O
out	O
of	O
nineteen	O
participants	O
with	O
supplement	O
use	O
who	O
was	O
also	O
positive	O
for	O
Vitamin	O
D2	O
received	O
Vitamin	O
D2	O
-	O
containing	O
supplements	O
.	O

Both	O
serum	O
25	O
(	O
OH	O
)	O
D3and	O
25	O
(	O
OH	O
)	O
D2were	O
measured	O
independently	O
and	O
combined	O
to	O
provide	O
a	O
total	O
25	O
(	O
OH	O
)	O
D	O
in	O
nmol	O
/	O
L	O
[	O
27	O
].	O

There	O
are	O
other	B
more	O
time	O
and	O
financially	O
economical	O
ways	O
in	O
which	O
lifetime	O
,	O
multigenerational	O
and	O
/	O
or	O
transgenerational	O
toxicity	O
could	B
be	I
assessed	B
,	O
for	O
example	O
using	O
zebrafish	O
models	B
,	O
both	O
respecting	O
the	O
3Rs	O
and	O
satisfying	O
sufficient	O
statistical	O
power	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
6	O
Effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
the	O
lipid	O
flux	O
and	O
storage	O
regulators	O
Ppar	O
α	O
and	O
Ppar	O
γ	O
in	O
the	O
liver	O
(	O
A	O
)	O
and	O
perirenal	O
adipose	O
tissue	O
(	O
PAT	O
)	O
(	O
B	O
)	O
of	O
male	O
and	O
female	O
offspring	O
at	O
adulthood	O
.	O

The	O
resources	O
to	O
assist	O
with	O
this	O
include	O
the	O
Condensed	O
Food	O
Composition	O
Tables	O
for	O
South	O
Africa	O
[	O
43	O
]	O
and	O
the	O
South	O
African	O
Medical	O
Research	O
Council	O
(	O
SAMRC	O
)	O
Food	O
Quantities	O
Manual	O
[	O
44	O
].	O

The	O
involvement	O
of	O
a	O
dietician	O
and	O
diabetes	O
educator	O
experienced	O
in	O
the	O
care	O
of	O
women	O
with	O
GDM	O
will	B
facilitate	O
these	O
areas	O
of	O
management	O
.	O

Birth	O
and	O
neonatal	O
assessments	O
Maternal	O
data	O
collected	O
at	O
birth	O
(	O
phase	O
4	O
)	O
are	O
obtained	O
from	O
maternal	O
medical	O
files	O
and	O
include	O
hospital	O
admission	O
and	O
discharge	O
dates	O
and	O
times	O
,	O
mode	O
of	O
delivery	O
,	O
induction	O
/	O
augmentation	O
of	O
delivery	O
,	O
type	O
of	O
anaesthetic	O
or	O
pain	O
relief	O
if	O
any	O
,	O
rapid	O
plasma	O
reagin	O
(	O
RPR	O
)	O
status	O
(	O
indicative	O
of	O
syphilis	O
infection	O
),	O
HIV	O
status	O
,	O
rhesus	O
negative	O
status	O
and	O
presence	O
of	O
maternal	O
diabetes	O
mellitus	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Herb	O
users	O
were	O
more	O
likely	B
to	O
make	O
a	O
dietary	O
change	O
during	O
pregnancy	O
.	O

Another	O
finding	B
of	O
this	B
study	I
was	O
that	O
vitamin	O
D3supplementation	O
was	O
effective	B
in	O
decreasing	O
depression	O
level	O
in	O
both	O
nulliparous	O
and	O
multiparous	O
subgroups	O
.	O

We	O
will	O
train	O
the	O
evaluation	O
team	O
over	O
a	O
four	O
-	O
week	O
period	O
,	O
and	O
standardize	O
measurement	O
methods	O
and	O
retrain	O
as	O
needed	O
every	O
six	O
months	O
.	O

Scope	O
of	O
the	O
Integrated	O
Child	O
Development	O
Scheme	O
in	O
Ensuring	O
Holistic	O
Development	O
of	O
the	O
Child	O
Dear	O
Editor	O
-	O
In	O
-	O
Chief	O
The	O
Government	O
of	O
India	O
launched	O
Integrated	O
Child	O
Development	O
Services	O
Scheme	O
(	O
ICDS	O
)	O
in	O
the	O
year	O
1975	O
to	O
prevent	O
malnutrition	O
in	O
children	O
,	O
reduce	O
infant	O
mortality	O
rate	O
,	O
and	O
empower	O
the	O
mothers	O
to	O
ensure	O
holistic	O
development	O
of	O
the	O
child	O
(	O
1	O
).	O

This	O
increment	O
may	B
be	I
brought	O
about	O
largely	B
by	O
thyroid	O
stimulation	O
induced	O
by	O
human	O
chorionic	O
gonadotropin	O
(	O
HCG	O
)	O
through	O
its	O
structural	O
affinity	O
with	O
thyrotropin	O
(	O
TSH	O
).	O

There	O
is	O
variation	O
in	O
haemoglobin	O
levels	O
during	O
pregnancy	O
;	O
at	O
the	O
beginning	O
of	O
a	O
pregnancy	O
,	O
there	O
is	O
a	O
normal	O
reduction	O
in	O
haemoglobin	O
level	O
followed	O
by	O
a	O
slight	O
rise	O
towards	O
the	O
end	O
of	O
pregnancy	O
[	O
2	O
].	O

Possible	O
responses	O
included	O
Yes	O
,	O
Sometimes	O
,	O
or	O
No	O
,	O
with	O
a	O
score	O
in	O
any	O
one	O
domain	O
>	O
2SD	O
below	O
the	O
mean	O
considered	O
indicative	O
of	O
the	O
need	O
for	O
further	O
assessment	O
and	O
when	O
identified	O
,	O
the	O
primary	O
caregiver	O
was	O
advised	O
to	O
seek	O
additional	O
medical	O
advice	O
.	O

Therefore	B
,	O
it	B
is	I
possible	I
that	O
vasopressinase	O
could	B
have	O
crossed	O
the	O
placenta	O
thereby	O
causing	O
infant	O
'	O
s	O
hypernatremia	O
and	O
subsequently	O
could	B
have	O
benefited	O
from	O
dDAVP	O
.	O

The	O
effects	B
are	O
also	O
seen	O
in	O
children	O
,	O
with	O
27	O
%	O
of	O
under	O
-	O
fives	O
being	O
stunted	O
[	O
22	O
].	O

Years	O
of	O
life	O
saved	O
will	O
be	O
based	O
on	O
any	O
difference	O
in	O
survival	O
of	O
mothers	O
and	O
infants	O
observed	O
during	O
the	O
trial	O
and	O
estimated	O
using	O
current	O
life	O
expectancy	O
in	O
Bangladesh	O
.	O

WAT	O
has	O
endocrine	O
activity	O
,	O
secreting	O
several	O
factors	O
and	O
hormones	O
,	O
such	O
as	O
leptin	O
and	O
adiponectin	O
.	O

Participants	O
are	O
asked	O
according	O
to	O
the	O
~	O
140	O
food	O
items	O
listed	O
in	O
the	O
QFFQ	O
,	O
the	O
type	O
/	O
brand	O
,	O
cooking	O
methods	O
,	O
frequency	O
and	O
the	O
amount	O
of	O
all	O
food	O
and	O
drink	O
consumed	O
in	O
the	O
past	O
4	O
weeks	O
.	O

The	O
timing	O
of	O
an	O
environmental	O
exposure	O
can	B
also	O
be	O
a	O
major	O
contributing	O
factor	B
to	O
the	O
significance	B
of	O
the	O
overall	O
outcome	O
.	O

Antibiotic	O
Resistance	O
Seen	O
in	O
Arctic	O
Wildfowl	O
Swedish	O
researchers	O
reported	O
in	O
the	O
January	O
2008	O
issue	O
of	O
Emerging	O
Infectious	O
Diseases	O
that	O
birds	O
living	O
in	O
three	O
different	O
geographic	O
regions	O
of	O
the	O
Arctic	O
tundra	O
carry	O
E	O
.	O
coli	O
bacteria	O
resistant	O
to	O
multiple	O
types	O
of	O
antibiotics	O
.	O

In	O
other	O
words	O
,	O
the	O
respective	O
growth	O
of	O
the	O
BAT	O
and	O
WAT	O
depots	O
depends	B
on	O
the	O
maternal	O
diet	O
during	O
gestation	O
and	O
it	O
may	B
be	I
responsible	O
for	O
the	O
development	O
of	O
obesity	O
,	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
in	O
the	O
offspring	O
,	O
later	O
in	O
life	O
(	O
Symonds	O
et	O
al	O
.,	O
2012	O
).	O

Statistical	O
analysis	O
Concentrations	O
of	O
25OHD	O
at	O
T1	O
and	O
T3	O
were	O
used	O
as	O
categorical	O
variables	O
,	O
grouped	O
into	O
25OHD	O
<	O
30	O
(	O
used	O
as	O
reference	O
category	O
),	O
30	O
–	O
49	O
.	O
9	O
,	O
50	O
–	O
74	O
.	O
9	O
,	O
75	O
–	O
99	O
.	O
9	O
and	O
≥	O
100	O
nmol	O
/	O
L	O
.	O

CC	O
females	O
exhibited	O
an	O
increased	O
caloric	O
intake	O
than	O
CC	O
males	O
from	O
the	O
13th	O
postnatal	O
week	O
(	O
adulthood	O
)	O
onward	O
,	O
meanwhile	O
RC	O
females	O
showed	O
a	O
higher	O
caloric	O
intake	O
than	O
RC	O
males	O
from	O
the	O
7th	O
postnatal	O
week	O
(	O
adolescence	O
)	O
to	O
adulthood	O
(	O
Figure2D	O
).	O

AM251	O
(	O
Tocris	O
,	O
Bioscence	O
,	O
Bristol	O
,	O
UK	O
)	O
was	O
dissolved	O
in	O
a	O
vehicle	O
containing	O
5	O
%	O
Tween	O
80	O
and	O
95	O
%	O
saline	O
.	O

For	O
continuous	O
outcomes	O
,	O
differences	O
in	O
means	O
with	O
95	O
%	O
CI	O
were	O
estimated	O
using	O
linear	O
regression	O
.	O

There	O
are	O
no	O
indications	O
for	O
termination	O
of	O
pregnancy4	O
.	O

[	O
40	O
]	O
shows	B
that	O
assisted	O
reproductive	O
therapy	O
and	O
a	O
history	O
of	O
infertility	O
do	O
not	I
increase	O
the	O
risk	O
for	O
autism	O
spectrum	O
disorders	O
.	O

Birth	O
weight	O
,	O
gestational	O
age	O
,	O
and	O
preterm	O
birth	O
may	B
correlate	B
with	O
autism	O
and	O
intellectual	O
disabilities	O
.	O

Therefore	B
,	O
during	O
pregnancy	O
,	O
thyroxin	O
and	O
ferrous	O
sulphate	O
doses	O
should	B
be	I
spaced	O
by	O
at	B
least	I
4	O
hours	O
.	O

It	O
should	O
be	O
added	O
that	O
the	O
understanding	O
of	O
the	O
role	B
of	O
IL	O
-	O
6	O
is	O
more	O
complex	B
,	O
as	B
this	O
cytokine	O
is	O
known	O
to	O
be	O
secreted	O
by	O
skeletal	O
muscle	O
in	O
response	O
to	O
exercise	O
,	O
exerting	O
insulin	O
sensitizing	O
effects	B
(	O
Kelly	O
et	O
al	O
.,	O
2004	O
;	O
Petersen	O
and	O
Pedersen	O
,	O
2005	O
).	O

Although	B
maternal	O
obesity	O
and	O
excessive	O
GWG	O
are	O
both	O
the	O
result	O
of	O
energy	O
intake	O
exceeding	O
energy	O
expenditure	O
,	O
few	B
studies	I
have	O
examined	O
the	O
specific	O
influences	B
of	O
maternal	O
dietary	O
and	O
exercise	O
behaviors	O
during	O
pregnancy	O
on	O
offspring	O
obesity	O
risk	O
.	O

A	O
control	O
group	O
of	O
offspring	O
from	O
dams	O
fed	O
the	O
RV	O
diet	O
was	O
weaned	O
to	O
the	O
RV	O
pup	O
diet	O
for	O
29	O
weeks	O
.	O

